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Abstract 
 Autophagy is catabolic process which sequesters large portions of cytoplasm as well as 
selected organelles and proteins for degradation. Recently, autophagy has been a topic of much 
debate owing to conflicting evidence regarding its role in cell death signaling. Interestingly, both 
apoptotic signaling and altered autophagy have been observed in states associated with muscular 
atrophy and dysfunction. However, the cross-talk between these two cell death-related processes 
is not well understood in skeletal muscle. Interestingly, myogenesis and the ability of muscle to 
regenerate, requires myoblast differentiation, a process which requires highly regulated cell 
death signaling. The interplay between autophagy and apoptosis and the integrated role between 
these two supposed cell death systems during myoblast differentiation is unknown. The purpose 
of this thesis was to examine the relationship between autophagy and apoptotic signaling during 
myoblast differentiation as well as during myotube apoptotic stress and recovery. Chapter II 
reveals that autophagy is induced during myoblast differentiation, but more importantly, is 
required for muscle cell differentiation and protection against cell death. Chapter III determined 
that the induction of autophagy is required for the regulation of apoptosis during muscle cell 
differentiation through the prevention of mitochondrial-mediated apoptotic signaling. Chapter IV 
established that autophagy is required for the protection and recovery of muscle cell viability and 
mitochondrial function during moderate levels of apoptotic stress. Together this thesis supports 
autophagy as a regulator of apoptotic processes in skeletal muscle. Furthermore, this thesis 
highlights a role for autophagy in skeletal muscle differentiation and recovery from apoptotic 
stress.   
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Introduction 
 Apoptosis and autophagy are two catabolic phenomena essential for skeletal muscle 
development and maintenance
1-3
. However, apoptotic signaling can also result in the cleavage of 
a number of cytoskeletal structures and the destruction of organelles which collectively impair 
muscle function and induce deleterious remodeling
4-7
. Similarly, autophagy is a degradative 
process which sequesters damaged or long lived proteins/organelles within a double membrane 
bound vesicle and delivers the sequestered cargo to the lysosome for degradation
8,9
. This process 
can contribute to muscle atrophy
8,9
. Both apoptosis and autophagy have been classified as cell 
death types I and II, respectively, due to their involvement and association with the destruction 
and removal of stressed or dying cells
10,11
. Despite major differences in the appearance of these 
two supposedly independent forms of cell death, recent evidence supports a remarkable level of 
cross-talk between the two systems
12
. Furthermore, their roles as independent processes have 
been documented in both beneficial as well as deleterious capacities
2,6,13,14
. Little is known 
regarding the integration of autophagy and apoptosis in developing and/or mature skeletal 
muscle, and whether they both contribute to the same end goal of cell death, or if they are both 
activated during similar conditions but with opposing commitments. The purpose of this 
literature review is to first discuss the regulation of skeletal muscle developmental and 
regenerative processes and how they are influenced by cell stress and apoptotic signaling. 
Second, it will outline the machinery and regulation of apoptosis and autophagy with a special 
emphasis on skeletal muscle where possible. Finally, this review will discuss the controversy 
regarding the role of autophagy in cell death processes and skeletal muscle biology/physiology.   
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Skeletal Muscle Differentiation and Myotube Formation Requires Cell Stress and 
Apoptotic Signaling  
  The determination of embryonic progenitor cells and satellite cells into a committed 
myogenic cell type, and the fusion of these myoblasts to produce mature myotubes requires the 
hierarchical induction and transcriptional activity of a specific set of basic helix loop helix 
(bHLH) transcription factors collectively known as myogenic regulatory factors (MRFs)
15
. The 
expression of myogenic determination protein (MYOD) and myogenic factor-5 (MYF-5), two 
bHLH transcription factors, results in the formation of a committed myogenic cell known as the 
myoblast
16
. In the absence of MYOD skeletal muscle develops with minimal abnormalities; 
however, a prolonged and 4-fold compensatory increase in MYF-5 expression drives the 
formation of myoblasts and the production of mature skeletal muscle
17
. In contrast, MYF-5
-/-
 
mice die at birth due to breathing difficulties and rib defects, yet skeletal muscle is formed and 
MYOD expression is not impaired
18
. However, MYOD
-/-
:MYF-5
-/-
 double knockout mice are 
immobile and die soon after birth with no detectable levels of muscle specific gene expression or 
myoblasts
19
. These results highlight a partial redundancy between these primary MRFs and 
during embryonic development but also demonstrate that their expression is essential for the 
determination of skeletal myoblast. Satellite cells are non-committed myogenic precursor cells 
which have a remarkable ability to promote regeneration of damaged skeletal muscle by re-
entering the cell cycle, committing to a skeletal myocyte lineage, differentiating, and fusing with 
the damaged fiber or producing a new myotube
16
. Following a similar genetic program as found 
in myogenesis, satellite cells begin to express primary MRFs following muscle injury. 
Interestingly, MYOD
-/-
 mice have a reduced capacity to regenerate skeletal muscle in a number 
of injury models and have a lack of differentiated myoblasts
20
. Furthermore, in adult skeletal 
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muscle following injury there is an increased number of undifferentiated satellite cells in MYOD 
null mice
20
. Collectively, these data suggests that primary MRFs such as MYOD and MYF-5 are 
essential for the determination and production of myoblast cells prior to the formation of 
myotubes during development and in mature skeletal muscle.      
 MRFs contain a conserved DNA binding domain that binds to E-Box motif and promotes 
transcription of several myogenic specific genes required for the formation of mature skeletal 
myotubes
21
. For example, the expression of secondary MRFs such as myogenin and MRF4 are 
impaired in MYOD:MYF-5 double knockout mice supporting the hierarchical expression of 
MRFs during myogenesis and myoblast differentiation
17-19
. Similarly, ablation of myogenin 
results in embryos with an increase in myoblast content, normal levels of MYOD and MYF-5, 
but a total lack of myofibers and death at birth
22
. Both myogenin as well as MRF4 are 
responsible for the activation of the terminal differentiation program, myoblast fusion, and 
expression of muscle specific proteins such as creatine kinase and myosin heavy chain
21,22
. 
Myogenin levels transiently increase as muscle cells become terminally differentiated and as 
myogenin expression attenuates, there is an increase in MRF4 protein for several days to ensure 
terminal differentiation
21,23-25
. In addition to myogenin and MRF4, primary MRFs such as 
MYOD promote the expression of myogenic enhancing factors (MEFs) which are transcription 
factors that also play vital roles in controlling muscle-specific proteins
16,21
. Furthermore, MEF-2 
sites are found within the promoter regions of muscle specific genes such as myogenin 
suggesting an amplification loop to ensure proper and terminal differentiation of myoblasts
26
. 
 Myoblast differentiation is associated with a number of stress-related events which are 
typically associated with cell death. First, significant remodeling and reprograming of organelles 
and organelle networks not only occurs with myoblast differentiation, but is essential for the 
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development of healthy myotube formation. For example, myoblasts contain endoplasmic 
reticulum (ER) which undergos a transition to sarcoplasmic reticulum during myotube 
formation
27
. ER remodeling can result in promotion of ER-stress signaling, toxic levels of 
cytosolic calcium, and the prolonged activation of MAPKs resulting in increased apoptotic 
protease activity
28
. However, myoblast fusion requires the induction of ER-stress and cells which 
fuse to form myotubes following regulated ER-stress pathways are less sensitive to apoptosis as 
a mature muscle
29,30
. In addition, increased mitochondrial reactive oxygen species (ROS) 
generation and mitochondrial fission occur during early stages of myoblast differentiation
31,32
. 
These events are commonly associated with increases in apoptotic signaling and cell death
33
. 
However, inhibition of mitochondrial ROS or fission during myoblast differentiation impairs 
myotube formation and terminal differentiation. This suggests that these potentially apoptotic 
precursors are required for myoblast differentiation and survival
32,34
. Furthermore, remodeling of 
the cell membrane is essential for the fusion of myoblasts and the formation of a syncytial cell 
type. A process integral to this hallmark morphological transition from a myoblast to a myotube 
is the exposures of phosphatidylserine (PL) residues
35
. Typically PL exposure occurs with 
apoptotic cell death and signals the removal of apoptotic bodies via macrophages
36
. However, in 
muscle differentiation PL exposure is required in the development of the tissue and not its 
destruction
35,36
.  
 In addition to significant remodeling, myogenic differentiation requires the activation of a 
number of signaling pathways to enhance the activity of MRFs. Interestingly, many of these 
pathways are best characterized as responses to, or factors contributing to, cell 
stress/death
2,30,31,34,37
. For example, the activation of the MAPK family protein p38 is associated 
with cell stress and can promote the induction of cell death
37,38
. However, activation of p38 is 
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required for myoblast differentiation as it enhances the transcriptional activity of both MYOD 
and MEF2a/c
37,39
. Furthermore, the activation of apoptotic signaling pathways is required for the 
promotion of myoblast differentiation
2,29
. The induction of CASP3 classically results in cell 
death. However, tightly regulated induction of CASP3 is required for myoblast differentiation 
and myoblast fusion through cleavage mediated activation of mammalian sterile twenty-like 
kinase (MST); a factor which enhances the activity of MRFs
2
. How CASP3 is regulated during 
myoblast differentiation is not well understood. However, research suggests that the induction of 
ER-stress induced caspase-12 is involved in CASP3activation during differentiation, further 
supporting the promotion of a required “cell death” signaling during myoblast differentiation.   
 A number of alterations occur throughout the determination as well as the differentiation 
process to protect against cell death. For example, the expression of MRFs and the promotion of 
myogenesis in both embryonic development and during muscle regeneration required the 
expression of paired box (PAX) transcription factors such as, PAX3 and PAX7 respectively
16,21
. 
The expression of PAX3 during embryogenesis mitigates the number of apoptotic cells within 
the somite and neural tube but also increases the expression of both MYOD and anti-apoptotic 
BCL2 proteins in myogenic precursor cells
40,41
. Furthermore, anti-apoptotic protein X-linked 
inhibitor of apoptosis (XIAP) is attenuated during differentiation whereas apoptosis repressor 
with caspase recruitment domain (ARC) is upregulated upon differentiation
42
. Upon myoblast 
differentiation, autocrine upregulation of IGF-II requires  MTOR-mediated transcriptional events 
and results in an increase of protein kinase B (AKT)1/2 activity
43,44
. AKT activity promotes 
myoblast differentiation through the negative regulation of FoxO transcription factors as well as 
promotion of MRF activity
45,46
. Furthermore, the activation of AKT also enhances the resistance 
to cell death and prevents anoikis during myoblast differentiation through the post-translational 
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regulation of BCL2 proteins such as Bad
47,48
. In addition, myoblast differentiation requires the 
transition from a predominantly glycolytic cell type to a myotube generating ATP predominantly 
through aerobic metabolism
49-51
. An important signaling factor in this transition is AMP-
activated protein kinase (AMPK)
52
. Accordingly, AMPK subunits are upregulated during 
differentiation and are suggested to promote the reprogramming of primary substrate 
utilization
53
. However, the increase in AMPK is also required to provide resistance to cell death 
induction in newly formed myotubes
53
. Similarly, the induction of c-Jun N-terminal kinase 
(JNK) in response to diverse types of cell stress can contribute to cell death
54-56
. However, the 
transient induction of JNK during myoblast differentiation has been shown to enable myoblast 
survival during differentiation
57
. Taken together, myoblast differentiation is a highly regulated 
process and requires potentially lethal signaling cascades to ensure hierarchical regulation of 
MRFs, in addition to significant organelle and structural remodeling. A thorough understanding 
on the regulation of cell death processes during myoblast differentiation may enhance our ability 
to promote muscle formation during embryogenesis as well as following myotrauma or apoptotic 
events. 
Apoptosis Machinery and Regulation  
 Apoptosis is classically defined by morphological changes to the cell including chromatin 
condensation, cell shrinkage, and membrane blebbing
36
. In these terms, mature skeletal muscle 
apoptosis is anything but classical. For example, apoptosis in skeletal muscle is commonly 
known as myonuclear apoptosis, a process which is proposed to result in the destruction of 
individual myonuclei along with the associated myonuclear domain
58
. As a result, the loss of the 
myonuclear domain attenuates fiber size while maintaining a consistent myonuclear number to 
cytoplasmic volume
58,60
.  Over the past decade evidence has challenged this concept suggesting 
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that “apoptosis” in skeletal muscle does not occur61,62. Although the morphological hallmarks of 
apoptosis may differ in skeletal muscle, apoptotic signaling does occur within the myofiber
59
. 
With over 400 cellular substrates, caspases, such as CASP3, are the primary proteolytic enzyme 
involved in apoptotic signaling
4
. Caspases can cleave architectural proteins and induce cellular 
remodeling, cleave enzymes and proteins within the nucleus to inhibit DNA repair processes, as 
well as alter membrane proteins and contractile proteins in order to induce membrane blebbing 
and targeting for infiltrating immune cells
36,63
. Considering the lethality of active caspases, the 
induction of such cell death effector enzymes are tightly controlled by several highly conserved 
signaling cascades
36
. Moreover the activation of caspases in skeletal muscle has significant 
consequences related to muscle remodeling and function
6,59
.   
 The induction of apoptosis in skeletal muscle typically occurs through two primary 
pathways; the extrinsic death-receptor pathway as well as the intrinsic or mitochondrial mediated 
pathway
36,59
. Briefly, the death-receptor pathway is an extracellular signaling pathway initiated 
through the binding of cell death ligands to a transmembrane death receptor resulting in the 
formation of a death inducing signaling complex (DISCs) and the activation of apical CASP 
8/10
64
. Activation of CASP8/10 promotes the cleavage-mediated activation of death effector 
caspases such as CASP3
64
. In a number of cell types, cell death signaling from extrinsic 
pathways may not be sufficient to induce apoptosis and therefore CASP8 or 10 enzyme 
activation must truncate pro-apoptotic BCL2 proteins such as BID in order to promote the 
activation of intracellular death pathways mediated by the mitochondria
36,65
. Mitochondria are 
the central component of the intrinsic pathways of apoptosis and are especially important in 
skeletal muscle apoptotic signaling
66
. Mitochondria participate in apoptosis through the release 
of apoptotic proteins such as CYTO C, second derived activator of caspases (SMAC), apoptosis 
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inducing factor (AIF), and endonuclease G (Endo G)
67
. Within the mitochondria these factors do 
not participate in apoptotic signaling and require mitochondrial outer membrane 
permeabilization (MOMP) and remodeling of the inner mitochondrial membrane (IMM) prior to 
their release
67
. The induction of MOMP largely depends on presence and function of the BCL2 
family of proteins
68
. The BCL2 family is divided into two groups; the anti-apoptotic proteins 
such as BCL2 and BCLXL, and the pro-apoptotic proteins which include BAX and BAK as well 
as the BH-3 only proteins such as BAD, PUMA, BNIP3 and BID which activate BAX and 
BAK
68
. MOMP can result from BAX/BAK induced mitochondrial apoptosis channel (MAC) 
formation
68
. BAX activation by upstream BH-3 proteins promotes the translocation of BAX to 
the mitochondria. Here, BAX undergoes a conformational change required to support 
oligomerization with additional mitochondrial bound BAX molecules
69
. On the other hand, BAK 
is constitutively localized to the outer mitochondrial membrane (OMM) even though it is in an 
inactive form. Activation of BAK exposes a BH-3 domain and a BCL2 binding groove which 
promotes the formation of BAK dimers required for MOMP
70
. In cell free systems, BAX/BAK 
can permeate lipid membranes by forming both proteinaceous channels composed of multiple 
BAX/BAK oligomers or and/or lipidic pores free of BAX/BAK proteins
69,71
. In skeletal muscle 
the opening of the mitochondrial permeability transition pore (mPTP) has been extensively 
studied and implicated in cell death signaling
66
. The mPTP is active at a low conductance to 
maintain an appropriate membrane potential ∆Ψ in order to facilitate cytosolic Ca2+ buffering and 
the production of ATP
72
. The mPTP spans the OMM to the mitochondrial matrix and is 
composed of the voltage-dependent anion channel (VDAC), the adenine nucleotide translocase 
(ANT), and cyclophilin D (Cyp D)
73
. mPTP opening occurs due to: i) increased uptake via the 
mitochondrial Ca
2+
 uniporter, ii) high levels of ROS produced from the mitochondrial electron 
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transport chain and other cellular compartments and iii) stimulation of VDAC and/or ANT by 
BAX/BAK
66,74,75
. mPTP opening causes a massive influx of high molecular weight solutes 
directly into the matrix, leading to swelling of the IMM and to physical rupture of the OMM 
66,76
.  
 A number of factors can protect the cell from MOMP through interactions with pro-
apoptotic BCL2 proteins. First, upstream BH-3 proteins are required for the activation of 
BAX/BAK
68
. BH-3 proteins are activated via transcriptional upregulation following intracellular 
stress events such as ER-stress and DNA damage
68,77
. The activity of BH-3 proteins can also 
depend upon phosphorylation status mediated by PI3K/AKT activity and MAPKs
55,78-80
. 
Furthermore, proteolytic cleavage mediated by CASP8 can also activate BH-3 proteins
81
. The 
mechanisms which BCL2 proteins interact with each other in order to induce, or protect from 
MOMP is unclear. Although the activation of BAX/BAK by BH-3 proteins is an important step 
in potentiating apoptosis, an increase in BAX/BAK expression relative to the level of anti-
apoptotic BCL2 proteins can also promote apoptosis
68
. For example, hindlimb suspension causes 
a significant increase in BAX and a reduction in BCL2, which is associated with an increase in 
CYTO C release and DNA fragmentation
82
. The anti-apoptotic protein ARC can inhibit MOMP 
through direct inhibitory interactions with cytosolic BAX which blocks BAX translocation to the 
mitochondria
83
. Heat shock protein 70 (Hsp70) can also inhibit MOMP by inhibiting the c-Jun 
N-terminal kinase (JNK)-mediated phosphorylation of BID as well as inhibiting BAX activation, 
AIF nuclear translocation as well as directly impairing the activation of CASP3
84-88
. Together, 
anti-apoptotic BCL2 proteins, ARC, and Hsp70 can mitigate apoptosis by inhibiting the 
upstream events leading to MOMP. 
 The release of apoptotic factors from the mitochondria followed by the activation of 
caspases represents a biochemically defining moment in apoptosis and typically marks the point 
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of no-return in cell death
89
. Differential kinetics and temporal regulation of the release of 
apoptotic factors from the mitochondria suggest that different stimuli induce different pores 
which mediate the release of selective proteins. For example, the formation of BAX/BAK pores 
promotes the initial release of CYTO C and SMAC over the release of AIF and ENDOG 
90
. 
Interestingly, the release of CYTO C and SMAC occurs simultaneously suggesting the release 
from a common source
90
. The full release of CYTO C and SMAC promote the activation of 
CASP9 followed by CASP3 and ultimately apoptosis
36
. For the activation of caspase-
independent cell death, the release of AIF and ENDOG must occur
91,92
. The release of AIF can 
occur following BAX activation and induction of mPTP opening
91,93
. It is important to note that 
pro-apoptotic proteins such as AIF and CYO C while residing within the mitochondria during 
basal states are essential for normal mitochondrial function. Therefore, not only does the release 
of these apoptotic proteins induce cell death signaling, but it also impairs mitochondrial function 
and can induce secondary damage through increased ROS generation and metabolic stress
94
. 
 A significant stage in mitochondrial-mediated apoptosis occurs with the activation of the 
apoptosome and CASP9 activation
95,96
. The apoptosome is an assembly of apoptotic protease 
activating factor (APAF1), CYTO C, dATP/ATP, and proCASP9
96,97
. In the cytosol, CYTO C 
binds to APAF1, which is followed by the hydrolysis of dATP or ATP when available in high 
concentrations
96,97
. The hydrolysis of dATP or ATP extends the conformation of APAF1, which 
unblocks the caspase recruitment domain (CARD) and the recruitment of proCASP9 via its N-
terminal CARD domain
98,99
. The high concentration of proCASP9 at the apoptosome promotes 
proximity induced dimerization and activation of CASP9
98,99
. However, the release of smac is 
required to inhibit XIAP which constitutively suppresses caspase dimer formation through direct 
interactions with proCASP9 as well as CASP3
100
.  Additionally, Smac must also bind to and 
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remove XIAP from directly blocking the catalytic site on active and inactive CASP3/7
101
. 
Furthermore, heat shock protein 70 (HSP70) can also bind to AIF following the release from the 
mitochondria and inhibit its translocation to the nucleus where it can promote caspase-
independent DNA fragmentation and apoptosis
84
. Considering the major impact apoptosis has on 
cell physiology, viability, and ultimately tissue formation and function, a number of regulatory 
mechanisms have evolved to regulate apoptotic activity. However, apoptosis is only one form of 
cell death. Autophagy or “type II cell death” is a paradigm that has been proposed, and its 
regulation is also fundamental to the muscle cell viability and function.  
Autophagic Machinery and Regulation  
 Macroautophagy is a process in which a double membrane structure, known as the 
phagophore, is produced and begins to sequester a portion of the cytoplasm
8,9
. The phagophore 
elongates and engulfs the cytosolic constituents forming a double membrane structure known as 
the autophagosome which contains the autophagic cargo to be degraded
8,9
. The mature 
autophagosome binds with the lysosome then the inner membrane and autophagic cargo become 
degraded via lysosomal hydrolases and cathepsins
8,9
. The degraded cargo is then recycled back 
into the cytosol to be reused for metabolic and biogenesis purposes
8,9
. Although multiple forms 
of autophagy are documented, the focus of the proposed research will be on macroautophagy, 
herein referred to as autophagy. Evidence suggests that autophagy in skeletal muscle is peculiar 
when compared to other tissues. For example, skeletal muscle has a particularly high level of 
basal and starvation-induced autophagy compared to other tissues
102
. In addition, the induction of 
autophagy in skeletal muscle can be both rapid and enduring suggesting both rapid post-
translational and prolonged transcriptional regulation
102-104
. Furthermore, the induction of 
autophagy and the rate of autophagosome formation and flux differ significantly across muscle 
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types
105
. Importantly, the induction as well as inhibition of autophagy in skeletal muscle induces 
deleterious alteration to muscle function, viability, and size
1,13,104,106
. 
 The induction of autophagy requires the activity of a multi-protein complex composed of 
BECN1, VPS34, VPS15, and AMBRA1which will herein be referred to as the BECN1 complex. 
Assembly of the BECN1 complex promotes the activation of VPS34 and the production of 
phosphatidylinositole–3 phosphate (PI(3)P)8. The formation of PI(3)P results in the recruitment 
of lipid adaptor proteins, double FYVE-containing protein 1 (DFCP1) and WD repeat domain 
phosphoinositide-interacting protein (WIPI) required for the localization of downstream 
autophagic membrane proteins 
107,108
. PI(3)P production is critical for autophagosome formation 
in skeletal muscle. For example, the phosphoinositide 3-phosphatase, JUMPY, can reduce PI(3)P 
production and negatively regulate autophagy during nutrient starvation in C2C12 
myoblasts
109,110
. In addition, inhibition of autophagy can be accomplished by administration of 3 
methyladenine (3MA) to inhibit PI(3)P production
111,112
.  
 A number of proteins can regulate the production of PI(3)P production by interacting 
with the BECN1 complex. Interestingly, BECN1 was originally discovered as a member of the 
BCL2 family due to the possession of a BH-3 domain
113,114
. Therefore, it was hypothesized that 
anti-apoptotic proteins such as BCL2 and BCLXL may be able to regulate autophagy in response 
to various stress stimuli. When BCL2 is bound to BECN1, Vps34 activity is suppressed and 
autophagy is reduced
113
. The affinity of BCL2 and BCLXL for BECN1 is relatively low
115
. As 
such, competitive binding of BCL2/BCLXL by other BH-3 only proteins such as BAD, BIK, 
NOXA, PUMA, BIM-EL, and BNIP3 which have a greater affinity to the anti-apoptotic BCL2 
proteins, disrupts the interaction between BCL2 and BECN1
116,117
. For example, knockdown of 
Bad impairs starvation-induced autophagy and knockdown of BCL2 can result in an increase in 
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autophagy
116,118
. Together, these data suggest that the content of BCL2-related proteins may 
influence autophagy induction. Changes to autophagy in skeletal muscle are also associated with 
altered BECN1 and/or BCL2 family proteins
13,103,119-124
. For example, increases in autophagic 
markers are associated with a reduction in BCL2 protein content in the white gastrocnemius of 
the hypertensive rats (McMillan et al. 2014, unpublished data). Autophagy induction mediated 
through the BECN1 complex also involves post-translational modification of either BECN1 
and/or BCL2/BCLXL
125
. Phosphorylation of BCL2 by JNK1 during starvation and exercise is 
essential for autophagy induction
103,126
. In support of these findings, increased markers of 
autophagy induction are associated with an increase in BCL2 phosphorylation in skeletal muscle 
(McMillan et al. 2014, unpublished data). Dissociation of BCL2/BCLXL from the BECN1 
complex also occurs with direct modification to the BECN1 protein
125,127,128
. For example, the 
death associated protein kinase (DAPK) phosphorylates BECN1 resulting in its disassociation 
from BCLXL and/or BCL2
127,128
. Furthermore, toll like receptor – 4 (TLR-4) stimulation 
resulted in the recruitment of BECN1 to the tumor necrosis factor receptor (TNFR1) associated 
factor 6 (TRAF6) and subsequent ubiquitination. The ubiquitination of BECN1 ultimately 
increases Vsp34 kinase activity and autophagy
129,130
.  
 In addition to the BECN1 complex, the ULK1/2 kinase complex is also involved in the 
induction stages of autophagy
8,9
. Under basal states where nutrients are abundant, the ULK1/2 
complex, composed of ATG13, ATG10, and FIP200, is inhibited though interactions with 
TORC1 of the mTORC1 complex
131
. Under nutrient poor conditions low mTOR activity results 
in the disassociation of mTOR from the ULK1/2 complex and the autophosphorylation of 
ULK1/2 as well as ULK1/2-mediated phosphorylation of ATG13 and FIPP200 which stabilizes 
the protein complex and promotes autophagy
132,133
. Once the ULK1/2 complex has been 
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activated, ULK1-mediated phosphorylation of FIP200 promotes the localization of the complex 
to the site of autophagy induction
133,134
. However, the downstream targets of the mammalian 
ULK1/2 kinase complex have not been fully elucidated. One study has shown that the ULK1/2 
complex can phosphorylate AMBRA1 of the BECN1 complex to enhance autophagy 
induction
135
.  
 Once BECN1 and the ULK1/2 complexes have created products for the initial membrane, 
this pre-autophagosomal membrane is elongated by two ubiquitin-like conjugation systems; 
ATG12-ATG5 and LC3B-PE. First, the assembly of a protein complex composed primarily of 
ATG12-ATG5-ATG16 develops E3 ligase-like activity required for the lipidation of the 
autophagosome
136,137
. The first conjugation step in this reaction is the activation ATG12 via E1-
like enzyme ATG7
138
. This is followed by the conjugation of ATG12 to ATG5 through the E2-
like activity of ATG10
139
. The ATG12-ATG5 conjugate is then bound to ATG16
137
. This newly 
produced E3-like enzyme complex translocates to the developing autophagosomal membrane. 
There, it assists in the localization of the second conjugation system as well as localizing integral 
autophagosomal membrane proteins such as LC3B-II to both the inner and outer autophagosomal 
membrane
8,137,111,112
. The production of LC3B-II involves the second conjugation system which 
is required to bind LC3B-I to phosphatidylethanolamine (PE) producing LC3B-II. First, LC3B is 
cleaved by ATG4 producing LC3-I which can now bind to PE
140
. Following activation by the 
E3-like enzyme ATG7, LC3B-I is conjugated to PE by the E2-like activity of ATG3 producing a 
lipidated LC3BI also referred to as LC3B-II
141
. Alterations to the production of these ubiquitin-
like conjugation systems can dramatically affect skeletal muscle autophagy. For example, 
knockdown of ATG7 results in impaired autophagy and inhibition of LC3B-II production in both 
basal and challenged states
1
. Furthermore, knockdown of ATG5 results in attenuated 
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autophagosomes in a model of Pompe’s disease142. Moreover, a reduction in ATG12-ATG5 
conjugation is associated with reduced autophagy in exercised mice treated with doxorubicin
123
. 
Together, both conjugation systems permit the elongation and maturation of the double 
membrane autophagosome and the complete sequestration of targeted autophagic cargo.  
 Autophagy was originally thought of as a bulk degradation system, sequestering large 
portions of the cytosol in a non-specific manner. However, research shows that autophagy is far 
more sophisticated and specific. Autophagy adaptor proteins are responsible for selecting targets 
and either directing them to the autophagosome or tethering autophagic substrates to proteins of 
the autophagosomal membrane
143
. In this way, cargo may be delivered to the autophagosomal 
membrane. In addition, given the number of sources for phagophore development, it is also 
possible that the development of the membrane may be localized to the site of cargo recognition. 
Regardless, several post-translational modifications of organelle membrane proteins and 
aged/damaged proteins are important in selective autophagy
144-148
. For example, damaged 
proteins and organelles can be targeted for ubiquitination. This post translational modification 
allows the substrate to be located and bound by an autophagy specific adaptor protein such as 
sequestrasome (SQSTM1/p62) and/or NBR
147,149,150
. As these adaptor proteins bind to one side 
of the ubiquitinated protein/organelle the other binds to autophagosomal-specific proteins such 
as LC3B or GABARAP
147
. Both the adaptor protein and selected cargo become engulfed by the 
autophagosome and degraded
150
. As such, adaptor protein content measured by western blotting, 
flow cytometry, or immunohistochemistry are commonly used to determine autophagic flux as a 
reduction in adaptor protein can reflect an increase in the degradation of autophagic 
material
111,112
.      
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 In the late stages of autophagy, the mature autophagosome fuses with the lysosome, and 
the lysosome degrades the autophagic cargo
151
. Binding of LC3 on the outer membrane of the 
autophagosome and to dynein along microtubules has been suggested to mobilize the 
autophagosome towards cellular pools rich in lysosomes
152,153
. Fusion of the autophagosome 
with the lysosome produces a morphologically distinct structure called the autophagolysosome
9
.  
In this structure the outer membrane of the autophagosome is bound to the lysosome and the 
inner membrane and autophagic cargo is exposed to the lumen of the lysosomal. This allows 
cathepsins and other proteolytic hydrolases to degrade the autophagic cargo and inner membrane 
while the outer autophagosomal membrane is recovered via ATG4
8
. The release of degradative 
products can be used for energy metabolism, organelle biogenesis as well as negatively 
regulating autophagy through activation of mTOR and mitigation of metabolic stress
154,155
.  
The Involvement of Autophagy in Cell Death 
 The induction of cell stress caused by nutrient or growth factor deprivation, ER/SR-
stress, hypoxia, oxidative stress, DNA damage as well as mitochondrial damage can induce an 
autophagic response
11,12,104,148,156-159
. Considering these cell stresses can produce an apoptotic or 
even necrotic response, cell stress at high levels is also often accompanied by the induction of 
autophagy and cell death mechanisms. The association of autophagy in dying cells has led to a 
paradigm of autophagic cell death
11
. Autophagic cell death is defined by morphological features 
such as the accumulation of autophagosomes within a dying cell that is not associated with 
chromatin condensation or phagocytosis of blebbing cell bodies
11
. However, the term 
“autophagic cell death” has led to the interpretation of cell death being executed by autophagic 
processes which may be a misinterpretation in certain situations
11
. The direct induction of cell 
death by autophagy is rarely observed in many contexts. One mechanism in which autophagy has 
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been suggested to induce cell death is through the degradation of critical regulators of the anti-
apoptotic/stress response. For example, upon prolonged exposure to ROS the induction of 
autophagy was shown to potentiate cell death by degrading the antioxidant catalase
160
. Under 
certain circumstances autophagy can in fact directly contribute to cell death. Overexpression of 
ATG1 in drosophila fat and salivary glands results in the massive induction of autophagy and 
cell death
161
. Interestingly, cell death was inhibited by a loss of ATG8 which also suppressed 
autophagy, suggesting that in this case autophagy contributed to cell death
161
. Furthermore, cell 
death was also mediated by apoptotic processes since CASP3 or p53 inhibition mitigated cell 
death in fat cells
161
. In this model of autophagic cell death, the over-activation of autophagy 
promoted cell death through the utilization of apoptotic machinery. Signs of autophagic cell 
death are also found in apoptotic resistant cell types suggesting autophagic cell death can be 
independent of apoptosis. For example, apoptosis resistant BAX
-/-
:BAK
-/-
 fibroblasts use 
autophagic machinery to induce cell death when treated with apoptotic inducers such as 
etoposide
162
. These results suggest that autophagy may indeed directly induce cell death when 
apoptosis is compromised. It is noteworthy that these effects may be tissue specific as well as 
dependent upon the trigger of cell death
12
. For example, hematopoietic cells of the same genetic 
background (BAX
-/-
:BAK
-/-
) undergo a prolonged activation of autophagy as a result of growth 
factor withdrawal or nutrient suppression. Instead of cell death, the induction of autophagy in 
this condition is related to cell survival since knockdown of autophagy proteins result in 
increased cell death
163
. Moreover, apoptotic death can occur in response to starvation, growth 
factor withdrawal, hypoxia, heat shock, DNA damage, and ER-stress. Interestingly, autophagy 
has been shown to occur during these conditions as well.  However, in these situations autophagy 
has been shown to protect the cell or at least prolong cell viability
156,163-167
. 
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 The role of autophagy in cell death is further complicated by the dual role of autophagy 
related proteins. For example, caspase activation can cleave BECN1 which not only inhibits the 
activation of autophagy, but produces a truncated version of BECN1 that contributes to 
MOMP
168,169,170,171
.  Normal autophagy induction relies on the recycling of ATGs from the 
autophagolysosome to rapidly produce more autophagosomes following lysosomal fusion.  
Interestingly, CASP3-mediated cleavage of ATG4 inhibits autophagy and promotes apoptosis. 
Research has also demonstrated that the cleaved product of ATG4 changes its localization and 
directly induces apoptosis via mitochondrial-mediated pathways
172
. Furthermore, Pyo et al. 
found that the interactions between ATG5 and FADD can produce a truncated form of ATG5 
which promotes MOMP
173
.  Data by Yousefi et al. support these findings by showing an 
apoptotic role of ATG5 following cleavage by calpains. The 24 kDa ATG5 fragment translocates 
to the mitochondria and participates in MOMP through interactions with anti-apoptotic protein 
BCLXL
174
. In certain contexts and cell types the induction of autophagy can mitigate cell stress 
and attenuate apoptotic signaling through the removal of damaged proteins and organelles.  
However, the close induction kinetics and dual role of certain autophagy proteins also questions 
whether or not autophagy is strictly a protective adaptation to cell stress or a process which is 
attempting to promote apoptotic events.  
The dual role of autophagy in skeletal muscle physiology and pathophysiology  
 The ambivalent role of autophagy in cell protection or cell death is extended to skeletal 
muscle research where autophagy as a promoter of muscle health or disease is controversial. The 
induction of autophagy in skeletal muscle and many other tissues has been described as a double 
edge sword. For example, the induction of autophagy can provide the cell with metabolic 
substrates in times of starvation and prevent cell death
166
. In contrast, such stress can lead to 
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muscle atrophy and dysfunction; an effect that is attenuated by the inhibition of autophagy
104
. As 
these examples demonstrate, the role of autophagy in skeletal muscle health and disease is 
controversial and suggest that autophagy can either be beneficial or deleterious.  
 Impairments to autophagy result in detrimental effects to skeletal muscle of mice during 
perinatal periods of life. For example, muscle-specific deletions of histone deacetylases 1 and 2 
abolish autophagy induction and results in characteristics of a neonatal myopathy and perinatal 
lethality. Interestingly, both muscle defects and survival are rescued by high fat feeding during 
the weaning phase
175
. These data suggests that the lack of autophagy results in metabolic stress 
which can lead to the destruction of skeletal muscle during early stages of life. Furthermore, 
basal levels of autophagy in mature skeletal muscle are also essential for muscle homeostasis. 
For example, deletion of ATG7 in mature skeletal muscle inhibits basal and induced autophagy 
which promotes the development of myopathic phenotypes including impaired contractile force 
and muscle atrophy
1
. Regulation of autophagy via mTOR requires the upstream formation of the 
TSC1/2 complex. Similarly, TSC1-deficient mice develop a late onset myopathy characterized 
by degenerative myofibers, centrally located nuclei, and reduced muscle weight and 
constitutively active mTOR by 9 months of age. Mice lacking TSC1 have elevated basal 
mTORC1 activity as well as impaired basal and starvation induced autophagy. This produces a 
myopathic phenotype since inhibition of mTORC1 allows basal and starvation induced 
autophagy to occur and also restores muscle integrity
3
. The accumulation of damaged organelles 
and proteotoxicity accompanies several myopathies including Duchene muscular dystrophy and 
collagen VI-1a muscular dystrophy as well as sarcopenia
14,176,177
. In these models of muscle 
disease, the basal levels of autophagy are significantly attenuated which is proposed to promote a 
number of myopathic features. Accordingly, the forced induction of autophagy via a low protein 
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diet or genetic upregulation of autophagy proteins or signaling factors can ameliorate muscle 
inflammation, fibrosis, apoptosis, and myofiber damage as well as improve contractile strength 
in both sarcopenia and myopathic animals
14,176-178
. Collectively, these results show that deletion 
of autophagy in healthy mature skeletal muscle results in the buildup of toxic protein aggregates 
and impaired organelles which contribute to the development of myopathy. In myopathic 
conditions the reduction in basal autophagy also contributes to muscle impairments
179
. However, 
in both healthy and diseased skeletal muscle, upregulation of autophagic flux can effectively 
remove toxic protein aggregates, clear damaged organelles, and re-establish muscle viability and 
function
180,181
.   
 In contrast, autophagy can also induce a number of deleterious changes to skeletal muscle 
function and size. Cachexic muscle wasting is associated with an increase in p38 kinase activity 
which promotes the upregulation of the catabolic processes including autophagy and apoptosis
13
. 
Collectively, the induction of these catabolic systems results in muscle dysfunction, diminished 
mass, and a rapid decline in protein synthesis
181
. Furthermore, when cultured myotubes are 
exposed to an apoptosis-inducing agent, myotubes undergo atrophy. Interestingly, myotube 
diameter can be recovered when myotubes are pre-treated with 3MA prior to the addition of 
apoptotic stimuli to culture media
106. Similarly, overexpression of PGC1α in aged animal’s 
results in lower autophagy as well as attenuated apoptosis, improved mitochondrial and 
contractile function, and increased muscle mass
182
. Muscle atrophy in a number of models 
including starvation and denervation can be abrogated through the inhibition of FOXO3A 
transcription factor
183
. Importantly, Massaerio et al. found that in addition to the upregulation of 
ubiquitin proteasome system (UPS) factors, FOXO3A signaling also induces autophagy related 
genes which directly contribute to muscle atrophy
1,183
. For example, the inhibition of BNIP3, a 
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transcriptional target of FOXO3A and a potent inducer of autophagy, mitigates autophagy and 
recovers muscle mass during several atrophic conditions
1
. These results demonstrate that the 
increase in autophagy occurs during muscle atrophy and has a direct role in promoting the loss of 
muscle mass and functional impairments.   
 Autophagy also contributes to the pathogenesis of a variety of myopathies. For example, 
Pompe’s disease is caused by a mutation in the acid alpha-glucosidase gene resulting in an 
inability to breakdown glycogen via the lysosomal pathway. Autophagic vesicles containing 
glycogen accumulate and increase muscle dysfunction as well as impair enzyme replacement 
therapies
184. By ablating autophagy through crossing Pompe’s disease mice with ATG5-deficient 
mice, Raben et al. were able to mitigate muscle vacuolization and improve the effectiveness of 
enzyme replacement therapy
142
. Spinal and Bulbar myopathies as well as sporadic inclusion 
body myositis are characterized by increased autophagy with impaired flux resulting in 
vacuolated fibers, misaligned sarcomeres, and the accumulation of autophagic substrates
120
. It is 
possible that the inability to degrade autophagic cargo may result in a reduction of metabolic 
substrates and further promotion of cell stress through both metabolic and structural 
impairments. This in turn may stimulate an increase in apoptotic signaling where more catabolic 
events could result in a further requirement and perpetual induction of autophagy.   
Statement of the problem 
 The induction of autophagy in skeletal muscle is currently described as the cliché double 
edged sword. In one situation promoting autophagy may improve the clearance of damaged 
organelles and proteins thus, reducing cytotoxity and promoting required turnover and biogenesis 
of cellular constituents.  In contrast, the induction of autophagy can also promote muscle wasting 
as well as vacuolated fibers and misaligned contractile filaments, thus contributing to muscle 
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impairments. Also, indirect evidence exists which supports an association between autophagy 
and apoptosis in skeletal muscle. However, the relationship between autophagy and apoptosis in 
skeletal muscle has not been directly investigated and the conclusion that autophagy is a cell 
death process in skeletal muscle may be inaccurate. 
 Since cell death signaling is increased upon muscle damage/disease as well as during the 
myoblast differentiation process. A better understanding of the role of autophagy in apoptotic 
signaling during physiological processes such as myoblast differentiation could be useful in 
developing strategies to improve muscle development and regeneration. Furthermore, exploring 
the role of autophagy during pathological cell stress causing apoptotic signaling and atrophy will 
improve our understanding of the role of autophagy in the skeletal muscle cell stress response. 
Importantly, examining the cross-talk between autophagy and apoptosis will provide us with 
insight and basic knowledge of processes that regulate life and death of skeletal muscle. This 
thesis sought to test the hypothesis that autophagy contributes to cell protection against apoptotic 
signaling during physiological and pathological stresses occurring in response to myoblast 
differentiation and cisplatin-induced injury, respectively.  
 
The main objectives of this thesis are as follows:  
1. Determine if autophagy occurs during myoblast differentiation and if autophagy is required for 
differentiation. 
2. Characterize the induction of autophagy in myoblast differentiation.   
3. Elucidate signaling mechanisms involved in autophagy induction during myoblast 
differentiation. 
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4. Determine if autophagy protects the differentiating myoblast from apoptotic cell death. 
5. Elucidate the direct role of autophagy in regulating apoptotic signaling during myoblast 
differentiation.  
6. Characterize both apoptosis and autophagy in response to cisplatin-induced cell stress in 
differentiated myotubes. 
7. Determine the role of autophagy in apoptotic signaling in response to submaximal levels of 
cell stress caused by cisplatin. 
8. Determine if autophagy is altered during recovery from submaximal levels of cell stress in 
myotubes. 
9. Examine the interplay between autophagy and apoptosis during recovery from submaximal 
levels of apoptotic stress in myotubes.  
The main hypotheses (and outcomes) of this thesis were: 
1. Autophagy will be increased during myoblast differentiation and required for the 
differentiation of myoblasts. Moreover, autophagy will be regulated by stress signaling. 
(Our data support this hypothesis. Autophagy was increased during myoblast differentiation and 
was induced by JNK activity. Inhibition of autophagy impaired differentiation and increased cell 
death) 
2. Autophagy is induced to regulate physiological levels of CASP activity  
(Our data support this hypothesis. The induction of autophagy during myoblast differentiation is 
required to control CASP3 activity through the regulation of mitochondrial-mediated apoptotic 
signaling.) 
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3. In response to pathological apoptotic stress induced by cisplatin both autophagy and apoptosis 
will increase.  
(Our data support this hypothesis. Autophagy was increased in conditions with elevated 
apoptotic signaling) 
4. The induction of autophagy is required to protect from apoptotic signaling in response to 
submaximal levels of stress. 
(Our data support this hypothesis. Inhibition of autophagy at submaximal levels of stress 
increased apoptotic signaling and promoted further determents to mitochondrial function) 
5. Autophagy will be required to attenuate apoptotic signaling as the myotubes recovery from 
submaximal levels of apoptotic signaling.  
(Our data support this hypothesis. An increase in autophagic flux was observed during recovery 
of myotubes which was required to improve mitochondrial viability and attenuate apoptotic 
signaling) 
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CHAPTER II – Autophagy is required and protects against apoptosis during myoblast 
differentiation 
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OVERVIEW 
Several degradative systems assist in formation of multinucleated, terminally 
differentiated myotubes. However, the role of autophagy in this process has not been examined. 
GFP-LC3B puncta, LC3B-II protein, and LysoTracker fluorescence increased during C2C12 
differentiation. Importantly, accumulation of LC3B-II protein occurred in chloroquine (CQ) 
treated cells throughout differentiation. Furthermore, BECN1, ATG7, and ATG12-5 protein 
increased, while SQSTM1/p62 protein was rapidly reduced during differentiation. A transient 
decrease in BECN1:BCL2 association was observed from D0.5 to D2 of differentiation. 
Chemical inhibition of JNK during differentiation reduced LC3B-II protein and GFP-LC3B 
puncta, and maintained BECN1:BCL2 association. Inhibition of autophagy by 3MA or shRNA 
against ATG7 (shAtg7) resulted in lower myosin heavy chain expression, as well as impaired 
myoblast fusion and differentiation. Interestingly, 3MA treatment during differentiation 
increased transient CASP3 activation, DNA fragmentation, and the percentage of apoptotic 
nuclei. Similarly, shAtg7 cells had increased DNA fragmentation during differentiation 
compared to controls. Collectively, these data demonstrate that autophagy increases and is 
required during myoblast differentiation. Moreover, autophagy protects differentiating myoblast 
from apoptotic cell death.  
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INTRODUCTION  
 Cellular differentiation is associated with rapid biochemical and morphological 
alterations as well as the removal of pre-existing structures and proteins. A rapid way to alter cell 
morphology, signaling pathways, genetic programs, and function is through the degradation of 
pre-existing structural and signaling proteins as well as organelles
131
. Previous work has shown 
that degradative processes are essential in the differentiation of myoblasts and in the formation of 
mature myotubes
185-187
. Although several degradative systems such as the ubiquitin proteasome 
system, calpains, and caspases are involved in myoblast differentiation, skeletal muscle 
formation requires organelle remodeling as well as significant morphological changes which 
may not be fully supported by these processes. In this case, myoblast differentiation may require 
the induction of autophagy; a bulk degradative process involved in the sequestration and targeted 
destruction of protein aggregates and superfluous/damaged organelles
8
.  
 Alterations to autophagy have been observed during the differentiation of several cell 
types including osteogenic, mesenchymal, neuroblastoma, and glioma-initiating cells
188-190
. 
Interestingly, autophagy seems to be involved in the differentiation of cell types which require 
significant
 
morphological and biochemical remodeling as well as cells which become terminally 
differentiated
131
.  For example, erythroid cells undergo enucleation and removal of organelles 
during terminal differentiation
191
.  Given these findings it seems likely that autophagy may play 
a role during myoblast differentiation; a process that involves significant remodeling 
 The induction of myoblast differentiation requires the activation of several signaling 
kinases which are also associated with the regulation of autophagy in skeletal muscle. For 
example, myoblast differentiation and myotube formation require AKT and MTOR signaling, 
two signaling kinases which inhibit autophagy in mature skeletal muscle
44,46,192
. In contrast, 
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differentiating myoblasts have altered AMPK activity. AMPK can induce autophagy through the 
activation of ULK1/2 as well as through the promotion of FOXO3A transcriptional activity
53,193
. 
In addition, myoblast differentiation is also associated with alterations to apoptotic proteins 
which could either induce or inhibit autophagy
125,194
.  An understanding of processes involved in 
myoblast differentiation as well as how these processes are regulated is vital to optimize muscle 
development and regeneration. Therefore, the purpose of this work was to characterize 
alterations to autophagy during myoblast differentiation, and to investigate its regulation and 
potential role in myoblast differentiation and myotube formation. 
 
METHODS 
Cell culture and treatments 
 Mouse C2C12 skeletal myoblasts (ATCC) were plated between passes 2-5 in polystyrene 
cell culture dishes (BD Biosciences) or on gelatin (Sigma) coated coverslips in growth media 
(GM) consisting of low-glucose Dulbecco’s Modified Eagles Medium (DMEM; Hyclone, 
Thermo Scientific) containing 10% fetal bovine serum (FBS; Hyclone, Thermo Scientific) with 
1% penicillin/streptomycin (Hyclone, Thermo Scientific) and incubated at 37ºC in 5% CO2. At 
24 hr intervals, culture dishes were aspirated of GM, washed with warmed phosphate buffered 
saline (PBS; Hyclone, Thermo Scientific), and fresh GM replaced. At 80-90% confluence, 
differentiation was induced by replacing GM with differentiation media (DM) consisting of 
DMEM supplemented with 2% horse serum (Hyclone, Thermo Scientific) and 1% 
penicillin/streptomycin. Cells were collected as subconfluent myoblasts prior to DM addition 
(D0) as well as at 12 hrs (D0.5), 24 hrs (D1), 36 hrs (D1.5), 48 hrs (D2), 72 hrs (D3) and 120 hrs 
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(D5) following the addition of DM. Cells were removed from culture dishes by trypsinization 
(0.25% trypsin with 0.2g/L EDTA; Thermo Scientific), collected by centrifugation (800 x g for 5 
min), resuspended/washed in PBS, and frozen at -80ºC until further analysis.  
 To measure autophagic flux over a full 24 hour period of differentiation
195,196
, 
chloroquine salt (CQ) (Sigma-Aldrich) was added to warm media at a working concentration of 
10µM for 24 hrs prior to collection of cells. To inhibit JNK activity 10µM SP600125 (LC 
Laboratories) was added to cell cultures in warm media and replaced every 24 hrs. Autophagy 
was inhibited by incubating cells with 5mM 3-methyladenine [3MA (Sigma-Aldrich)] and 
replaced every 24 hrs. In pilot experiments, 5mM 3MA was the lowest dose which attenuated 
LC3B-II production and did not have any effects on other PI3K targets such as AKT throughout 
the differentiation period (Appendix 1). 
Transient expression of GFP-LC3B and stable knockdown of ATG7 
 C2C12 myoblasts grown on gelatin coated coverslips were transiently transfected with 
GFP-LC3B plasmid DNA generously provided by Dr. Terje Johansen (Institute of Medical 
Biology; University of Tromsᴓ) to qualitatively examine the presence of autophagic puncta. 
Plasmid DNA was transfected into myoblasts once cultures reached 50-60% confluence using 
Lipofectamine 2000 (Life Technologies) according to manufactures instructions. Briefly, 
Lipofectamine 2000 (6µl) and plasmid DNA (3µg) were separately diluted in Opti-MEM 
(Gibco) and incubated at room temperature for 5 min. The diluted Lipofectamine and DNA 
solutions were complexed for 5 min at room temperature. Cells were washed twice with Opti-
MEM. A total of 100µl of Lipo/DNA complexes (6µl/3µg) was added to 400µl of Opti-MEM for 
a final transfection volume of 500µl/well and incubated for 12 hrs at 37ºC with 5% CO2. 
Transfection media was then aspirated and cells were washed 2x with warm PBS and incubated 
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overnight in GM. Once GFP-LC3B transfected cells reached 80-90% confluence they were 
treated with reagents discussed above and induced to differentiate. Glass coverslips of cells 
transfected with GFP-LC3B were removed from culture dishes, washed 2x in warm PBS and 
mounted on glass slides using Prolong Gold Antifade Reagent (Life Technologies).  
 The ATG7 (TR30017) and scramble (TR30013) HuSH-29 shRNA plasmids (Origene) 
were transfected into C2C12 cells using Lipofectamine 2000 (Life Technologies) according to 
the manufactures instructions. Stable clones were obtained using puromycin (Enzo Life 
Sciences), passaged, and characterized for ATG7 and LC3B protein content.  
Fluorescence microscopy  
 For immunofluorescence analysis of myosin heavy chain expression cells were grown on 
glass coverslips in culture dishes and removed at indicated time points. Coverslips were washed 
2 x 5 min with PBS. Cells were then fixed with 4% formaldehyde-PBS for 10 min at room 
temperature, and washed 2 x 5 min with PBS. Next, cells were permeabilized with 0.5% Triton 
X100 for 10 min, and washed 2 x 5 min in PBS. Cells were then blocked with 10% goat serum 
(Sigma-Aldrich) (in PBS) for 30 min, incubated with a primary antibody against myosin heavy 
chain (Developmental Studies Hybridoma Bank; MF20) diluted in blocking solution for 1 hr, and 
washed 2 x 5 min with PBS. An anti-mouse PE-conjugated secondary antibody (Santa Cruz) was 
diluted in blocking solution and incubated with cells for 1 hr, cells were then washed 2 x 5 min 
in PBS, counterstained with DAPI nuclear stain (Life Technologies) for 5 min, washed 2 x 5 min 
in PBS, and mounted with Prolong Gold Antifade Reagent (Life Technologies). The fusion index 
was calculated as the percentage of nuclei present in multinucleated (two or more nuclei) cells 
relative to total nuclei. The differentiation index was calculated as the percentage of cells 
expressing myosin heavy chain relative to total cell number.  
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To visualize lysosomal content, live cells were incubated with LysoTracker Red (LTR; 
50nM) (Life Technologies) for 30 min. Cells were then washed 3 x 5 min in PBS and fixed with 
4% formaldehyde-PBS, and counterstained with Hoescht NucBlue (Life Technologies) for 5 min 
at room temperature to visualize nuclei.  
To image healthy and apoptotic nuclei, Hoechst NucBlue staining was conducted as 
follows. Cells were washed 3 x 5 in PBS and incubated in Hoechst NucBlue for 5 min at room 
temperature. Nuclei presenting with bright and fragmented nuclei were considered apoptotic 
while cells with round un-fragmented nuclei without signs of chromatin condensations were 
considered healthy. Cells were washed and mounted on glass slides using Prolong Gold Antifade 
Reagent (Life Technologies). Slides were visualized with an Axio Observer Z1 structured-
illumination fluorescent microscope equipped with standard Red/Green/Blue filters, an AxioCam 
HRm camera, and AxioVision software (Carl Zeiss).  
Immunoprecipitation  
 Immunoprecipitation of BECN1:BCL2 was performed using ImmunoCruz IP/WB 
Optima B system (Santa Cruz Biotechnology) according to the manufactures protocol. Briefly, 
500µl of PBS, 50µl of suspended (25% v/v) IP matrix, and 5µg of BECN1 primary antibody 
(Santa Cruz) were combined and gently resuspended. Matrix:antibody complexes were formed 
overnight during rotation at 4ºC. Frozen pelleted cells were resuspended and lysed in 200µl of  
immunoprecipitation lysis buffer [(50 mM Tris; pH 7.9, 150 mM NaCl, 1 mM EDTA, 1% Triton 
X100), protease inhibitor cocktail (Roche Applied Sciences) and phosphatase inhibitor cocktail 
(Thermo Scientific)] on ice for 30 min while shaking. Protein assays were conducted using the 
BCA method. Matrix:antibody complexes were then centrifuged at 28000g for 1 min at 4ºC and 
washed twice in PBS. 500µg of cell lysates were added to the pelleted matrix:antibody complex 
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and gently resuspended. Matrix and lysates were complexed by overnight rotation at 4ºC. Matrix 
complexes were then centrifuged at 28000g for 1 min to pellet the matrix and the supernatant 
aspirated and discarded. The pellet was washed 3 x in PBS. After the last wash the pelleted 
matrix received 50µl of sample buffer containing sodium dodecyl sulfate (SDS) and boiled for 3 
min at 95ºC. The IP pellet was then centrifuged at 28000g for 30 seconds and equal volumes of 
supernatant were loaded on a 12% SDS-PAGE gel and transferred onto PVDF membranes as 
described below. 
Immunoblotting 
 Immunoblotting was conducted as previously described by our lab
197,198
. Briefly, cells 
were lysed in ice cold lysis buffer (20 mM HEPES, 10 mM NaCl, 1.5 mM MgCl, 1 mM DTT, 
20% glycerol and 0.1% Triton X100; pH 7.4) with protease (Roche Applied Sciences) and 
phosphatase (Thermo Scientific) inhibitor cocktails. Equal amounts of cell lysates were loaded 
and separated on 7.5-15% SDS-PAGE gels, transferred onto PVDF membranes (Bio-Rad 
Laboratories), and blocked for 1 hr at room temperature or overnight at 4°C with 5% milk-Tris-
buffered saline-Tween 20 (milk-TBST). Membranes were incubated either overnight at 4°C or 
for 1 hr at room temperature with primary antibodies against: AKT, pAKT (Thr
308
), ULK1, 
pULK1 (Ser
467
), FOXO3A, pFOXO3A (Ser
318/321), AMPKα, pAMPKα (Thr172), BECN1, ATG7, 
ATG12-5, ATG4B, LC3B, pJNK1 (Thr
183
/Try
185
) (Cell Signaling Technology); BCL2, BCLXL, 
JNK1 (Santa Cruz Biotechnology); myogenin, myosin heavy chain (Developmental Studies 
Hybridoma Bank), SQSTM1/p62 (Progen Biotechnik), BNIP3, PIK3C3/VPS34, and Actin 
(Sigma-Aldrich). Membranes were then washed with TBST, incubated with the appropriate 
horseradish peroxidase (HRP)-conjugated secondary antibodies (Santa Cruz Biotechnology) for 
1 hr at room temperature, washed with TBST, and bands visualized using enhanced 
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chemiluminescence western blotting detection reagents (BioVision) and the ChemiGenius 2 Bio-
Imaging System (Syngene). The approximate molecular weight for each protein was estimated 
using Precision Plus Protein WesternC Standards and Precision Protein Strep-Tactin HRP 
Conjugate (Bio-Rad Laboratories). Equal loading and quality of transfer was confirmed by 
staining membranes with Ponceau S (BioShop). All immunoblotting was performed and 
quantified in duplicate. 
Proteolytic enzyme activity assay and DNA fragmentation 
 Enzymatic activity of CASP3 was determined in cells using the substrate Ac-DEVD-
AMC (Enzo Life Sciences). Cells were isolated as mentioned above (without protease inhibitor 
cocktail) and incubated in duplicate in black 96-well plates (Costar) with fluorogenic substrate at 
room temperature. Fluorescence was measured using a SPECTRAmax Gemini XS microplate 
spectrofluorometer (Molecular Devices) with excitation and emission wavelengths of 360 nm 
and 440 nm, respectively. CASP3 activity was normalized to total protein content and expressed 
as fluorescence intensity in arbitrary units (AU) per milligram protein.  
 DNA fragmentation, a hallmark of apoptotic cell death, was determined using the Cell 
Death Detection ELISA
PLUS
 Kit (Roche Diagnostics). Briefly, cells were collected as described 
above and homogenized in the supplied lysis buffer and centrifuged at 200 g for 10 min at room 
temperature. 20µl of supernatant was incubated with 80µl of anti-histone-biotin/anti-DNA-POD 
reagent in a streptavidin-coated microplate for 2 hours at room temperature with gentle shaking. 
Each well was then aspirated and washed several times followed by the addition of 100µl of 
ABTS substrate solution. Absorbance was measured at 405nm and 490nm with a SPECTRAmax 
Plus spectrophotometer (Molecular Devices). Absorbance was normalized to total protein 
content and expressed as AU per mg protein.  
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Statistical analysis 
 A One-Way repeated measure ANOVA was used to assess the effect of differentiation. If 
a main effect of differentiation was observed, Tukey’s post hoc test was used to determined 
differences from D0 within each group independently. To examine differences between groups 
on specific time points (within the same day) a Students T-Test was used. p<0.05 was considered 
statistically significant. 
 
RESULTS 
Markers of autophagy are altered during myoblast differentiation 
 The induction of myoblast differentiation resulted in the appearance of GFP-LC3B 
puncta, indicating an increase in autophagosome formation (Fig. 1A). To quantify this 
observation we examined LC3B-I and LC3B-II protein content. Compared to D0, LC3B-II was 
elevated (p<0.05) on D1 and thereafter throughout differentiation, supporting the observed 
increase in GFP-LC3B puncta. In addition, non-lipidated LC3B-I protein content was greater on 
D2 (p<0.05) and D3 (p<0.01) relative to D0 (Fig. 1B). SQSTM1/p62 is an autophagic adaptor 
protein which can be degraded during increased autophagy
143
 and thus has been used to 
determine autophagic activity
112
. In support of increasing LC3B-II protein and GFP-LC3B 
puncta, SQSTM1 protein was dramatically reduced in differentiating cells (p<0.001) (Fig. 1C).  
 The formation of the autophagosome requires the upregulation of several autophagy 
related proteins as well as the assembly of protein kinase complexes
8
. To determine if these 
autophagy related proteins are altered during differentiation we first measured the protein content 
of BECN1 and PIK3C3/VPS34, two proteins integral to the production of phosphatidylinositol 
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3-phosphate and the expansion of the autophagosomal membrane
8
. Although PIK3C3 was not 
significantly elevated during differentiation, BECN1 protein (p<0.05) increased throughout 
differentiation (Fig. 1D). The induction of autophagy is also associated with the activation of the 
ULK1 kinase complex
8
. Interestingly, an early increase (p<0.001) in ULK1 protein was observed 
(D0.5 vs D0); however, ULK1 protein levels returned to baseline on D1 and D2, and declined 
further on D3 (p<0.05) and D5 (p<0.01) (Fig. 1E). However, phosphorylation of ULK1 (Ser
467
) 
and the resulting pULK1/ULK1 ratio did not differ significantly from D0 throughout 
differentiation.  
 The lipidation of LC3B requires activation through proteolytic modifications made by 
ATG4B
8
. LC3B-I is then activated by E2-like enzymes such as ATG7 and conjugated to 
phosphatidylethanolamine via the E3-like activity of the ATG12-5-16 conjugation complex
8
. 
During differentiation of C2C12 myoblasts, ATG4B protein levels were lower (p<0.01) on D5 vs 
D0 (Fig. 1F). In contrast, ATG7 and ATG12-5 protein were significantly elevated (p<0.05) 
throughout differentiation (Fig. 1F). Collectively, these findings suggested that upstream and 
downstream autophagy-related proteins are significantly altered during myoblast differentiation. 
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Fig. II - 1: Markers of autophagy are altered during myoblast differentiation 
(A) Representative images of GFP-LC3B puncta in differentiating C2C12 myoblasts. 
Representative immunoblots and quantitative analysis of (B) LC3B-I and LC3B-II protein, (C) 
SQSTM1/p62 protein, (D) BECN1 and PIK3C3/VPS34 protein, (E) ULK and pULK1 (Ser
467
) 
protein, and (F)  ATG4B, ATG7, and ATG12-5 protein in differentiating myoblasts. Also shown 
are representative Actin loading control blots.  Scale bar=10µm. A one-way ANOVA was used 
to examine the effect of differentiation.
*
p<0.05, 
#
p<0.01, 
$
p<0.001 compared to D0; (n=3-6). 
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Increased lysosomal content and autophagic flux during myoblast differentiation 
To determine if the changes to autophagic proteins were indicative of increased 
autophagic flux, we first investigated lysosomal content. We observed an increase (p<0.05) in 
LysoTracker fluorescence during differentiation (D0.5, D1, D3 vs. D0) (Fig. 2A & 2B). 
Interestingly, the LC3B-II/I ratio was not statistical different from D0 despite a 90% increase on 
D0.5 and a 50% increase on D1 (Fig. 2C). To ensure that the observed increase in LC3B-II 
protein and decline in SQSTM1 protein were due to increased autophagic flux, we treated cells 
for 24 hours with 10µM of CQ. Compared to non-treated cells, greater GFP-LC3B puncta along 
with an accumulation of LC3B-II protein (p<0.001) were observed in D0 myoblasts and 
differentiating cells (Fig. 2D & 2E). The accumulation of LC3B-II protein in D0 CQ treated cells 
suggests basal levels of autophagy are occurring in proliferating myoblast. However, the 
accumulation of LC3B-II in D0 myoblasts was significantly less (p<0.001) compared to 
differentiating cells (D1, D2, D3); providing evidence that autophagic flux is increased further 
during myoblast differentiation.  
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Fig. II - 2: Increase in lysosomal content and autophagic flux during myoblast 
differentiation 
(A) Representative images of lysosomal content and, (B) quantitative analysis of LysoTracker 
Red fluorescence during myoblast differentiation. (C) Quantitative analysis of the LC3B-II/I 
protein ratio during myoblast differentiation. (D) Representative immunoblots of LC3B-I and 
LC3B-II as well as quantitative analysis of LC3B-II protein accumulation over 24 hours from 
CTRL and CQ treated C2C12 cells. LC3B CTRL and CQ experiments were conducted and 
blotted simultaneously. However, for representative purposes membranes are shown as separate 
CTRL and CQ images. Also shown is a representative Actin loading control blot. (E)  
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Representative images of GFP-LC3B puncta from CTRL and CQ treated differentiating 
myoblasts. Scale bar=10µm.  A one-way ANOVA was used to examine the effect of 
differentiation. A Students T-Test was used to determine differences between CTRL and CQ 
groups within the same time point. 
*
p<0.05, 
$
p<0.001 compared to D0. 
¢
p<0.001 between 
treatment at same time point; (n=3). 
 
Induction of autophagy during myoblast differentiation requires JNK activity  
 Myoblast differentiation and autophagy regulation share several signaling pathways. For 
example, AMPK has previously been shown to be involved in skeletal muscle development as 
well as autophagy regulation
53,193
.  We observed no change in AMPKα protein throughout 
differentiation (Fig. 3A). In contrast, pAMPKα (Thr172) levels increased upon induction of 
differentiation, becoming statistically significant (p<0.05) by D2. Similarly, the ratio of 
pAMPKα/AMPKα was elevated during differentiation, becoming statistically significant on D5 
(p<0.05). These results suggest that the activation of AMPKα increases during myoblast 
differentiation. However, considering the lack of change in pULK1 (Ser
467
), an AMPK target, 
AMPKα may not be involved in the induction of autophagy during myoblast differentiation. 
Thus, AMPK may be supporting other roles such as the transition from a predominantly 
glycolytic metabolism to a more oxidative phenotype
31,51,52,199
.   
 AKT and FOXO3A have important roles in both myoblast differentiation and autophagy 
regulation
46,104
. AKT protein significantly increased (p<0.05) on D3 of differentiation (Fig. 3B). 
Relative to D0, phosphorylated AKT (Thr
308
) increased several-fold during differentiation, 
becoming significantly greater (p<0.001) on D3. Similarly, the ratio of pAKT/AKT gradually 
increased with differentiation reaching significance on D3 (p<0.01) and D5 (p<0.05) compared 
to D0 myoblasts (Fig. 3B). A downstream target of AKT and transcription factor involved in the 
expression of several autophagy related genes in skeletal muscle is FOXO3A
46,104
. Interestingly, 
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FOXO3A protein and the pFOXO3A/FOXO3A ratio were not statistically altered during 
differentiation. However, similar to AKT phosphorylation, pFOXO3A (Ser
318/321
) levels 
increased (p<0.01) throughout differentiation (Fig. 3C).  
 Since we observed an increase in BECN1 protein we investigated the expression of 
several BCL2 family members which have been shown to interact with BECN1 to regulate 
autophagy induction. BCL2 protein increased during differentiation, becoming significantly 
greater than D0 on D2 (p<0.001), D3 (p<0.01) and D5 (p<0.05) (Fig. 3D). Similarly, BCLXL 
protein gradually increased but only reached significance (p<0.01) on D5 (Fig. 3D). BNIP3 is a 
member of the BCL2 protein family and can exert both autophagic and apoptotic functions 
12,143
. 
Although BNIP3 protein gradually increased during differentiation, it only reached significance 
on D5 (p<0.05) (Fig. 3D). Together, this suggests a role for BCL2 in myoblast differentiation 
and possibly in the regulation of autophagy.  
 Previous research has shown an important role for JNK in differentiation and regulation 
of autophagy through interactions with BCL2
200
. Interestingly, JNK1 protein did not change 
during myoblast differentiation. However, we observed a transient but non-significant increase 
pJNK1 (Thr
183
/Try
185
) levels on D0.5 (85%) and D1 (112%) before declining. Similarly, a 
transient yet non-significant increase in the pJNK1/JNK1 ratio was observed on D0.5 (119%) 
and D1 (72%) (Fig. 3E). Although the rise in pJNK1/JNK1 ratio did not reach statistical 
significance relative to D0, immunoprecipitation assays demonstrated a reduction in the 
association between BECN1 and BCL2 on D0.5 (p<0.05), D1 (p<0.01) and D2 (p<0.05) (Fig. 
3F). This dissociation is required for the induction of autophagy which can be mediated by JNK. 
Interestingly, treatment of differentiating cells with the JNK inhibitor SP600125 maintained the 
association between BECN1 and BCL2 during the early days of differentiation (D0.5, D1, D2). 
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Furthermore, compared to CTRL (untreated) cells at the same time point, JNK inhibition resulted 
in a significantly higher association between BECN1 and BCL2 on D0.5 (p<0.05) and D2 
(p<0.05) (Fig. 3F). Importantly, cells treated with SP600125 did not show increased LC3B-II 
protein content or appearance of GFP-LC3B puncta during differentiation. Furthermore, 
compared to CTRL cells at the same time point, cells treated with the JNK inhibitor had lower 
LC3B-II protein on D0.5, D1, and D2 (p<0.05) (Fig. 3G and 3H). Collectively, these data 
suggests that JNK plays a key role in regulating the association between BECN1 and BCL2, as 
well as the production of LC3B-II and the promotion of autophagy shortly after the induction of 
myoblast differentiation. 
 43 
 
 
Fig. II - 3: JNK activity is required for BCL2 dissociation from BECN1 and LC3B-II 
formation during myoblast differentiation  
(A) Representative immunoblots and quantitative analysis of AMPKα and pAMPKα (Thr172) 
protein, (B) AKT and pAKT (Thr
308
) protein, (C) FOXO3A and pFOXO3A (Ser
318/321
) protein, 
(D) BNIP3, BCL2, and BCLXL protein, and (E) JNK1 and pJNK1 (Thr
183
/Try
185
) protein during 
C2C12 differentiation. (F) Representative immunoblots and quantitative analysis of 
BECN1:BCL2 immunoprecipitation during C2C12 differentiation in CRTL and SP600125 
treated cells. (G) Representative images of GFP-LC3B puncta formation during C2C12 
differentiation in CTRL and SP600125 treated cells. (H) Representative immunoblots of LC3B-I 
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and LC3B-II as well as quantitative analysis of LC3B-II from CTRL and SP600125 treated cells 
during C2C12 differentiation. LC3B CTRL and JNK inhibition experiments were conducted and 
blotted simultaneously. However, for representative purposes membranes are shown as separate 
CTRL and SP600125 images. Also shown are representative Actin loading control blots. Scale 
bar=10µm. A one-way ANOVA was used to examine the effect of differentiation. A Students T-
Test was used to determine differences between CTRL and SP600125 groups within the same 
time point. 
*
p<0.05, 
#
p<0.01, 
$
p<0.001 compared to D0. 
†
p<0.05, between treatment at same time 
point; (n=2-6) 
 
Autophagy is required for proper myoblast differentiation  
 To determine if autophagy is critical for myoblast differentiation, 3MA, a specific 
autophagy inhibitor which mitigates the activity of the BECN1/PIK3C3 complex was used
112
. T-
reatment of cells with 5mM 3MA resulted in significantly lower (p<0.05) LC3B-II protein and 
GFP-LC3B puncta compared to CTRL cells on all days of differentiation (Fig. 4A & 4B). 
Interestingly, inhibition of autophagy with 3MA resulted in impaired myotube formation and 
fewer tubes expressing myosin (Fig. 4E). More specifically, the differentiation index was 
significantly elevated in CTRL cells beginning on D2 (p<0.001) and continued throughout 
differentiation (p<0.001) (Fig. 4F). Although the differentiation index also increased in 3MA 
treated cells, differentiation was delayed compared to CTRL cells, reaching significance on D3 
(p<0.001) (Fig. 4F).  More importantly, 3MA treated cells had a lower differentiation index on 
D1, D2, D3 and D5 (p<0.01) compared to CTRL cells of the same day (Fig. 4F). Myoblast 
fusion was significantly greater by D3 (p<0.001) in CTRL and 3MA treated cells (Fig. 4G). 
However, fusion was significantly lower in 3MA compared to CTRL cells on D3 (p<0.01) and 
D5 (p<0.001) (Fig. 4G).  
 We next measured myogenin and myosin heavy chain protein content to examine if the 
delayed differentiation was associated with impaired expression of myogenic specific factors. In 
CTRL cells, myogenin protein significantly increased above D0 levels at D2 (p<0.001) and 
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remained elevated at D3 and D5 (p<0.001). In comparison, myogenin protein was not 
significantly elevated until D5 (p<0.001) in 3MA treated cells, and was dramatically lower 
(p<0.05) compared to CTRL cells of the same time point (Fig. 4C). Myosin heavy chain protein 
was significantly increased on D3 in CTRL cells (p<0.001) but was not significantly increased in 
3MA treated myoblasts until D5 (p<0.001). Further, myosin heavy chain protein was 
dramatically lower (p<0.05) in 3MA treated cells compared to CTRL cells of the same time point 
(Fig. 4D). Collectively, these results suggest that the reduction of autophagy by 3MA impairs 
myoblast differentiation. 
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Fig. II - 4: Inhibition of autophagy impairs myoblast differentiation 
(A) Representative images of GFP-LC3B puncta formation in CTRL and 3MA treated 
differentiating myoblasts. Scale bar=10µm. (B) Representative immunoblots of LC3B-I and 
LC3B-II as well as quantitative analysis of LC3B-II from CTRL and 3MA treated C2C12 cells 
during differentiation. A representative Actin immunoblot is also shown as a loading control. (C) 
Representative immunoblots and quantitative analysis of myogenin protein and, (D) myosin 
heavy chain protein in CTRL and 3MA treated C2C12 cells during differentiation. LC3B, 
myogenin, and myosin CTRL and 3MA experiments were conducted and blotted simultaneously 
within the same gel. However, for representative purposes membranes are shown as separate 
CTRL and 3MA images. (E) Representative images of C2C12 myoblast differentiation in CTRL 
and 3MA treated cells. Cells were stained with DAPI (blue) and MF20 (red) to image nuclei and 
myosin heavy chain, respectively. Scale bar=100µm. (F) Quantitative analysis of the 
differentiation index and (G) fusion index in CTRL and 3MA treated cells over 5 days of 
differentiation. A one-way ANOVA was used to examine the effect of differentiation. A 
Students T-Test was used to determine differences between CTRL and 3MA groups within the 
same time points.  
#
p<0.01, 
$
p<0.001 compared to D0. 
†
p<0.05, 
‡
p<0.01, 
¢
p<0.001 between 
treatment at same time point; (n=3-6). 
 
To further confirm the role of autophagy on myoblast differentiation, we performed 
experiments in C2C12 cells stably transfected with ATG7 shRNA (shAtg7) or scramble shRNA 
(SCR). ATG7 protein was markedly reduced in shAtg7 compared to SCR cells, which remained 
throughout differentiation (Fig. 5A). Consistent with this, LC3B-II was dramatically lower in 
shAtg7 cells throughout differentiation (Fig. 5B). Consistent with our 3MA experiments, shAtg7 
cells demonstrated impaired differentiation. Specifically, myosin heavy chain protein content 
dramatically increased throughout differentiation in SCR but not shAtg7 cells. Compared to SCR 
cells, myosin heavy chain expression in shAtg7 cells was significantly lower (p<0.05) on D1, 
D2, D3, and D5 (Fig. 5C). Likewise, the formation of myotubes was rare in shAtg7 cells whereas 
myotubes expressing myosin heavy chain were abundant in SCR cells (Fig. 5D). Together, these 
data support a critical role for autophagy during myoblast differentiation and myotube formation.  
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Fig. II - 5: Inhibition of autophagy by stable ATG7 knockdown inhibits myoblast 
differentiation 
(A) Representative immunoblots of ATG7 protein in shAtg7 and SCR control myoblasts during 
differentiation. (B) Representative immunoblot of LC3B-I and LC3B-II from differentiating 
SCR and shAtg7 cells. (C) Representative immunoblots and quantitative analysis of myosin 
heavy chain protein in SCR and shAtg7 myoblasts throughout differentiation. Also shown are 
representative Actin loading control blots. (D) Representative images of myotube formation in 
SCR and shAtg7 cells at D3 and D5 of differentiation. ATG7 and myosin blots across groups 
were performed simultaneously; however, for representative purposes membranes are shown as 
separate SCR and shAtg7 images. Scale bar=50µm. A one-way ANOVA was used to examine 
the effect of differentiation. A Students T-Test was used to determine differences between CTRL 
and shAtg7 groups within the same time point.  
#
p<0.01, 
$
p<0.001 compared to D0. 
†
p<0.05, 
‡
p<0.01, 
¢
p<0.001 between treatment at same time point; (n=3). 
 
Autophagy protects differentiating myoblasts from apoptosis 
 Throughout differentiation, we observed that 3MA treated cultures had an increase in the 
number of non-adherent cells that were smaller in size (4-11µm), suggesting increased apoptosis. 
To examine the possibility that inhibition of autophagy during myoblast differentiation results in 
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increased apoptosis we first examined the activity of a main death effector enzyme, CASP3
36
. 
Similar to previous results
2
, we observed a transient increase in CASP3 activity during 
differentiation whereby CASP3 activity immediately increased on D0.5 (p<0.01) and continued 
to increase until D1.5 (p<0.001) before dropping down to baseline levels on D3 and D5 (Fig. 
6A). Cells treated with 3MA also demonstrated a transient increase in CASP3 activity. However, 
3MA treatment augmented CASP3 activity compared to CTRL cells on D0.5 (p<0.01), D1 
(p<0.001), D1.5 (p<0.01), D2 (p<0.05), and D3 (p<0.05) (Fig. 6A). These data suggest that 
inhibition of autophagy results in a large transient activation of CASP3 during differentiation.  
To further examine apoptotic events we characterized nuclei with apoptotic morphology such as 
chromatin condensation, a hallmark of apoptosis 
36
. The percentage of apoptotic nuclei was not 
significantly altered in CTRL cells during differentiation. However, 3MA treatment significantly 
(p<0.001) elevated the percentage of apoptotic nuclei throughout differentiation; which was 
significantly higher (p<0.05) then CTRL cells at each time point (Fig. 6B & 6C). Moreover, 
quantification of DNA fragmentation via ELISA revealed higher levels (p<0.05) in CTRL cells 
on D1 which was significantly attenuated (p<0.05) on D3 and D5 of differentiation (Fig. 6D). In 
3MA treated cells, DNA fragmentation also increased on D1 (p<0.001); however, higher levels 
were also observed on D3 and D5 (p<0.05). Relative to CTRL cells, inhibition of autophagy with 
3MA resulted in increased DNA fragmentation on D2, D3 and D5 (p<0.05) (Fig. 6D). In 
agreement with these experiments, SCR cells displayed a transient elevation (p<0.01) in DNA 
fragmentation on D1 which declined (p>0.05) on D2 through to D5. In contrast, shAtg7 cells had 
significantly greater (p<0.05) DNA fragmentation throughout differentiation (Fig. 6E). 
Importantly, shAtg7 cells had dramatically elevated (p<0.01) levels of DNA fragmentation 
compared to SCR controls on D1 through to D5 (Fig. 6E). Overall, these results suggest that 
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inhibition of autophagy results in increased apoptotic events which may be contributing to 
impaired myoblast differentiation.  
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Fig. II - 6: Inhibition of autophagy leads to increased CASP3 activity and apoptosis  
Quantitative analysis of (A) CASP3 activity, and (B) nuclei presenting with apoptotic features in 
CTRL and 3MA treated differentiating myoblasts. (C) Representative images of healthy (arrow) 
and apoptotic (arrow head) nuclei in CTRL and 3MA treated differentiating myoblasts. (D) 
Quantitative analysis of DNA fragmentation in CTRL and 3MA treated differentiating 
myoblasts. (E) Quantitative analysis of DNA fragmentation in shAtg7 and SCR myoblasts 
during differentiation. Scale bar=10µm.  A one-way ANOVA was used to examine the effect of 
differentiation. A Students T-Test was used to determine differences between CTRL and shAtg7 
or CTRL and 3MA groups within the same time point.  
*
p<0.05, 
#
p<0.01, 
$
p<0.001 compared to 
D0. 
†
p<0.05, 
‡
p<0.01, 
¢
p<0.001 between treatment at same time point; (n=3-4) 
 
DISCUSSION 
 Myogenesis involves the terminal differentiation of muscle precursor cells and the fusion 
of mononucleated myoblasts into long syncytial cells
15,16
. Although this process is associated 
with increased protein synthesis and organelle biogenesis/remodeling
51,201
, an increase in 
catabolic processes are required for the execution of the differentiation program and the 
formation of mature myotubes
2,186,202
. Accordingly, our data demonstrate the appearance of GFP-
LC3B puncta, and that autophagic markers such as LC3B-II is elevated while SQSTM1 protein 
is depressed during myoblast differentiation. Importantly, inhibition of lysosomal degradation 
resulted in a significant accumulation of LC3B-II protein and GFP-LC3B puncta in 
differentiating myoblasts, supporting increased autophagic activity during this process. This 
confirms previous research which also shows an increase in LC3B-II in association with 
myoblast differentiation
138
. Similar to skeletal muscle, other cell types which undergo dramatic 
remodeling during differentiation also require the induction of autophagy
188,200,203
. Therefore, it 
stands to reason that autophagy may be rapidly induced upon myoblast differentiation to 
facilitate the elimination of pre-existing structures and proteins in order to promote 
differentiation and remodeling. 
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 The ubiquitin-like conjugation systems involving ATG4B, ATG7 and ATG12-5 as well 
as both the BECN1/PIK3C3 and ULK1 kinase complexes are required for the formation of 
autophagosomes
188,203,204
. Accordingly, we found that changes to these autophagy regulatory 
proteins mirrored the induction of autophagy, further supporting the role of autophagy in 
myoblast differentiation. In agreement, Jacquel et al. demonstrated that silencing of ATG5, 
ATG7, BECN1 and ULK1 can inhibit the production of LC3B-II as well as impair macrophagic 
differentiation
203
.   
 Myoblast differentiation requires the coordinated expression and activity of myogenic 
regulatory factors
16
. For example, impaired myogenin expression can inhibit terminal 
differentiation as well as delay markers of myotube formation
22,25,205
. We found that chemical 
inhibition of autophagy with 3MA delayed myogenin and myosin heavy chain expression, as 
well as impaired myoblast fusion and differentiation. Previous work has shown that targeted 
knockdown of ATGs in myogenic factor 5 expressing cells results in smaller myotubes along 
with reduced myogenic regulatory factor mRNA
206
. In agreement with these finding, we found 
that ATG7 knockdown resulted in dramatically lower myosin heavy chain protein expression as 
well as impaired myotube formation during differentiation. Thus, these data confirm that 
autophagy is required for proper muscle differentiation. Interestingly, there is also evidence that 
too much autophagy during muscle differentiation is detrimental
207
. Together with our results, 
this highlights the importance of regulated autophagy during myoblast differentiation.  
 The activation of several common signaling cascades regulates both muscle 
differentiation and autophagy. Myoblast differentiation requires the activation of the 
phosphoinositide 3-kinase-AKT axis for the promotion of myogenic regulatory factor activity 
and suppression of FOXO transcriptional activity
46,208
; however, FOXO3A also promotes the 
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transcription of several autophagy related genes
3,192
. AKT can also inhibit autophagy by 
increasing MTOR activity
3,209
. Although several reports confirm the requirement of MTOR 
activity in skeletal muscle differentiation, Tanida et al. found that increased MTOR activity 
occurs despite an elevation in LC3B-II content in differentiating C2C12 myoblasts
138
. Similarly, 
despite observing a gradual increase in AKT and FOXO3A phosphorylation during myoblast 
differentiation in this study, an increase in autophagy was observed. We suggest that the elevated 
AKT signaling along with increased pFOXO3A at D3 may be important in mitigating a further 
increase in autophagy; thus, contributing to a fine balance between too much and too little 
autophagy during myoblast differentiation.   
 MAPKs play an important role in both myoblast differentiation and autophagy
13,37
. In the 
current study we observed a transient increase in JNK1 phosphorylation which coincided with 
the dissociation of BCL2 from BECN1. JNK1 can promote autophagy by phosphorylating BCL2 
which results in its dissociation from BECN1 allowing for enhanced activity of PIK3C3
125
. 
Accordingly, an increase in BCL2 has previously been shown to inhibit autophagy by 
suppressing the activity of the BECN1 complex
116,117
. In this study, the temporal pattern of JNK 
phosphorylation was similar to the dissociation of BCL2 from BECN1. This also corresponded 
to an increase in LC3B-II protein content and GFP-LC3B puncta during differentiation. 
Moreover, chemical inhibition of JNK activity resulted in higher BECN1:BCL2 association and 
a reduction in LC3B-II protein and GFP-LC3B puncta. Similarly, the induction of JNK activity 
in differentiating macrophages was shown to mediate the dissociation of BECN1 and BCL2 as 
well as contribute to the induction of autophagy and monocyte survival
200
. Collectively, our data 
supports a role for JNK1 in promoting autophagy during myoblast differentiation through the 
disassociation of BECN1:BCL2 complexes.   
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 Apoptotic signaling has been shown to play an important regulatory role in promoting 
myoblast differentiation. For example, the transient activation of CASP3 is essential for the 
formation of myotubes 
2
. However, the induction of apoptotic signaling must be highly regulated 
in order to avoid the loss of cell viability
210
. Previous work has shown that autophagy can protect 
cells from apoptosis by regulating the induction of caspase activity
12
. The present results suggest 
that autophagy may regulate CASP3 activation during myoblast differentiation and thus may 
influence cell viability. Specifically, we found that inhibition of autophagy using 3MA 
significantly elevated CASP3 activity, increased the percentage of nuclei with apoptotic 
morphology, and augmented DNA fragmentation throughout differentiation. Knockdown of 
ATG7 also increased DNA fragmentation confirming that autophagy is required to protect 
differentiating myoblasts from cell death. In agreement with our results, autophagy is required to 
protect against cell death during monocyte-macrophage differentiation
200
. Interestingly, JNK 
inhibition not only impairs monocyte differentiation, but results in lower autophagy and 
increased cell death
200
. Collectively, our data suggests that autophagy protects myoblasts from 
apoptosis during differentiation.  
 In conclusion, the induction of autophagy-related proteins and autophagic flux 
throughout the differentiation period demonstrates a role for autophagy in myoblast 
differentiation. This study demonstrates that the induction of autophagy occurs and is required 
for myoblast differentiation; a process which involves JNK-mediated regulation of 
BECN1:BCL2 signaling. Importantly, the inhibition of autophagy not only impairs myoblast 
differentiation and fusion, but is associated with increased apoptotic signaling, including 
elevated CASP3 activity, DNA fragmentation, and nuclear condensation. We propose that 
impaired myoblast differentiation in the absence of autophagy is likely due to diminished cell 
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viability. Together, the results of this work demonstrate a critical role for autophagy during 
myoblast differentiation.  
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CHAPTER III – Autophagy regulates mitochondrial-mediated apoptosis during myoblast 
differentiation 
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OVERVIEW 
Autophagy is an essential degradative process involved in myoblast differentiation. We have 
previously shown that the inhibition of autophagy results in increased apoptosis and impaired 
myotube formation. The purpose of the present study was to further examine the role of 
autophagy in myoblast differentiation with particular emphasis on mitochondrial stress/apoptotic 
signaling. Similar to previous results, an increase (p<0.05) in LC3B-II and ATG7 protein was 
observed early during differentiation. Furthermore, the induction of myoblast differentiation was 
associated with an increase (p<0.05) in GFP-LC3:pDsRed2-Mito co-localization and LC3B-II 
protein content in mitochondrial-enriched fractions. shRNA-mediated knockdown of ATG7 
resulted in an increase (p<0.05) in CASP3 activity, Annexin V staining, and a decrease of 
mitophagy markers. Inhibition of autophagy increased (p<0.05) CAPN activity, HSP70 protein 
content, mitochondrial permeability transition pore formation, as well as reduced mitochondrial 
membrane potential. We also observed an increase in mitochondrial-mediated apoptotic 
signaling events such as increased (p<0.05) cytosolic CYTO C protein and CASP9 activity in 
shAtg7 cells. Attenuation (p<0.05) of CASP3 activity in shAtg7 cells early during differentiation 
partially restored (p<0.05) MHC protein content, as well as differentiation and fusion indexes. 
Together, this data demonstrates a role for autophagy in protecting differentiating myoblasts 
from mitochondrial-mediated apoptotic signaling.  
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INTRODUCTION 
 The formation of mature skeletal muscle requires mononucleated myoblasts to endure 
tremendous levels of cell stress
29,31,211
. In fact, skeletal muscle development requires the 
induction of potentially lethal apoptotic signaling
2
. During apoptosis the cleavage of numerous 
intracellular proteins results in regulated cellular dismantling and packaging of cellular material 
into apoptotic bodies which are subsequently removed by immune cells
4
. However, apoptotic 
events such as phosphatidylserine exposure and submaximal/transient caspase (CASP) activation 
are integral for normal myoblast differentiation and myotube formation
2,58,60
.  
 How apoptotic signaling is induced during skeletal muscle differentiation and how it 
contributes to cell specialization instead of cell death is inconclusive
210
. Evidence suggests that 
canonical apoptotic pathways may be involved in CASP3 activation
2
, including the apoptotic 
proteases CASP12 and CASP8
29,212
. Of particular interest is the observation that CASP9 activity 
has been shown to contribute to the activation of CASP3 during myogenesis
211
; although its 
involvement has recently been disputed
42
. Typically, engagement of the mitochondrial-mediated 
pathway of apoptosis and the activation of CASP9 is considered a point of no return in cell death 
signaling
89
. Mitochondrial-mediated apoptotic signaling often requires a decline in mitochondrial 
membrane potential, a loss of mitochondrial membrane integrity, and full release of CYTO C
89
. 
As a result, the cell undergoes a rapid loss of ATP followed by the activation of cell death 
amplification loops
89
. However, some research suggests that the activation of mitochondrial-
mediated pathways may not be an all or nothing event
210
. For example, during lens cell 
differentiation, a submaximal release of CYTO C results in the activation of caspases below the 
threshold required to induce cell death
213
. Similarly, active CASP12, CASP9 and CASP3 is 
detected in myoblasts which continue to differentiate
29,30
; however, their levels are significantly 
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greater in myoblasts which have undergone developmentally regulated apoptosis
29,30
. Together, 
these results suggest that the level of caspase activity and apoptotic stress must be maintained at 
sub-apoptotic levels in cells which progress through the myogenic program. Recent evidence 
suggests that CASP9 may not be directly involved in myoblast differentiation
42
. However, 
additional observations demonstrate that CASP12 and CASP9 are elevated in dead 
differentiating myoblasts suggesting that the level of mitochondrial-mediated apoptotic signaling 
occurring during myoblast differentiation must be regulated to protect myoblasts from cell death. 
Therefore, factors which control mitochondrial viability and integrity may be essential in the 
regulation of apoptotic signaling and cell death during myoblast differentiation. 
 Autophagy is a degradative process intimately involved with the cells stress response
12
. 
Accordingly, autophagy is induced by the stress related kinase JNK during myoblast 
differentiation
214
. Interestingly, recent work in our lab demonstrates that a loss of autophagy via 
3MA administration or knockdown of ATG7 impairs myoblast differentiation and result in cell 
death
214
. Therefore, autophagy plays a critical role in regulating cell death signaling during 
myoblast differentiation. Although autophagy was originally characterized as a bulk degradation 
system, autophagy is now understood to be far more sophisticated, being able to target and 
selectively remove damaged, superfluous or dysfunctional proteins and organelles
12
. The 
clearance of mitochondria through autophagic processes is known as mitophagy and occurs as a 
protective response to mitochondrial damage 
215,216
. The removal of damaged mitochondria prior 
to the induction of mitochondrial-mediated apoptotic signaling has been shown to regulate the 
promotion of cell death and mitigation of cell stress
12
. Therefore, we hypothesize that autophagy 
may protect myoblasts from apoptosis by regulating the level of caspase activity and cellular 
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stress which occurs during myogenesis specifically through the regulation of mitochondrial-
mediated apoptotic signaling which has not yet been investigated.   
 
METHODS 
Transfections and Cell culturing  
 Mouse C2C12 skeletal myoblasts (ATCC) were plated at a low passage in polystyrene 
cell culture dishes (BD Biosciences) in growth media (GM) consisting of low-glucose 
Dulbecco’s Modified Eagles Medium (DMEM; Hyclone, Thermo Scientific) containing 10% 
fetal bovine serum (FBS; Hyclone, Thermo Scientific) with 1% penicillin/streptomycin 
(Hyclone, Thermo Scientific) and incubated at 37ºC in 5% CO2. Myoblast differentiation was 
induced once C2C12 myoblasts reached 80-90% confluence by replacing GM with 
differentiation media (DM) consisting of DMEM supplemented with 2% horse serum (Hyclone, 
Thermo Scientific) and 1% penicillin/streptomycin. Subconfluent myoblasts were collected prior 
to the addition of DM (D0) as well as at 12 hrs (D0.5), 24 hrs (D1), 36 hrs (D1.5), 48 hrs (D2), 
72 hrs (D3) and 120 hrs (D5) following the addition of DM.  
 C2C12 cells stably expressing shRNA against ATG7 or scramble control sequence (SCR) 
CTRL were generated as previously described
214
. Stably transfected C2C12 cells were co-
transfected with GFP-LC3B (generously provided by Dr. Terje Johansen, Institute of Medical 
Biology; University of Tromsᴓ) and pDsRed2-Mito (generously provided by Dr. D. R. Green, St 
Jude’s Children’s Research Hospital, Memphis, Tennessee) plasmid DNA to investigate the 
percentage of cell with co-localization of autophagic puncta with mitochondria during 
differentiation. Cells were transfected upon reaching 60-70% confluence on gelatin coated glass 
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coverslips, and induced to differentiate 36 hr following transfection. Transfections were 
performed with Lipofectamine 2000 (Life Technologies) optimized according to the 
manufactures instructions. Glass coverslips with co-transfected cells were removed from culture 
dishes, washed in warm PBS and mounted on glass slides using Prolong Gold Antifade Reagent 
(Life Technologies) prior to imaging on an Axio Observer Z1 fluorescent microscope equipped 
with a Apotome/structured-illumination system (Carl Zeiss). Co-localization analysis was 
conducted using AxioVision Software. 
 Attenuation of caspase activity was achieved with either CASP3 inhibitor (Ac-DEVD-
CHO; Enzo Life Sciences) or CASP9 inhibitor (Ac-LEHD-CHO; Enzo Life Sciences). Both 
inhibitors are cell permeable and have been documented to effectively inhibit the activity of 
CASP3 directly or indirectly via inhibition of upstream CASP9 activity. CASP3 activity was 
attenuated in shAtg7 CTRL cells using 1.5 µM and 1 µM of CASP9 and CASP3 inhibitors, 
respectively. Differentiating myoblasts were exposed to caspase inhibitors or equal volumes of 
DMSO in DM during all days of differentiation and replaced with new media/drug every 24 
hours.   
Cell Isolations and Acquisition of Enriched Subcellular Fractions 
 For whole cell lysates, cells were removed from culture dishes by trypsinization (0.25% 
trypsin with 0.2g/L EDTA; Thermo Scientific), and collected by centrifugation (800 x g for 5 
min). Cell pellets were resuspended and washed in ice cold PBS, centrifuged (800 x g for 5 min) 
and then frozen at -80°C until further analysis. 
 Fresh cells were separated into cytosolic-, mitochondrial- and nuclear-enriched 
subcellular fractions. Briefly, cells were resuspended and incubated in digitonin buffer (PBS with 
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250 mM sucrose, 80 mM KCl, and 50 µg/mL digitonin, Sigma Aldrich) for 5 min on ice. Cells 
were then centrifuged at 1000 x g for 10 min, the supernatant was then centrifuged at 16,000 x g 
for 10 min to pellet mitochondrial contamination. The supernatant was removed and frozen as 
the cytosolic-enriched fraction. The pellet from the 1000 x g spin was resuspended in ice cold 
PBS and centrifuged at 1000 x g for 5 min. The pellet was then resuspended in lysis buffer (20 
mM HEPES, 10 mM NaCl, 1.5 mM MgCl, 1 mM DTT, 20% glycerol and 0.1% Triton X-100; 
pH 7.4) and incubated on ice for 5 min before centrifugation at 1000 x g for 10 min. The 
supernatant containing mitochondria was isolated and centrifuge for 10 min at 1000 x g to 
remove nuclear contamination. The resulting supernatant was removed and frozen as the 
mitochondrial-enriched fraction. The pellet was resuspended in lysis buffer, centrifuged at 1000 
x g for 10 min. The pellet was resuspended in lysis buffer and sonicated for 20 seconds and 
frozen as the nuclear-enriched fraction. Protein content of whole cell and subcellular fractions 
was determined using the BCA protein assay. Purity of subcellular fractions was determined 
through immunoblotting for CuZnSOD (SOD1) (cytosol), MnSOD (SOD2) (mitochondria), and 
histone H2B (nucleus). 
Immunoblotting 
 Immuoblotting was conducted as previously described
214
. Briefly, cells were lysed in ice 
cold lysis buffer with or without protease inhibitor (Roche Applied Sciences). Equal amounts of 
cell lysates were loaded and separated on 7.5-15% SDS-PAGE gels, transferred onto PVDF 
membranes (Bio-Rad Laboratories), and blocked for 1 hr at room temperature or overnight at 
4°C with 5% milk-Tris-buffered saline-Tween 20 (milk-TBST). Membranes were incubated 
either overnight at 4°C or for 1 hr at room temperature with primary antibodies against: BECN1, 
ATG7, LC3B (Cell Signaling Technology); BCL2, BAX, ARC, CYTO C, AIF (Santa Cruz 
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Biotechnology); Myogenin (MYOG), myosin heavy chain (MYH) (Developmental Studies 
Hybridoma Bank); BNIP3, Actin (Sigma-Aldrich); Catalase (CAT), HSP70, SOD2, SOD1 
(Stressgen Bioreagents); histone H2B (Enzo Life Sciences); and 4-HNE (Abcam). Membranes 
were then washed with TBST, incubated with the appropriate horseradish peroxidase (HRP)-
conjugated secondary antibodies (Santa Cruz Biotechnology) for 1 hr at room temperature, 
washed with TBST, and bands visualized using enhanced chemiluminescence western blotting 
detection reagents (BioVision) and the ChemiGenius 2 Bio-Imaging System (Syngene). The 
approximate molecular weight for each protein was estimated using Precision Plus Protein 
WesternC Standards and Precision Protein Strep-Tactin HRP Conjugate (Bio-Rad Laboratories). 
Equal loading and quality of transfer was confirmed by staining membranes with Ponceau S 
(BioShop). 
Flow Cytometry 
 Cells were collected and washed/resuspended in Hank’s Balanced Salt Solution (HBSS). 
Mitochondrial membrane depolarization was monitored by changes in the JC-1 red:green 
fluorescence ratio. A decreased ratio is indicative of decreased mitochondrial membrane 
potential. Briefly, cells were incubated with 2 μM JC-1 (Life Technologies) in HBSS for 15 min 
at 37 °C. Following incubation, cells were washed by centrifugation and resuspended in HBSS. 
 Calcein AM was used to measure the formation of the mitochondrial permeability 
transition pore (mPTP). The fluorescent dye calcein AM which accumulates in intact 
mitochondria is quenched by cobalt following mitochondrial membrane permeabilization. Thus, 
a decrease in calcein fluorescence is indicative of mPTP formation. Briefly, cells were incubated 
with 1 μM calcein AM (Life Technologies) and 1 mM CoCl2 in HBSS for 15 min at 37°C. 
Following incubation, cells were washed by centrifugation and resuspended in 500 μl HBSS.  
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 For analysis of phosphatidylserine (PS) exposure Annexin V staining was performed. 
Briefly, cells were washed in PBS then resuspended in buffer (10 mM HEPES/NaOH, 150 mM 
NaCl, 1.8 mM CaCl2; pH 7.4). Cells were then incubated with 5 µl of Annexin V-FITC 
(BioVision) for 20 min at room temperature. All analyses were performed on a flow cytometer 
(BD FACSCalibur) equipped with Cell Quest Pro software (BD Bioscience) as previously 
described
93
. 
Proteolytic Enzyme Activity Assay and ROS Generation 
 Enzymatic activity of CASP3 and CASP9 was determined using the substrates Ac-
DEVD-AMC and Ac-LEHD-AMC (Enzo Life Sciences), respectively, as previously 
described
93,214
. Enzymatic activity of calpain (CAPN) was assessed using the fluorogenic 
substrate Suc-LLVY-AMC (Enzo Life Sciences) as previously described
93
. Measurement of 
ROS generation was conducted as previously demonstrated using 5 µM DCFH-DA (Life 
Technologies)
217
. CASP, CAPN and DCF fluorescence was normalized to total protein content 
and expressed as arbitrary units (AU) per milligram protein.  
Fluorescence Microscopy  
 Immunofluorescence analysis of MYH expression was determined on cells grown on 
glass coverslips in culture dishes following their removal at indicated time points as previously 
described
214
. Briefly, coverslips were washed 2 x 5 min with PBS. Cells were fixed with 4% 
formaldehyde in PBS for 10 min at room temperature, and washed 2 x 5 min with PBS. Cells 
were permeabilized for 10 min with 0.5% Triton X-100, and then washed 2 x 5 min in PBS. 
Cells were blocked with 10% goat serum (Sigma-Aldrich) (in PBS) for 30 min, then incubated 
with a primary antibody against MYH (Developmental Studies Hybridoma Bank; MF20) diluted 
in blocking solution for 2 hr, and washed 2 x 5 min with PBS. An anti-mouse PE-conjugated 
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secondary antibody (Santa Cruz) was made in 10% goat serum blocking solution. Cells were 
incubated in secondary solution for 1 hr, washed 2 x 5 min in PBS, counterstained with DAPI 
nuclear stain (Life Technologies) for 5 min, then washed 2 x 5 min in PBS. Coverslips were 
mounted with Prolong Gold Antifade Reagent (Life Technologies). Slides were visualized with 
an Axio Observer Z1 fluorescent microscope equipped with standard Red/Green/Blue filters, an 
AxioCam HRm camera, and AxioVision software (Carl Zeiss). The fusion index was calculated 
as a percentage of nuclei present in multinucleated (two or more nuclei) cells relative to total 
nuclei present and represents the formation of nascent myotubes. The differentiation index was 
calculated as the percentage of cells expressing MYH relative to total number of cells. 
Statistics  
 A One-Way repeated measure ANOVA was used to assess the effect of differentiation. If 
a main effect of differentiation was observed, Tukey’s post hoc test was used to determined 
differences from D0. Differences between time-matched SCR and shAtg7 cells were assessed 
using a Students T-Test. A Two-Way ANOVA was used to assess the effects of differentiation in 
caspase inhibitor experiments with the use of a Tukey’s post-hoc test where appropriate. For all 
experiments p<0.05 was considered statistically significant. 
 
RESULTS 
Inhibition of autophagy impairs myoblast differentiation and myoblast fusion 
 C2C12 myoblasts stably transfected with a scramble control plasmid (SCR) had 
significantly elevated (p<0.05) LC3B-I and LC3B-II protein content throughout differentiation 
compared to D0 (Fig. 1A, B). Interestingly, the LC3B-II/I ratio was only elevated (p<0.05) on 
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D0.5 and D5 (p<0.01; Fig. 1A, B). Autophagosome formation requires the assembly and 
activation of several protein complexes which direct its creation and substrate targeting
9
. Similar 
to previous results
214
, ATG7 protein content was increased (p<0.05) during differentiation 
beginning on D1 (Fig. 1B, C). Additionally, the protein levels of BECN1 and BNIP3 were 
elevated (p<0.05) on D3 and D5 compared to D0. These results support our previous findings 
demonstrating increased autophagy during myoblast differentiation
214
.  
 Consistent with our previous report
214
, stable knockdown of ATG7 (shAtg7) resulted in 
impaired differentiation compared to SCR cells (Fig. 1E). MYOG was elevated (p<0.05) in SCR 
cells but was decreased (p<0.05) throughout differentiation in shAtg7 cells (Fig.1F). This 
resulted in dramatically lower MYOG protein during differentiation in shAtg7 cells compared to 
SCR cells (Fig 1F). In agreement with our previous results, ATG7 knockdown attenuated the 
formation of myosin-positive myotubes during differentiation (Fig. 1E). Accordingly, shAtg7 
cells displayed significantly decreased (p<0.01) cell fusion and differentiation indexes on D3 
(p<0.01) and D5 (p<0.001) compared to SCR cells (Fig. 1G & 1H).  
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Fig. III - 1: Autophagy is induced during and required for myoblast differentiation  
(A) Quantitative analysis of LC3B-I, LC3B-II and LC3B-II/I protein ratio during myoblast 
differentiation. (B) Representative immunoblots of LC3B-I, LC3B-II, ATG7, BECN1, and 
BNIP3 protein in differentiating myoblasts. (C) Quantitative analysis of ATG7, BECN1 and 
BNIP3 protein during myoblast differentiation. (D) Representative immunoblots of ATG7, 
LC3B-I and LC3B-II protein in SCR and shAtg7 cells. (E) Representative images of C2C12 
myotube formation in SCR and shAtg7 cells at D3 and D5 of differentiation. Cells were stained 
with DAPI (blue) and MF20 (red) to image nuclei and MYH, respectively. Scale bar=100 µm. 
(F) Representative immunoblots and quantitative analysis of MYOG protein in SCR and shAtg7 
myoblast cells during differentiation. Quantitative analysis of the (G) fusion index and (H) 
differentiation index in SCR and shAtg7 cells on D0, D3 and D5 of differentiation. Also shown 
are representative Actin loading control blots.  Representative immunoblots of MYOG were 
blotted simultaneously. However, for representative purposes membranes are shown as separate 
SCR and shAtg7 images. A one-way ANOVA was used to examine the effect of differentiation. 
A Students T-Test was used to determine differences between CTRL and shAtg7 groups within 
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the same time point.  *p<0.05, 
#
p<0.01, 
$
p<0.001 compared to D0. 
†
p<0.05, 
‡
p<0.01, 
¢
p<0.001 
between treatment at same time point; (n=3-5).  
 
Inhibition of autophagy during myoblast differentiation results in apoptotic features 
 Inhibition of autophagy during myoblast differentiation results in increased DNA 
fragmentation, a hallmark of apoptosis
200,214
. In the current study we add to this finding by 
demonstrating that ATG7 knockdown results in increased (p<0.05) Annexin staining early 
(p<0.05) and throughout (p<0.001) differentiation in shAtg7 cells (Fig 2A). Interestingly, 
Annexin levels were higher (p<0.05) in SCR on D0 compared to shAtg7 cells; however, 
Annexin staining was greater (p<0.05) in shAtg7 cells throughout differentiation. An increase 
(p<0.05) in CASP3 activity was observed in both SCR and ATG7 cells during differentiation
214
 
(Fig 2B); however, levels were significantly greater in shAtg7 compared to SCR at each time 
point (p<0.01) (Fig 2B). In addition, shAtg7 cells displayed increased (p<0.01) CAPN 
proteolytic activity early during differentiation (D0.5, D1, D1.5 and D2) compared to SCR cells 
(Fig. 2C). However, CAPN activity was reduced (p<0.05) below D0 levels in SCR and shAtg7 
cells on D3 and D5 (Fig. 2C). 
 Changes to BCL2 family proteins often occur during the induction of apoptosis
68
. 
Interestingly, neither SCR nor shAtg7 myoblasts demonstrated a change (p>0.05) in BAX 
protein levels during differentiation (Fig 2D); however, levels were higher in shAtg7 cells on D2 
and D3 (Fig 2D). BCL2 protein was increased (p<0.05) on D1 and D2 in SCR but not shAtg7 
cells (Fig 2E). Accordingly, significantly higher (p<0.01) BCL2 protein levels were observed in 
SCR compared to shAtg7 cells on D0.5, D1, D2 and D3 (Fig 2E). In addition, the BAX:BCL2 
ratio was lower (p<0.05) on D1, D2 and D5 compared to D0 in SCR but not shAtg7 cells (Fig 
2F).  
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 The anti-apoptotic protein, ARC, increased (p<0.01) on D5 compared to D0 in SCR but 
not shAtg7 cells (Fig 2H). Further, ARC content was significantly greater (p<0.01) on D0.5, D1, 
and D2 of differentiation in SCR compared to shAtg7 cells (Fig 2H). Interestingly, HSP70 
decreased (p<0.05) throughout differentiation in SCR cells (Fig. 2G). In contrast, shAtg7 cells 
demonstrated a robust increase (p<0.05) in HSP70 protein content during differentiation, 
resulting in dramatically higher (p<0.01) levels at each time point when compared to SCR cells 
(Fig. 2G). Together, the elevated Annexin staining, increased CASP3 activity, and changes to 
critical anti-apoptotic proteins support our previous findings of altered cellular stress and 
apoptosis in autophagy-deficient myoblasts during differentiation.  
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Fig. III - 2: Inhibition of autophagy during myoblast differentiation alters proteolytic 
activity and apoptotic protein content  
(A) Quantitative analysis of Annexin staining in SCR and shAtg7 differentiating myoblasts. (B) 
CASP3 activity and (C) CAPN activity in SCR and shAtg7 cells during differentiation. 
Representative immunoblots and quantitative analysis of (D) BAX protein and (E) BCL2 protein 
content and (F) BAX/BCL2 protein ratio in SCR and shAtg7 myoblast cells during 
differentiation. Representative immunoblots and quantitative analysis of (G) HSP70 and (H) 
ARC protein in SCR and shAtg7 myoblast cells during differentiation. Also shown are 
representative Actin loading control blots. Representative immunoblots of BAX, BCL2, HSP70, 
ARC and Actin protein in SCR and shAtg7 cells were blotted simultaneously. However, for 
representative purposes membranes are shown as separate SCR and shAtg7 images. A one-way 
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ANOVA was used to examine the effect of differentiation. A Students T-Test was used to 
determine differences between CTRL and shAtg7 groups within the same time point.  *p<0.05, 
#
p<0.01, 
$
p<0.001 compared to D0. 
†
p<0.05, 
‡
p<0.01, 
¢
p<0.001 between treatment at same time 
point; (n=3-5). 
 
Autophagy prevents oxidative damage and ROS generation in myoblasts and 
differentiating myocytes 
 Previous reports have shown that in the absence of autophagy, changes to the redox 
environment can contribute to cellular stress and apoptosis
216
. Here, SCR myoblasts showed 
reduced (p<0.01) ROS generation beginning on D2 of differentiation (Fig 3A). However, shAtg7 
cells displayed increased (p<0.05) whole-cell ROS generation on D1, D1.5 and D5 (Fig 3A). As 
a result, shAtg7 cells displayed greater (p<0.01) ROS generation compared to SCR cells 
beginning on D1 (Fig 3A). In response to increased ROS generation, oxidative stress and cell 
damage can occur if antioxidant defences are not sufficient
216
. In both SCR and shAtg7 cells, 
CAT protein content was decreased (p<0.05) during differentiation (Fig. 3B). Interestingly, 
shAtg7 cells had higher (p<0.01) CAT expression than SCR cells on D0 (Fig 3B). Conversely, 
levels of CAT in SCR cells were greater than shAtg7 cells on D1 (p<0.001), D3 (p<0.01) and D5 
(p<0.01) (Fig 3B). SOD1 expression was increased (p<0.05) on D5 in SCR cells but did not 
change throughout differentiation in shAtg7 cells (Fig. 3C). However, SOD1 levels were higher 
(p<0.05) in shAtg7 compared to SCR cells on D0 and D0.5 (Fig. 3C). SOD2 protein expression 
increased (p<0.01) in shAtg7 cells by D2 and continued to rise throughout differentiation (Fig. 
3C). Similarly, SCR myoblasts displayed increased (p<0.05) SOD2 on D3 and D5 compared to 
D0 (Fig. 3C). Interestingly, SOD2 content was greater (p<0.01) in shAtg7 compared to SCR 
cells on D2, D3 and D5. The levels of lipid peroxidation in mitochondrial-enriched fractions of 
SCR cells was greater (p<0.05) than D0 from D1 throughout differentiation (Fig. 3E & F). 
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However, in shAtg7 myoblasts, the level of lipid peroxidation in mitochondrial-enriched 
fractions was significantly greater (p<0.001) than SCR on D0 and D0.5 but declined their after to 
levels similar to SCR cells (Fig. 3E & F). Collectively, the inhibition of autophagy resulted in 
altered ROS defences as well as markers of oxidative damage during differentiation. 
 
 
Fig. III - 3: Inhibition of autophagy during myoblast differentiation alters the expression of 
antioxidant and ROS generation 
(A) Quantitative analysis of ROS generation in SCR and shAtg7 myoblasts during 
differentiation. Representative immunoblots and quantitative analysis of (B) CAT, (C) SOD1, 
and (D) SOD2 in SCR and shAtg7 myoblast cells during differentiation. (E) Representative 
immunoblot and (F) quantitative analysis of 4-HNE content from mitochondrial-enriched 
fractions of SCR and shAtg7 myoblasts during differentiation. Also shown are representative 
Actin loading control blots. Representative immunoblots of CAT, SOD1, SOD2 and Actin 
protein in SCR and shAtg7 cells were blotted simultaneously. However, for representative 
purposes membranes are shown as separate SCR and shAtg7 images. A one-way ANOVA was 
used to examine the effect of differentiation. A Students T-Test was used to determine 
differences between CTRL and shAtg7 groups within the same time point.  *p<0.05, 
#
p<0.01, 
$
p<0.001 compared to D0. 
†
p<0.05, 
‡
p<0.01, 
¢
p<0.001 between treatment at same time point; 
(n=3-4). 
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Markers of mitophagy are altered during myoblast differentiation 
 The removal of damaged mitochondria may regulate apoptotic signaling during muscle 
differentiation. However, mitophagy has not been previously studied in this context. Our results 
show increased (p<0.01) co-localization of mitochondria and autophagic puncta on D0.5 
compared to D0 in SCR cells (Fig. 4D & E). This effect remained (p<0.001) on D1 but subsided 
by D2, indicating the co-localization of mitochondria and autophagosomes in C2C12 cells is 
rapid and transient during differentiation (Fig. 4D & E). Compared to shAtg7 cells, the level of 
co-localization was greater (p<0.01) in SCR cells at each time point (Fig. 4D & E). In addition, 
we observed increased (p<0.05) LC3B-II protein content in mitochondrial-enriched subcellular 
fractions of SCR cells on all days of differentiation compared to D0 (Fig. 4B). LC3B-II protein 
in mitochondrial fractions was not altered during differentiation in shAtg7 cells, and was also 
dramatically reduced (p<0.05) compared to SCR cells (Fig. 4B). These results support the 
induction of mitophagy during myoblast differentiation. 
 Mitophagy is regulated by a diverse array of signaling events originating at the 
mitochondria
215
. One of the initiators of mitophagy is the reduction in mitochondrial membrane 
potential
215
. Early during differentiation both SCR and shAtg7 myoblast showed reduced 
(p<0.001) mitochondrial membrane potential compared to D0 levels. However, compared to 
SCR cells, shAtg7 cells had significantly reduced (p<0.001) membrane potential at all-time 
points (Fig. 4C). Together, this data demonstrates that myoblast differentiation results in changes 
to mitochondrial membrane potential, which may participate in the induction of mitophagy.  
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Fig. III - 4: Myoblast differentiation is associated with increased markers of mitophagy 
which are inhibited in the absence of ATG7 
(A) Representative immunoblots of histone H2B, SOD1 and SOD2 protein in nuclear- (nuc) 
mitochondrial- (mito) and cytosolic-enriched (cyto) subcellular fractions. (B) Representative 
immunoblots and quantitative analysis of LC3B-II protein in mitochondrial-enriched subcellular 
fractions. Also shown is a representative ponceau stained membrane to display equal protein 
loading and quality of transfer. (C) Quantitative analysis of the JC-1 red:green fluorescence ratio 
in SCR and shAtg7 myoblasts during differentiation. (D) Quantitative analysis of GFP-LC3B 
and pDsRed2-Mito co-localization. Scale bar=25 µm.  (E) Representative images of GFP-LC3B 
and pDsRed2-Mito co-transfected SCR and shAtg7 myoblasts during early time points of 
differentiation. Representative immunoblots of LC3B protein in SCR and shAtg7 cells were 
blotted simultaneously. However, for representative purposes membranes are shown as separate 
SCR and shAtg7 images. A one-way ANOVA was used to examine the effect of differentiation. 
A Students T-Test was used to determine differences between CTRL and shAtg7 groups within 
the same time point.  *p<0.05, 
#
p<0.01, 
$
p<0.001 compared to D0. 
†
p<0.05, 
¢
p<0.001 between 
treatment at same time point; (n=2-3). 
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Inhibition of autophagy results in increased mitochondrial-mediated apoptotic signaling 
during myoblast differentiation 
 Mitochondrial apoptotic signaling begins with the loss of mitochondrial membrane 
integrity through processes such as opening of the mitochondrial permeability transition pore
89
 . 
Decreased (p<0.05) calcein fluorescence (indicative of mPTP formation) was observed on D1, 
D2 and D3 compared to D0 in shAtg7 cells (Fig. 5A). In contrast, SCR cells displayed increased 
(p<0.001) calcein fluorescence from D1 to D3 of differentiation (Fig. 5A).  Interestingly, the 
level of calcein fluorescence was lower (p<0.001) in shAtg7 at all measured time points, 
indicating a more permeable mitochondrial membrane in autophagy-deficient myocytes. 
Following the permeabilization of mitochondrial membranes, the release of proteins such as 
CYTO C and AIF can promote the induction of apoptosis
36
. Both SCR and shAtg7 cells had a 
transient increase (p<0.05) in cytosolic CYTO C during differentiation (Fig. 5 & D). However, 
the level of cytosolic CYTO C protein content was greater (p<0.01) in shAtg7 compared to SCR 
cells during all days of differentiation (Fig. 5B & D). The release of mitochondrial CYTO C 
promotes the activation of CASP9
99
. In contrast to SCR cells, shAtg7 cells displayed elevated 
(p<0.05) CASP9 activity early during differentiation (Fig. 5E). Mitochondrial disruption can also 
contribute to caspase-independent forms of cell death through AIF-induced DNA 
fragmentation
36
. Cytosolic AIF was greater (p<0.05) on D3 than D0 in SCR cells (Fig. 5C & D). 
Interestingly, the level of cytosolic AIF was significantly greater (p<0.01) in shAtg7 than SCR 
myoblasts on D0 and D0.5 (Fig. 5C & D). For AIF to promote DNA fragmentation, it must 
translocate to the nucleus. While nuclear AIF levels increased (p<0.05) on D3 of differentiation 
in SCR cells, this increase (p<0.05) occurred on D0.5 in shAtg7 cells (Fig 5F & G). Collectively, 
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this data demonstrates that autophagy contributes to the regulation of mitochondrial-mediated 
apoptotic signaling during myoblast differentiation.   
 
Fig. III - 5: Inhibition of autophagy during myoblast differentiation promotes increased 
mitochondrial-mediated apoptotic signaling  
(A) Qualitative analysis of calcein fluorescence (where a decrease is indicative of mitochondrial 
permeability transition pore formation) in SCR and shAtg7 myoblasts during early 
differentiation. Quantitative analysis of cytosolic (B) CYTO C and (C) AIF protein as well as 
(D) representative immunoblots of cytosolic CYTO C and AIF protein in SCR and shAtg7 
myoblasts during early differentiation. (E) Quantitative analysis of CASP9 activity in SCR and 
shAtg7 myoblasts during early differentiation. (F) Quantitative analysis of AIF protein content 
and (G) representative immunoblots of AIF and histone H2B protein in nuclear-enriched 
fractions from SCR and shAtg7 myoblasts during early differentiation. Also shown are 
representative Actin and histone H2B loading control blots. Representative immunoblots of 
CYTO C, AIF, histone H2B and Actin protein in SCR and shAtg7 cells were blotted 
simultaneously. However, for representative purposes membranes are shown as separate SCR 
and shAtg7 images. A one-way ANOVA was used to examine the effect of differentiation. A 
Students T-Test was used to determine differences between CTRL and shAtg7 groups within the 
same time point.  *p<0.05, 
#
p<0.01, 
$
p<0.001 compared to D0. 
†
p<0.05, 
‡
p<0.01, 
¢
p<0.001 
between treatment at same time point; (n=3-5). 
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Inhibition of CASP9 and CASP3 partially recover markers of myoblast differentiation  
 Cell types which require caspase activity to accomplish cellular differentiation are at risk 
of cell death
210
. In our previous work we demonstrated that 3MA administration resulted in 
increased CASP3 activity and cell death in differentiating myoblasts
214
. To test whether elevated 
caspase activity is linked to the impaired myoblast differentiation observed in autophagy-
deficient cells, shAtg7 cells were treated with a CASP3 or CASP9 inhibitor to limit caspase 
activity near to that observed in SCR cells. At the concentrations used, both CASP inhibitors 
reduced (p<0.05) CASP3 activity in shAtg7 myoblasts on D0.5 and D1 compared to non-treated 
shAtg7 cells (Fig. 6A). Attenuated CASP3 activity in shAtg7 cells resulted in increased (p<0.05) 
MYH protein content on D2 and D5 of differentiation compared to D0 in shAtg7 myocytes (Fig. 
6B). However, MYH protein was not fully recovered to levels observed in SCR cells. 
Attenuation of CASP3 activity in shAtg7 myoblasts resulted in increased (p<0.05) fusion and 
differentiation indexes on D2 and D5 compared to non-treated shAtg7 cells (Fig. 6D & C). 
Overall, these results suggest that increased CASP3 activity is partially linked to impaired 
differentiation in autophagy-deficient myoblasts; an effect mediated by CASP9 activation. 
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Fig. III - 6 Attenuation of CASP3 activity in shAtg7 myoblasts partially recovers myogenic 
markers and myotube formation 
(A) Quantitative analysis of CASP3 activity in SCR, shAtg7, and shAtg7 myoblasts treated with 
caspase inhibitors during differentiation. (B) Quantitative analysis and representative 
immunoblot of MYH protein content in SCR, shAtg7, and treated shAtg7 myoblasts during 
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differentiation. (C) Representative images of myotube formation in SCR, shAtg7, and treated 
shAtg7 cells at D2 and D5 of differentiation. Cells were stained with DAPI (blue) and MF20 
(red) to image nuclei and MYH, respectively. Scale bar=100 µm. Quantitative analysis of the (D) 
fusion index and (E) differentiation index in SCR, shAtg7, and treated shAtg7 myoblasts on D2 
and D5 of differentiation. SCR and shAtg7: cells treated with DMSO vehicle; CASP9: shAtg7 
cells treated with Ac-LEHD-CHO; CASP3: shAtg7 cells treated with Ac-DEVD-CHO. A two-
way ANOVA with appropriate post hoc test was used to examine differences between treatment 
groups and differentiation.*p<0.05, 
#
p<0.01, 
$
p<0.001 compared to D0. a, significantly different 
than all (p<0.05), b, significantly different than shAtg7 (p<0.05). 
 
DISCUSSION 
Autophagy is required for myoblast differentiation and protects against apoptosis. 
 The formation and regeneration of myofibers involves the differentiation of myoblasts, 
followed by their fusion with other mononucleated myoblasts to form nascent myotubes or 
fusion with mature myofibers for regeneration
16,218
. We previously reported that autophagy 
increased during differentiation and was required for C2C12 differentiation. Furthermore, 
pharmacologic inhibition of autophagy increased DNA fragmentation and morphological 
features of apoptosis during differentiation
214
. In line with our previous study, inhibition of 
autophagy through stable knockdown of ATG7 reduced myotube formation and significantly 
increased apoptotic signaling and phosphatidylserine exposure. Although previous studies have 
shown that phosphatidylserine is required for the formation of myotubes
35
, the presence of 
elevated CASP3 activity and mitochondrial-mediated cell death signaling suggests that this 
increase in phosphatidylserine exposure represents a cell death event in this context.  
The loss of autophagy increases ROS generation, oxidative damage and CAPN activity  
 Our data suggests that ATG7 knockdown resulted in elevated oxidative stress in 
myoblasts prior to the induction of differentiation as supported by increased antioxidants such as 
SOD1 and CAT, and augmented ROS generation
219-221
. Although elevated SOD1 and CAT could 
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protect cells against oxidative damage, this is likely not the case here as 4HNE levels were 
elevated in shAtg7 cells during early differentiation. 4HNE can also contribute to ROS 
generation through oxidative modification of other proteins and lipids as well as by damaging 
ETC proteins 
222
. Since the inhibition of autophagy in shAtg7 cells impaired mitophagy, it is 
likely that the inability to clear damaged mitochondria resulted in increased oxidative stress and 
susceptibility to cell death signaling upon the induction of differentiation.  
 Autophagy can also attenuate oxidative and ER-stress by degrading aggregated/misfolded 
proteins
12,156
. Previous work has demonstrated that damaged proteins can accumulate in the 
absence of autophagy 
1
. In response to this, molecular chaperones such as HSP70 are upregulated 
to prevent proteotoxicity 
223
. As such we observed a robust increase in HSP70 in shAtg7 cells 
which may have been an attempt to process damaged or misfolded proteins. HSP70 has also been 
shown to respond to apoptotic stress by sequestering and inhibiting pro-apoptotic proteins such 
as BAX and AIF 
88,224
. Therefore, increased HSP70 may be a compensatory response to 
autophagy impairment. Together, the increased HSP70 protein content and CAPN activity in 
autophagy-deficient cells at the onset of differentiation suggests elevated ER-stress
28,156,225
. 
Interestingly, when induced in myoblasts prior to differentiation, ER-stress has been shown to 
promote skeletal myotube formation
30
. However, ER-stress and CAPN activity can also 
participate in CASP12 activation, cleavage of several muscle-specific contractile proteins, impair 
AKT signaling, and directly contribute to the induction of mitochondrial-mediated apoptotic 
pathways
226-229
. Accordingly, these factors may have contributed to the induction of apoptosis 
during myoblast differentiation. Collectively, the damage caused by oxidative and possibly ER 
stress early during the differentiation process likely promoted mitochondrial-mediated death 
signaling during differentiation. 
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Autophagy regulates mitochondrial-mediated apoptotic signaling during myoblast 
differentiation  
 In the absence of autophagy, reduced mitochondrial membrane potential was associated 
with the formation of mPTP. Increased ROS, lipid peroxidation, ER-stress, and reduced BCL2 
and ARC protein have all been shown to promote mitochondrial-mediated apoptosis associated 
with the formation of the mPTP
67,77,230-232
. Considering that all these occurred in the absence of 
autophagy during differentiation, it is likely that one or more contributed to the formation of 
mPTP. This would suggest that autophagy can attenuate cellular stress and mitigate the 
formation of mPTP; a key event in mitochondrial-mediated apoptosis. Consistent with our 
results, inhibition of autophagy has been shown to promote the induction of mitochondrial-
mediated apoptosis through the loss of mitochondrial membrane integrity
233
.  
 The formation of mPTP promotes the release of CYTO C and AIF into the cytosol where 
they contribute to the induction of mitochondrial-mediated apoptotic signaling
67
. We observed 
higher levels of cytosolic CYTO C in autophagy-deficient myoblasts during differentiation. Once 
in the cytosol, CYTO C promotes the induction of apical CASP9 which leads to CASP3 
activation and cell death
63
. Importantly, increased cytosolic CYTO C was associated with 
elevated CASP9 activity in shAtg7 cells during differentiation. This augmented CASP9 activity 
in shAtg7 cells promoted cell death signaling and associated events above levels observed in 
SCR control cells. Together, these data demonstrate that autophagy is required to protect from 
caspase-dependent, mitochondrial-mediated apoptotic signaling and cellular stress events. In 
addition, autophagy may also protect against caspase-independent apoptotic signaling (AIF) 
early during myoblast differentiation.  
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 In control cells, differentiation resulted in a small reduction in mitochondrial membrane 
potential and a submaximal increase in cytosolic CYTO C. Interestingly, these events did not 
result in increased CASP9 activity. The maintenance of sub-apoptotic cytosolic CYTO C and 
reduced mitochondrial membrane potential observed in control cells during differentiation may 
have been due to normal regulation of mitophagy. During mitophagy, mitochondria can be 
sequestered and degraded in response to decreased mitochondrial membrane potential, 
mitochondrial lipid peroxidation, and/or increased ROS
234
, all factors observed in control 
myoblasts during differentiation. The induction of mitophagy and selective sequestration of 
mitochondria with lower membrane potential and dysfunction acts as a quality control 
mechanisms removing these aberrant organelles before they promote apoptotic signaling
235
. It is 
therefore likely that the inability to clear dysfunctional mitochondria in shAtg7 myoblasts via 
mitophagy led to the initiation of mitochondrial-mediated apoptotic signaling during 
differentiation. Additional work should be designed to further study the direct influence of 
mitophagy during myoblast differentiation and to ascertain why and how certain mitochondria 
may be selected for degradation.  
Autophagy regulates the magnitude of CASP activity during myoblast differentiation  
 Compared to cells which die during differentiation, adherent myocytes display low levels 
of cleaved CASP12, CASP9, and CASP3 suggesting that these enzymes may contribute to non-
cell death signaling events
29,30
. Furthermore, this data indicates that the magnitude of CASP3 
activity is essential in the balance between the induction of physiological apoptosis-related 
signaling and apoptotic cell death during myoblast differentiation
210
. In the current study, we 
postulate that ATG7 knockdown induced mitochondrial apoptotic signaling that exceeded a 
threshold set for CASP9 and CASP3. Rather than causing physiological adaptation, the high 
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level of upstream signaling resulted in apoptotic cell death. Similarly, autophagy is required to 
protect from caspase-mediated cell death during monocyte to macrophage specialization, and 
during endothelial cell precursor cell differentiation
200,236
. In addition, the current results 
demonstrate that autophagy regulates caspase activity during myoblast differentiation by 
attenuating the level of mitochondrial cell death signaling. 
Impaired myoblast differentiation is directly involved in increased caspase activity 
 We found that the caspase inhibitors used to reduce CASP3 activity in shAtg7 cells to 
levels observed in untreated control cells partially recovered the loss of MYH expression and 
morphological indices. These data demonstrate that increased CASP3 activity is partially linked 
to the reduction in myoblast differentiation observed in the absence of autophagy and points to a 
critical role of autophagy in regulating the magnitude of CASP3 activity during myoblast 
differentiation. Furthermore, treating shAtg7 cells with a CASP9 inhibitor during differentiation 
reduced CASP3 activity to levels similar to cells treated with a CASP3 inhibitor. This finding 
suggests that the rise in CASP3 activity observed in shAtg7 myocytes during differentiation is 
mediated by CASP9. Together, these data provide evidence that autophagy plays a critical role in 
regulating the quantity of apoptotic signaling during myoblast differentiation.  It should be noted 
that differentiation was not fully recovered in shAtg7 cells with attenuated CASP3 activity, 
suggesting that autophagy regulates other elements of myoblast differentiation in addition to 
apoptotic signaling. This may include the regulation of amino acid or fatty acid availability for 
organelle biogenesis and protein accretion. Furthermore, autophagy may be required for the 
degradation of specific signaling molecules required for myoblast differentiation. However, 
further research will be required to identify these roles.  
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 The induction of catabolic processes such as autophagy and apoptotic signaling is 
required for normal differentiation and formation of skeletal muscle
2,210,211
. We recently 
observed increased autophagy-related proteins and markers of autophagosome content during 
C2C12 differentiation
214
. Furthermore, we found that inhibition of autophagy impaired 
differentiation and increased markers of cell death.  We now show that mitochondrial-mediated 
apoptosis and mitochondrial stress are elevated in the absence of autophagy during myoblast 
differentiation and are associated with impaired mitophagy. Moreover, the impairments observed 
in myoblast differentiation due to inhibition of autophagy were linked to increased caspase 
activity, suggesting that autophagy helps regulate the level of apoptotic signaling during 
myoblast differentiation. 
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CHAPTER IV: Autophagy is required to protect against apoptotic signaling during and 
following CisPT injury 
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OVERVIEW 
 Both apoptosis and autophagy are associated with muscle atrophy and dysfunction. 
However, the interplay between these two “cell death” processes is complex and has not been 
directly investigated in skeletal muscle. The purpose of this study was to examine the cross-talk 
between autophagy and apoptosis in response to the cell death and muscle atrophy inducer 
cisplatin (CisPT). Our data demonstrates that in C2C12 myotube cultures CisPT causes a 
reduction (p<0.05) in myotube diameter and elevation (p<0.05) of autophagy markers LC3B-II, 
BNIP3, BECN1, CTS as well as apoptotic measures, BAX, BAX/BCL2, CASP3, and DNA 
fragmentation. Interestingly, when autophagy is inhibited during submaximal levels of apoptotic 
stress, apoptotic hallmarks such as mPTP formation, CASP9 and CASP3 activity, and DNA 
fragmentation are further augmented (p<0.05). However, inhibition of autophagy during CisPT 
exposure does not alter myotube diameter. To examine the role of autophagy in the recovery 
following stress, CisPT was removed from C2C12 myotube cultures after 24hrs of exposure and 
replace with fresh media or media with 3MA for 48hr. Following the removal of CisPT, myotube 
recovery required autophagy to mitigate (p<0.05) CASP9 and CASP3 activity. Autophagy is also 
required to attenuate (p<0.05) mPTP formation, restore (p<0.05) mitochondrial membrane 
potential, and increase differentiation and fusion indexes during recovery. Together, this data 
supports an anti-apoptotic role for autophagy during muscle atrophy induced by CisPT. In 
addition, autophagy is required to promote the recovery of damaged myotubes following CisPT-
induced apoptotic stress.   
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INTRODUCTION 
 The interplay between autophagic and apoptotic processes in skeletal muscle remains 
unresolved and is complex. Hindlimb unloading, denervation, and the administration of 
chemotherapeutic agents have been shown to induce apoptotic signaling in skeletal muscle; 
moreover, they have also been shown to alter autophagic signaling
6,104,106,123,237
. Some skeletal 
muscle literature has hypothesized that autophagy is a cell death system which promotes muscle 
atrophy
11,123,157,181
. In contrast, evidence is accumulating which demonstrates that autophagy 
plays an important pro-survival role in the cell stress response
12
. For example, following a 
cellular insult resulting in damaged mitochondria, mitophagy, a form of selective autophagy, can 
specifically target damaged mitochondria and promote their degradation through the lysosome. 
In effect, dysfunctional mitochondria are removed thus preserving mitochondrial function and 
preventing the release of pro-apoptotic proteins
235,238,239
. Further, autophagy has as a well-
established role in the removal of aggregated proteins, which can also promote pro-apoptotic 
signaling and compromise cellular function
12,156,240
. Together, these data suggest that autophagy 
is present during periods of skeletal muscle apoptosis and atrophy but could protect the myofiber 
from stress. 
 Apoptotic signaling in skeletal muscle results in the cleavage of structural/contractile 
proteins, destruction of organelles, and loss of nuclei within the myofiber
241
. Collectively, this 
promotes the remodeling of the entire myofiber resulting in atrophy of the cell and 
tissue
4,36,241,242
; however, the cell remains intact and functional, albeit at a lower capacity
6,58
.  
Research shows, that degradative processes can be stimulated by apoptotic signaling and 
contribute to the removal of apoptotic debris
242
.  In skeletal muscle, autophagic proteins are 
altered during the recovery from apoptotic inducing events such as hindlimb suspension and 
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crush injury
243,244
; suggesting that autophagy may also respond to apoptotic signaling by clearing 
damaged protein and organelles once the stress has been removed. Thus, the ability of the muscle 
to recover from apoptotic events is associated with altered markers of autophagy, yet the role of 
autophagy in these processes has not been specifically investigated. 
 Cisplatin (CisPT) is a commonly used chemotherapeutic drug due to its ability to induce 
cell death through multiple mechanisms in several cancer cell types
245
. CisPT is highly effective 
at promoting cell death in cancer cells; however, non-target tissues such as skeletal muscle are 
also adversely effected
246
. Although CisPT treatment in skeletal muscle cultures results in an 
alteration to both autophagic and apoptotic processes and both are associated with a loss in cell 
size
247-249
,  the role of autophagy in cell death signaling and the interplay between apoptosis and 
autophagy are not known.  Furthermore, following the cessation of CisPT treatments the muscle 
must recover from the cytotoxicity/injury
246
. In order to recover muscle mass, inhibiting 
degradative pathways has been suggested
250
; however, how or what affect this may have on 
muscle viability and regeneration after CisPT treatments is unknown. 
 
METHODS 
Cell culturing and drug administration  
 Mouse C2C12 skeletal myoblasts (ATCC) were plated at a low passage in polystyrene 
cell culture dishes (BD Biosciences) in growth media (GM) consisting of low-glucose 
Dulbecco’s Modified Eagles Medium (DMEM; Hyclone, Thermo Scientific) containing 10% 
fetal bovine serum (FBS; Hyclone, Thermo Scientific) with 1% penicillin/streptomycin 
(Hyclone, Thermo Scientific) and incubated at 37ºC in 5% CO2. Myoblast differentiation was 
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induced once C2C12 myoblasts attained 80-90% confluence by replacing GM with 
differentiation media (DM) consisting of DMEM supplemented with 2% horse serum (Hyclone, 
Thermo Scientific) and 1% penicillin/streptomycin following 3 washes in warm phosphate 
buffered saline (PBS; Hyclone, Thermo Scientific). 
 To investigate the effects of CisPT on differentiated myotubes, C2C12 myotubes at day 4 
of differentiation were exposed to vehicle (0.9% NaCl
- 
solution) or CisPT (made in vehicle) for 
24 hr at various doses as indicated in the results. To examine myotube recovery following CisPT 
injury, myotubes at day 4 of differentiation were given 50 µM of CisPT for 24 hr. After 24 hr of 
CisPT cells were either immediately collected (0 hr recovery cells), or given fresh DM with or 
without 5 mM of 3MA and collected at various time points up to 48 hr. Inhibition of 
autophagosome formation was achieved with 5 mM doses of 3MA as previously described over 
24 hr periods
214
. Inhibition of autophagic flux was achieved using 10 µM of chloroquine (CQ) 
for 12 hr.  
 Cells were removed from culture dishes by trypsinization (0.25% trypsin with 0.2 g/L 
EDTA; Thermo Scientific), and collected by centrifugation (800 x g for 5 min). Cell pellets were 
resuspended and washed in ice cold PBS, centrifuged (800 x g for 5 min), and frozen at  -80°C 
until further analysis. Protein concentrations were determined using the BCA protein assay. 
Immunoblotting 
 Immuoblotting was conducted as previously described
214
. Briefly, cells were lysed in ice 
cold buffer (20 mM HEPES, 10 mM NaCl, 1.5 mM MgCl, 1 mM DTT, 20% glycerol and 0.1% 
Triton X100; pH 7.4) with protease inhibitor (Roche Applied Sciences). Equal amounts of cell 
protein was loaded and separated on 7.5-15% SDS-PAGE gels, transferred onto PVDF 
membranes (Bio-Rad Laboratories), and blocked for 1 hr at room temperature or overnight at 
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4°C with 5% milk-Tris-buffered saline-Tween 20 (milk-TBST). Membranes were incubated 
overnight at 4°C or for 1 hr at room temperature with primary antibodies against: BECN1, 
ATG7, LC3B (Cell Signaling Technology); BCL2, BAX (Santa Cruz Biotechnology); BNIP3 
and Actin (Sigma-Aldrich). Membranes were washed with TBST, incubated with the appropriate 
horseradish peroxidase (HRP)-conjugated secondary antibodies (Santa Cruz Biotechnology) for 
1 hr at room temperature and washed with TBST.  Bands were visualized using enhanced 
chemiluminescence western blotting detection reagents (BioVision) and the ChemiGenius 2 Bio-
Imaging System (Syngene). The approximate molecular weight for each protein was estimated 
using Precision Plus Protein WesternC Standards and Precision Protein Strep-Tactin HRP 
Conjugate (Bio-Rad Laboratories). Equal loading and quality of transfer was confirmed by 
staining membranes with Ponceau S (BioShop). 
Flow cytometry 
 To measure mitochondrial-membrane potential, cells were washed in Hank’s Buffered 
Salt Solution (HBSS) and then incubated with 2 μM JC-1 (Life Technologies) for 15 min at 
37°C. Following incubation, cells were washed, centrifuged, and resuspended in HBSS. To 
measure the formation of the mitochondrial permeability transition pore (mPTP) cells were 
incubated with 1 μM calcein AM (Life Technologies) and 1 mM CoCl2 in HBSS for 15 min at 
37°C, washed, centrifuged, and resuspended in HBSS. All analyses were performed on a flow 
cytometer (BD FACSCalibur) equipped with Cell Quest Pro software (BD Bioscience) as 
previously described
93
. 
Proteolytic enzyme activity and ROS generation 
 Enzymatic activity of CASP3 (CASP3) and CASP9 (CASP9) was determined in cells 
lysates using the substrate Ac-DEVD-AMC and Ac-LEHD-AMC (Enzo Life Sciences), 
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respectively, as previously described
93,214
. Enzymatic activity of cathepsin (CTS) was assessed 
using the fluorogenic substrate z-FR-ARC (Enzo Life Sciences) as previously described
251
. 
CASP and CTS enzymatic activity was normalized to total protein content and expressed as 
fluorescence intensity in arbitrary units (AU) per milligram protein. 
 DNA fragmentation was determined using the Cell Death Detection ELISA
PLUS
 Kit 
(Roche Diagnostics) as previously described
214
. Briefly, cells were homogenized in the supplied 
lysis buffer and centrifuged at 200 g for 10 min at room temperature. 20 µl of supernatant was 
incubated with 80 µl of anti-histone-biotin/anti-DNA-POD reagent in a streptavidin-coated 
microplate for 2 hr at room temperature with gentle shaking. Each well was washed several times 
followed by the addition of 100 µl of ABTS substrate solution. Absorbance was measured with a 
SPECTRAmax Plus spectrophotometer (Molecular Devices), normalized to total protein content, 
and expressed as AU per mg protein. 
Fluorescence microscopy 
 Myosin heavy chain (MYH) immunofluorescence analysis was conducted on cells grown 
on glass coverslips in culture dishes
214
 to determine myotube size as well as differentiation and 
fusion indexes. Coverslips were first washed with PBS, fixed with 4% formaldehyde-PBS for 10 
min at room temperature, and washed with PBS. Cells were permeablized for 10 min with 0.5% 
Triton X100, and washed in PBS. Cells were then blocked with 10% goat serum (Sigma-Aldrich) 
for 30 min, incubated with a primary antibody against MYH (Developmental Studies Hybridoma 
Bank; MF20) for 2 hr, washed with PBS, and incubated with an anti-mouse PE-conjugated 
secondary antibody (Santa Cruz). Cells were washed in PBS, counterstained with DAPI nuclear 
stain (Life Technologies) for 5 min, washed min in PBS, and mounted with Prolong Gold 
Antifade Reagent (Life Technologies). Slides were visualized with an Axio Observer Z1 
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fluorescent microscope equipped with Red/Green/Blue filters, an AxioCam HRm camera, and 
AxioVision software (Carl Zeiss). Myotube diameter was quantified as the average diameter of 3 
random areas of each myotube per field (between 4-5 images per sample). The fusion index was 
calculated as the percentage of nuclei present in multinucleated (two or more nuclei) cells 
relative to total nuclei. The differentiation index was calculated as the percentage of cells 
expressing MYH relative to total cell number. 
To visualize lysosomal and mitochondrial content, live cells were incubated with either 
LysoTracker Red (LTR; 75nM) (Life Technologies) and/or MitoTracker Green (MTG; 50nM) 
(Life Technologies) for 30 min at 37ºC in 5% CO2. Cells were then washed in PBS, fixed with 
4% formaldehyde, and counterstained with Hoescht NucBlue (Life Technologies) for 5 min at 
room temperature to visualize nuclei. LTR fluorescence and LTR:MTG co-localization was 
determined in multinucleated cells (2 or more nuclei within a single cell) using Image J software. 
Statistics 
 A One-Way repeated measure ANOVA was used to assess the dose response of CisPT. If 
a main effect was observed, Tukey’s post hoc test was used to determine differences. A Two-
Way ANOVA was used to assess the effects of treatment over time, along with the Tukey’s post-
hoc test. For all experiments p<0.05 was considered statistically significant. 
 
RESULTS 
CisPT induces dose-dependent changes to autophagy and apoptosis in C2C12 myotubes. 
 To investigate autophagy and apoptosis in response to CisPT exposure, C2C12 myotubes 
were incubated with vehicle, 25 µM, 50 µM, 100 µM, or 200 µM CisPT for 24 hours. LC3B-II 
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and LC3B-I increased (p<0.05) in response to CisPT. Moreover, the LC3B-II/I protein ratio was 
elevated (p<0.05) in response to 200 µM CisPT (Fig. 1A). We also observed changes to key 
autophagy-related proteins which regulate the formation of the autophagosome. BNIP3 and 
BECN1 protein were elevated (p<0.05) at various doses of CisPT, but not ATG7 protein (Fig. 
1B). CTS activity is required for the degradation of autophagosomal cargo, and showed a dose-
dependent change to CisPT (p<0.01) (Fig. 1C).  
 CisPT also induced several changes to apoptosis-related proteins, including up-regulating 
(p<0.05) BAX and down-regulating (p<0.001) BCL2 (Fig. 1D). As such, the BAX/BCL2 protein 
ratio was significantly increased (p<0.001) at 25 µM, 50 µM, and 100 µM CisPT (Fig. 1D). 
Interestingly, the BAX/BCL2 protein ratio during 50 µM CisPT was greater (p<0.001) than all 
other doses. CASP3 activity increased (p<0.01) in a dose-dependent manner in response to 
CisPT (Fig. 1E). Activation of downstream apoptotic signaling enzymes such as CASP3 
promotes DNA fragmentation, a hallmark of late stages of apoptosis
36
. As such, DNA 
fragmentation was increased (p<0.001) in response to 50 µM, 100 µM, and 200 µM CisPT (Fig. 
1F).  
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Fig. IV - 1: Autophagic and apoptotic dose response to CisPT 
Quantitative analysis and representative immunoblots of (A) LC3B-I and LC3B-II protein as 
well as LC3B-II/I protein ratio, and (B) BNIP3, BECN1, and ATG7 protein in response to 
various doses of CisPT after 24 hr. Quantitative analysis of  (C) CTS activity and (D) 
quantitative analysis and representative immunoblots of BAX and BCL2 protein as well as the 
BAX/BCL2 protein ratio in response to various doses of CisPT after 24 hr. Quantitative analysis 
of (E) CASP3 activity and (F) DNA fragmentation in response to various doses of CisPT after 
24 hr. Also shown are representative Actin loading control blots. A one-way ANOVA was used 
to examine the effect of dose. *p<0.05, #p<0.01, $p<0.001 compared to non-treated CTRL. ¶ 
p<0.05 compared to all. a, b, c, d p<0.05 compared to non-matching letters; (n=3-5).   
 
To ensure changes observed to markers of autophagy represented increased autophagic 
flux we administered 50 µM and 200 µM CisPT to C2C12 myotubes along with 5 µM of 
chloroquine (CQ), a commonly used inhibitor of lysosomal enzymes. LC3B-II protein 
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accumulation in CQ treated cells was significantly greater (p<0.01) at both 50 µM and 200 µM 
doses of CisPT relative to CTRL (Fig 2C & D). These results suggest that the increase in 
autophagy markers during CisPT exposure is due to increased autophagic flux. 
 Increased proteolytic activity in skeletal muscle can contribute to muscle atrophy
59
. 
Accordingly CisPT caused a dose-dependent decline (p<0.01) in myotube diameter. 
Interestingly, myotube diameter did not differ between 100 µM and 200 µM CisPT (Fig. 2A & 
B). 
 
Fig. IV - 2: CisPT induces myotube atrophy and an increase in autophagic flux 
(A) Representative images of myotubes exposed to CisPT after 24 hr. Cells were stained with 
DAPI (blue) and MF20 (red) to image nuclei and MYH, respectively. Scale bar=100µm. (B) 
Quantitative analysis of myotube diameter. (C) Quantitative analysis and (D) representative 
immunoblot of LC3B-II in CisPT and CisPT + CQ exposed cells after 24 hr of incubation. Also 
shown is a representative Actin loading control blot. A one-way ANOVA was used to examine 
the effect of dose. A Students T-Test was used to determine differences between CisPT and CQ 
groups.  
$
p<0.001 compared to non-treated CTRL. 
†
p<0.05, 
‡
p<0.01 compared to treatment at 
same dose point. a, b, c, d p<0.05 compared to non-matching letters. (n=3).    
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Time-course analysis of autophagy- and apoptosis-related markers over 24 hr of CisPT 
exposure  
 We next examined the temporal kinetics of autophagy and apoptosis over a 24 hr period 
to submaximal (50 µM) and maximal (200 µM) levels of CisPT. CASP3 activity was elevated 
(p<0.01) at 12 hr and 24 hr in response to 200 µM CisPT but only at 24 hr (p<0.001) in 
myotubes treated with 50 µM CisPT (Fig. 3A). CASP3 activity was greater to 200 µM than 50 
µM CisPT beginning at 6 hr (Fig. 3A). BAX protein increased (p<0.05) at 12 hr and 24 hr in 
cells incubated with 200 µM CisPT (Fig. 3B). Similarly, 50 µM CisPT increased (p<0.05) BAX 
protein at 3 hr, 12 hr, and 24 hr (Fig. 3B). Furthermore, BAX protein was higher (p<0.05) with 
200 µM compared to 50 µM CisPT at 24 hr (Fig. 3B). BCL2 protein was also significantly 
(p<0.05) reduced with CisPT at 12 hr (50 µM) and 24 hr (200 µM) (Fig. 3C). 
 CTS activity was elevated (p<0.05) from 6 hr to 24 hr in myotubes incubated with 200 
µM CisPT but only at 24 hr (p<0.05) to 50 µM CisPT (Fig. 3D). LC3B-II increased (p<0.01) at 3 
hr and remained elevated at 24 hr in response to 50 µM of CisPT; however, in response to 200 
µM LC3B-II levels increased only at 12 hr.  Compared to 50 µM, LC3B-II was greater (p<0.05) 
at 3hr, 6 hr, and 24 hr to 200 µM (Fig. 3E). BECN1 levels were increased (p<0.05) at 3 hr and 6 
hr in both 50 µM and 200 µM CisPT groups; as well as at 24 hr in 50 µM CisPT (Fig. 3G). 
BNIP3 increased (p<0.001) at 24 hr in response to both 50 µM and 200 µM CisPT. Interestingly, 
both BECN1 and BNIP3 protein were greater (p<0.05) with 50 µM compared to 200 µM CisPT 
at 24 hrs (Fig. 3H). ATG7 protein increased (p<0.01) at 3 hr and 6 hr in response to 50 µM 
CisPT (Fig. 3I).  
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Fig. IV - 3: Time course analysis of apoptotic and autophagic responses to 50 µM and 200 
µM of CisPT over 24 hrs 
(A) Quantitative analysis of CASP3 activity. Quantitative analysis and representative 
immunoblots of (B) BAX and (C) BCL2 protein. (D) Quantitative analysis of  CTS activity. (E) 
Quantitative analysis of LC3B-II protein, and (F) representative immunoblots of LC3B-I and 
LC3B-II protein. Quantitative analysis and representative immunoblots for (G) BECN1, (H) 
BNIP3 and (I) ATG7 protein. Also shown are representative Actin loading control blots. A one-
way ANOVA was used to examine the effect of time or doses independently. A Students T-Test 
was used to determine differences between 50µM and 200µM groups within a single time point.    
*p<0.05, #p<0.01, $p<0.001 compared to 0 hr CTRL. †p<0.05, ‡p<0.01, compared between 50 
µM and 200 µM doses at same time point; (n=3-4).  
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Pharmacological inhibition of autophagy with 3MA increases apoptosis 
 To test whether the induction of autophagy was promoting or mitigating apoptotic 
signaling we attenuated the formation of the autophagosome with 3MA
214,248
. Experiments were 
performed with 50 µM of CisPT given that we observed a large increase in autophagy and 
submaximal levels of apoptosis. 3MA effectively attenuated (p<0.05) LC3B-II protein during 
CisPT exposure (Fig. 4A). Although CisPT affected BAX, BCL2 and the BAX:BCL2 ratio at 
later time points (p<0.05), 3MA had little effect (Fig. 4B, C & D). In contrast, the elevated 
CASP3 and DNA fragmentation caused by CisPT was further augmented (p<0.05) by 3MA 
treatment (Fig 4E & F). 
 
Fig. IV - 4: Effect of 3MA-mediated inhibition of autophagy on apoptotic signaling  
(A) Quantitative analysis of LC3B-II protein as well as representative immunoblots of LC3B-I 
and LC3B-II protein in response to CisPT and CisPT + 3MA at 6 hr, 12 hr, and 24 hr of 
incubation. Quantitative analysis of (B) BAX protein, (C) BCL2 protein, (D) BAX:BCL2 protein 
 99 
 
ratio as well as, representative immunoblots of BAX and BCL2 protein, (E) CASP3 activity and, 
(F) DNA fragmentation in response to CisPT and/or CisPT + 3MA over 24 hr of treatment. Also 
shown are representative Actin loading control blots. Differences were examined with a two-way 
ANOVA with post hoc analysis if significant interactions were found. *p<0.05, #p<0.01, 
$
p<0.001 compared to 0 hr CTRL. a, time matched CTRL p<0.05 compared to CisPT. b, CisPT 
p<0.05 compared to CisPT + 3MA. c, CisPT + 3MA  p<0.05 compared time matched CTRL; 
(n=3-4).  
 
Inhibition of autophagy during CisPT treatment induces mitochondrial-mediated apoptotic 
events 
 Autophagy has been shown to attenuate mitochondrial-mediated apoptotic signaling 
through the degradation of mitochondria presenting with low membrane potential
239
. MTG:LTR 
co-localization increased (p<0.05) in CisPT treated myotubes compared to non-treated controls; 
an effect which was attenuated (p<0.05) with 3MA (Fig. 5A & B). LTR fluorescence increased 
(p<0.05) with CisPT at 12 hr and 24 hr but was not affected by 3MA treatment (Fig. 5C).  
 The induction of mitochondrial-mediated apoptotic events is often associated with a loss 
of mitochondrial membrane potential
67
.  While CisPT increased (p<0.05) the number of cells 
with low mitochondrial membrane potential, this effect was further exacerbated (p<0.05) by 
3MA (Fig. 5D). Cell stress can promote the formation of the mitochondrial permeability 
transition pore (mPTP) which can result in the loss of mitochondrial membrane integrity, release 
of apoptotic factors and induction of CASP9
67
.  There was greater (p=0.11) mPTP formation at 
24 hr following CisPT treatment but this did not reach statistical significance. However, this was 
further elevated (p<0.05) during 3MA administration (Fig. 5E). Moreover, the CisPT-induced 
increase (p<0.05) in CASP9 was further augmented (p<0.03) with 3MA (Fig. 5F).   
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Fig. IV - 5: Effect of autophagy inhibition on mitochondrial-mediated apoptotic signaling 
events in response to CisPT over a 24 hr time course 
(A) Quantitative analysis of MTG:LTR co-localization. (B) Representative images of 
mitochondrial content (MTG: green) lysosomal content (LTR: red), and MTG:LTR co-
localization (orange). (C) Quantitative analysis of LTR fluorescence, (D) JC-1 staining (E) 
calcein fluorescence, and (F) CASP9 activity. Scale bar=100µm. Differences were examined 
with a two-way ANOVA with post hoc analysis if significant interactions were found.  *p<0.05, 
#
p<0.01, 
$
p<0.001 compared to 0 hr CTRL. a, time matched CTRL p<0.05 compared to CisPT. 
b, CisPT p<0.05 compared to CisPT + 3MA. c, CisPT + 3MA  p<0.05 compared time matched 
CTRL; (n=3-4). 
 
With respect to morphological characteristics, myotube diameter was lower (p<0.001) 
after 24 hr of CisPT. Interestingly, despite the differences in mitochondrial-mediated events 
between CisPT and CisPT+3MA, myotube diameter was not further affected by 3MA (Fig. 6A 
& B).  
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Fig. IV - 6: Effect of inhibition of autophagy on myotube atrophy during CisPT exposure 
(A) Quantitative analysis of myotube diameter. (B) Representative images of myotube size. Cells 
were stained with DAPI (blue) and MF20 (red) to image nuclei and MYH, respectively. Scale 
bar=100µm. Differences were examined with a two-way ANOVA with post hoc analysis if 
significant interactions were found. 
$
p<0.001 compared to non-treated CTRL. a, time matched 
CTRL p<0.05 compared to CisPT. c, CisPT + 3MA  p<0.05 compared time matched CTRL. 
(n=4). 
 
Autophagic flux increases following the removal of CisPT 
 To better understand if autophagy is involved in the recovery of muscle viability and 
integrity following CisPT-induced apoptotic signaling, we removed CisPT treated media after 24 
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hr and replaced it with fresh DM.  Addition of fresh media caused a reduction (p<0.01) in LC3B-
II content at 24 hr and 48 hr of recovery (Fig. 7A). We observed elevated (p<0.001) levels of 
BNIP3 protein at 0 hr and 24 hr of recovery (Fig. 7B). Interestingly, the level of BNIP3 dropped 
significantly to CTRL levels by 48 hr (Fig. 7B). To determine the cause of reduced LC3B-II 
levels we treated recovering cells with 5 µM of CQ for 12 hr to examine autophagic flux. We 
found that LC3B-II and SQSTM1 levels dramatically accumulated (p<0.05) in the presence of 
CQ during recovery, suggesting that the decrease in LC3B-II and SQSTM1 was due to increased 
lysosomal degradation (Fig. 7D, E & F).  
 
Fig. IV - 7: Alterations to autophagic proteins and flux during 48 hr of recovery from 
CisPT injury 
(A) Quantitative analysis of LC3B-II protein content at 0 hr, 24 hr, and 48 hr of recovery (Rec). 
(B) Quantitative analysis of BNIP3 protein. (C) Representative immunoblots of LC3B-II and 
BNIP3 protein. (D) Quantitative analysis of LC3B-II accumulation. (E) Representative 
immunoblots of LC3B-II and SQSTM1 accumulation and (F) quantitative analysis of SQSTM1 
accumulation after CQ treatment at 24 hr and 48 hr of recovery. Also shown are representative 
Actin loading control blots. A one-way ANOVA was used to examine differences over time 
within independent groups (A and B). A Students T-Test was used to examine differences 
between CTRL and Rec groups within a time point (A and B). Differences between CTRL, Rec 
and Rec + CQ over time and within groups were examined with a two-way ANOVA with post 
hoc analysis if significant interactions were found. 
$
p<0.001 compared to non-treated CTRL. 
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‡
p<0.01, 
¢
p<0.001 between groups at same time point. a, time matched CTRL p<0.05 compared 
to CisPT. c, CisPT + CQ p<0.05 compared time matched CTRL. (n=3-4). 
 
The reduction in apoptotic signaling during recovery is dependent on autophagy  
 To examine if autophagy is required for recovery following CisPT-induced apoptotic 
signaling we added 5 mM of 3MA for 24 hours prior to the collection of cells at 24 hr and 48 hr 
into recovery. 3MA treatment successfully reduced (p<0.05) LC3B-II protein content at 24 hr 
and 48 hr (Fig 8A).  
 The BAX/BCL2 ratio was elevated (p<0.001) in recovery cells at 24 hr. Interestingly, the 
BAX/BCL2 ratio was increased (p<0.05) further in 3MA exposed cells at both 24 hrs and 48 hrs 
(Fig. 8B). While CASP3 activity remained elevated (p<0.001) at 24 hr and returned to baseline 
by 48 hr in recovery cells, 3MA exposed cells displayed a further elevation (p<0.05) in CASP3 
activity at 24 hr, which remained higher (p<0.05) at 48 hrs (Fig. 8C).  
Similarly, DNA fragmentation remained elevated at 24 hr of recovery then dropped (p<0.001) 
towards baseline at 48 hr; however, DNA fragmentation was elevated (p<0.05) with 3MA at both 
time points (Fig. 8D).  
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Fig. IV - 8: Effect of inhibition of autophagy on apoptotic markers during 48 hr of recovery 
from CisPT injury 
 (A) Quantitative analysis of LC3B-II protein and representative immunoblots of LC3B-II 
protein. (B) Quantitative analysis of BAX/BCL2 protein ratio as well as representative 
immunoblots to BAX and BCL2 protein. (C) Quantitative analysis of CASP3 activity, and (D) 
DNA fragmentation. Also shown is a representative Actin loading control blot. A Students T-
Test was used to examine differences between Rec and Rec + 3MA (A). Differences were 
examined with a two-way ANOVA with post hoc analysis if significant interactions were found 
(B, C, D).  
$
p<0.001 compared to 0 hr CTRL. 
†
p<0.05, between groups at the same time point. a, 
time matched CTRL p<0.05 compared to Rec. b, Rec p<0.05 compared to Rec + 3MA. c, Rec + 
3MA  p<0.05 compared time matched CTRL; (n=3-4).  
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Inhibition of autophagy during recovery leads to mitochondrial-mediated apoptotic 
signaling 
 Next, we examined the effects of autophagy on mitochondrial viability and apoptotic 
signaling during recovery. The elevated MTG:LTR co-localization was somewhat maintained 
(p<0.05) at 24 hr; however, 3MA restored levels to baseline. A similar trend was shown at 48 hrs 
(Fig. 9A & B). While LTR fluorescence was restored at 48 hr, levels were higher in cells treated 
with 3MA (Fig. 9B & C). We then investigated the ability of mitochondrial membrane potential 
to recovery following CisPT treatment. Although CisPT decreased membrane potential, this 
declined (p<0.05) during recovery (Fig. 9D). In contrast, the number of cells with lower 
membrane potential was dramatically more evident (p<0.05) into recovery with 3MA (Fig. 9D). 
While CisPT caused mPTP formation (p<0.05), there was recovery by 48 hrs. In contrast, mPTP 
formation continued to increase (p<0.001) throughout recovery in the presence of 3MA (Fig. 
9E). Accordingly, the elevated CASP9 levels in response to CisPT declined (p<0.05) during 
recovery, but continued to increase (p<0.05) in cells treated with 3MA (Fig. 9F).  
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Fig. IV - 9: Effect of inhibition of autophagy on mitochondrial apoptotic signaling during 
recovery from CisPT injury 
(A) Quantitative analysis of MTG:LTR co-localization over 48 hr of recovery from CisPT injury 
with or without 3MA. (B) Representative images of MTG, LTR, and MTG:LTR co-localization. 
(C) Quantitative analysis of LTR over 48 hr of recovery from CisPT injury with or without 
3MA. Quantitative analysis of (D) JC-1 staining, (D) calcein fluorescence and, (E) CASP9 
activity. Scale bar=100µm. Differences were examined with a two-way ANOVA with post hoc 
analysis if significant interactions were found. *p<0.05, $p<0.001 compared to 0 hr CTRL. a, 
time matched CTRL p<0.05 compared to Rec. b, Rec p<0.05 compared to Rec + 3MA. c, Rec + 
3MA  p<0.05 compared time matched CTRL; (n=3-4). 
 
Autophagy is required for regenerative processes   
 We next determined the importance of autophagy in the recovery of myotube 
morphology from CisPT. As previously shown, 24 hr of 50 µM CisPT decreased (p<0.05) 
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myotube diameter (Fig. 10A & D). However, both recovery with or without 3MA had no effect 
on myotube diameter (Fig. 10A & D). 
 We decided to examine if the lack of change to myotube diameter was a result of 
impaired differentiation and fusion of the reserve myoblasts remaining following the removal of 
CisPT. We observed a significant reduction (p<0.05) in the number of differentiated and fused 
cells immediately after CisPT exposure. Both differentiation and fusion increased (p<0.05) 
during recovery in both CTRL and recovery cells (Fig. 10 B, C & D). In contrast, differentiation 
and fusion not only lower with 3MA, but tended to be reduced throughout recovery (Fig. 10B, C 
& D).  
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Fig. IV - 10: Effect of inhibition of autophagy on myotube size and regenerative capacity 
during recovery from CisPT injury 
(A) Quantitative analysis of myotube diameter over 48 hr of recovery from CisPT injury with or 
without 3MA. Quantitative analysis of the (B) differentiation index and (C) fusion index over 48 
hr of recovery from CisPT injury with or without 3MA. (D) Representative images of myotube 
size in response to drug exposure after 24 hr. Cells were stained with DAPI (blue) and MF20 
(red) to image nuclei and MYH, respectively. Scale bar=100µm. Differences were examined 
with a two-way ANOVA with post hoc analysis if significant interactions were found. *p<0.05, 
#
p<0.01, 
$
p<0.001 compared to 0 hr CTRL. a, time matched CTRL p<0.05 compared to Rec. b, 
Rec p<0.05 compared to Rec + 3MA. c, Rec + 3MA  p<0.05 compared time matched CTRL; 
(n=3-4) 
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DISCUSSION 
CisPT-induced myotube atrophy is associated with autophagy, apoptosis, and proteolytic 
activity  
 Our results demonstrate that CisPT induces an increase in apoptotic proteolytic enzyme 
activity, DNA fragmentation, and autophagy along with decreases in myotube size. In support of 
our results, Stacchiotti et al. found an increase in apoptosis, autophagy, and myotube atrophy in 
myotubes exposed to 50 µM CisPT after 24 hr
248
, implicating these processes as contributing 
factors to muscle atrophy. The induction of apoptosis results in the destruction of genomic 
material and the loss of myonuclei
58,60
. According to Allen et al. this loss of myonuclei can 
promote muscle atrophy by reducing the transcriptional potential of the remaining myotube
58,60
. 
Thus, increased DNA fragmentation could be responsible, at least in part, for the reduction in 
myotube diameter at submaximal doses. Interestingly, we observed a plateau in muscle atrophy 
at high doses of CisPT which was associated with a plateau in DNA fragmentation suggesting 
that the further reduction in myotube size may depend upon the level of DNA fragmentation. 
Other apoptotic signaling mechanisms can result in the destruction of myofibrillar proteins and 
organelles which may contribute to the altered morphology and function
241,242
. The degradation 
of such proteins and organelles is orchestrated by degradative systems such as the UPS and 
likely autophagy
241
. We observed an increase in autophagy as noted by increased LC3B-II, 
BNIP3, and BECN1 protein content as well as altered autophagic flux following 24 hr of 50 µM 
CisPT. Interestingly, CisPT doses greater than 50 µM caused a decline in autophagy-related 
proteins, and augmented CASP3 activity. CASP3 activity can promote the loss of autophagic 
protein stability and as a result impairing the induction of autophagy
252
. Interestingly, at higher 
doses of CisPT when CASP3 activity was greatest and autophagy was attenuated, there were no 
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further decrements in myotube size. Therefore, it is possible that for the muscle to continue to 
undergo remodeling a further induction of autophagy is required.  As such, inhibition of 
autophagy using 3MA did not result in further loss of myotube size even though an increase in 
CASP3 was observed. Our results contribute to previous evidence suggesting that inhibition of 
autophagy and autophagic signaling can preserve muscle size in the presence of cell stress
106,250
 
Autophagy is required to attenuate mitochondrial-mediated apoptotic signaling induced by 
submaximal doses of CisPT 
 Observations of both apoptotic and autophagic processes in similar models of skeletal 
muscle stress have promoted a theory suggesting that autophagy contributes to cell death 
signaling and atrophy in muscle
6,192,241
. We found that autophagy is required to mitigate the 
magnitude and induction kinetics of apoptotic signaling in C2C12 myotubes. For example, 
inhibition of autophagy augmented and more rapidly induced CASP3 activity. Interestingly, 
DNA fragmentation was greater in CisPT exposed cells when autophagy was inhibited at 12 hr 
but not at 24 hr. This suggests that autophagy can slow down the induction of DNA 
fragmentation but not inhibit it completely. It is possible that caspase independent modes of cell 
death are occurring simultaneously in addition to caspase-mediated apoptotic signaling 
59,245
. 
Collectively, these data demonstrate that the induction of autophagy can mitigate apoptotic 
proteolytic activity and DNA fragmentation in skeletal muscle. 
 The promotion of CASP3 activity and apoptosis can be achieved through the 
mitochondrial-mediated activation of apical CASP9
67
. In response to CisPT we observed a 
reduction in mitochondrial membrane potential, the formation of the mPTP, and the activation of 
CASP9, which strongly suggests mitochondrial-mediated apoptotic signaling likely contributed 
to the increase in cell death signaling and apoptosis. Interestingly, inhibition of autophagy 
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resulted in cells with lower mitochondrial membrane potential, likely due to impaired 
mitochondrial clearance
235
. Mitophagy can maintain mitochondrial viability by selectively 
degrading damaged mitochondria prior to their participation in apoptotic signaling thus, 
protecting the cell
235,239
. BNIP3 and other mitophagy-related proteins co-localize with 
mitochondria during mitochondrial stress and induce mitochondrial membrane depolarization or 
simply respond to mitochondria with low membrane potential in order to promote their 
degradation
238
. During CisPT exposure, the induction of autophagy occurred with increased 
BNIP3 and MTG:LTR co-localization as early as 6 hr after treatment suggesting that 
mitochondrial degradation occurs at submaximal apoptotic doses of CisPT. Interestingly, 3MA 
attenuated MTG:LTR co-localization and elevated mitochondrial-mediated cell death signaling. 
Similarly, it has been previously shown that 3MA impairs mitochondrial degradation through 
inhibition of autophagosome-lysosome co-localization resulting in the accumulation of impaired 
mitochondria and increased cell death
233
. Furthermore, we found that inhibition of autophagy 
increased mPTP formation and augmented CASP9. Collectively, this data demonstrates that 
degradation of mitochondria via autophagic processes is critical in regulating mitochondrial-
mediated apoptotic signaling. Similarly, previous work has shown that the forced induction of 
autophagy in muscle can attenuate levels of apoptotic signaling
176,179,238
. 
Recovery from CisPT toxicity involves altered autophagic flux and autophagy-dependent 
recovery from mitochondrial-mediated apoptotic signaling 
  Recovery from muscle wasting and damage is relevant in a number of stress and disease 
states. We found that following the removal of CisPT, myotubes begin to recover; a process that 
occurs with increased autophagic flux. It is peculiar that we observed an increase in LC3B-II 
protein content during incubation with CisPT and a decrease in LC3B-II protein content during 
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recovery even though both were associated with increased flux. These results demonstrate the 
importance of investigating autophagic flux as autophagy is highly dynamic system
9,112
. To date, 
few studies have characterized the induction or flux of autophagy during recovery from muscle 
stress
243,244
.  
 Evidence suggests that during recovery from muscle injury, CASP activity and cell death 
signaling is attenuated over time, a phenomena which largely depends on the type, duration, and 
magnitude of the injury
15
. In agreement with this, myotubes allowed to recover following CisPT 
exposure displayed reduced CASP3 activity and DNA fragmentation. Teng et al. observed a 
decrease in apoptotic signaling along with a moderate increase in autophagy markers and 
improved muscle morphology, suggesting a relationship between apoptosis and autophagy may 
exist in recovering skeletal muscle
244
. In the present work, inhibiting autophagy by 3MA during 
the recovery form CisPT augmented apoptotic markers such as the BAX:BCL2 ratio, CASP3 
activity, and DNA fragmentation. In addition, 3MA treated recovering myotubes had lower 
mitochondrial membrane potential, greater mPTP formation, and elevated CASP9 activity 
suggesting that autophagy can improve the cellular environment following stress. In support of 
this, the forced induction of autophagy in dystrophic mice promoted the recovery of 
mitochondria morphology and attenuation of cell stress
14,179
. Previous work has shown that 
autophagy can target damaged mitochondria for degradation and in doing so likely improve the 
function and viability of the available mitochondrial population
238,253
. Cells treated with 3MA 
had reduced mitochondrial-lysosomal co-localization suggesting a reduction in mitochondrial 
degradation and the accumulation of damaged mitochondria. These results demonstrate that 
autophagy is required to regulate apoptotic events and signaling via promotion of mitochondrial 
viability in myotubes recovering from injury.  
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Autophagy is required to promote regenerative processes in recovering myotubes 
 Following myotrauma the differentiation of myogenic precursor cells is followed by their 
fusion into the damaged myofiber or de novo synthesis of new myotubes
16
. We have previously 
shown that autophagy is required for myoblast differentiation and myotube formation
214
. In the 
current study we observed an increase in markers of differentiation and fusion by 48 hr of 
recovery, processes which were also dependent upon autophagy. The increase in both fusion and 
differentiation are factors which can contribute to the increase in myotube size, complexity, and 
anti-apoptotic profile
254
. Interestingly, we did not see any significant changes to myotube size 
during recovery. However, skeletal muscle regeneration has been shown to take several days in 
mammalian models of muscle injury
15
. Furthermore, the lack of immune cell presence in the 
myotube cultures would be expected to delay recovery
255
. Overall these, our results demonstrate 
that autophagy is required for increasing the regenerative potential within cultures of 
differentiated C2C12 myocytes by promoting differentiation and fusion. 
 Autophagy is required to suppress cell death signaling and delay the induction of muscle 
cell death events that occur during and following recovery to CisPT exposure. More specifically, 
autophagy is vital in this apoptotic response through regulation of mitochondrial-mediated cell 
death signaling and health. Furthermore, autophagy is required to promote an increase in 
regenerative potential in C2C12 myotubes following the removal of CisPT. In conclusion, these 
data suggest that autophagic processes are critical in maintaining muscle viability and 
regenerative potential.  
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SUMMARY   
 Autophagic processes are required to maintain basal cell viability and contractile function 
in skeletal muscle
1,256
. Acting as a quality control system, autophagy can target and promote the 
degradation of damaged cellular constituents before they pose a risk to cell health
180,181,257
. As 
such, several models presenting with muscle dysfunction, associated with an accumulation of 
damaged/dysfunctional proteins and organelles, have been shown to have diminished levels of 
autophagy
179,181
. Importantly, the integrity of the muscle can be improved in these conditions 
through the forced induction of autophagy
14,175,176
. In contrast, several models including 
denervation, nutrient deprivation, sarcopenia, unloading, cachexia, and myopathies such as 
Pompe disease and Danones disease are associated with impaired muscle function and 
atrophy
181,184
. In these conditions the induction of autophagy has been suggested to contribute to 
muscle atrophy
104,157,182,184
. Based on the available literature the role of autophagy in skeletal 
muscle health is complex.  
 Autophagy is often observed in dying cells and many studies have suggested this 
“autophagic cell death” occurs in models of skeletal muscle atrophy and disease. For example, 
O’Leary et al. observed an increase in LC3B-II protein content in whole cell and mitochondrial 
fractions of denervated skeletal muscle. Since denervation also induces atrophy and apoptotic 
events/signaling, the induction of autophagy was interpreted as a “cell death inducing” 
mechanism
157
. Furthermore, Smuder et al; reported an increase in skeletal muscle apoptotic 
signaling and muscle atrophy in response to the chemotherapeutic drug doxorubicin. In a follow 
up study this group reported an increase in autophagy and atrophy in response to doxorubicin. 
Interestingly, this study demonstrated that exercise training can mitigate the autophagy following 
doxorubicin exposure. Ultimately the authors concluded that the induction of autophagy was a 
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mechanism contributing to skeletal muscle cell death processes and that exercise mitigated cell 
death and muscular atrophy through the suppression of autophagy
123
.  
 Despite these reports, autophagy has never been shown to be the direct cause of cell death 
in skeletal muscle. Only associative evidence exists.  Recently, accumulating evidence points to 
a pro-survival role of autophagy through the disposal of damaged organelles, clearance of 
proteotoxicity factors, and recycling of nutrients to conserve energy under starvation 
conditions
181
. Skeletal muscle apoptotic signaling is directly linked to muscle atrophy and 
contractile dysfunction; however, it is also required for physiological remodeling and 
developmental processes
59,66
. Therefore, understanding the role of autophagy in skeletal muscle 
will improve our basic understanding of the interplay between autophagy and apoptosis, and 
allow us to better understand processes which regulate cell death processes.  
Autophagy is required to protect differentiated myotubes from apoptosis 
 The induction of skeletal muscle apoptosis is associated with the increase in autophagy 
and muscle atrophy
181
. As such, the present work reveals that autophagy occurs prior to the 
induction of apoptotic signaling in response to submaximal apoptotic stress. Previous reports 
have concluded that this association suggests that autophagy is a cell death mechanism
123,157
. 
Importantly, these data also demonstrates that when autophagy is inhibited at a submaximal 
dose, the level of apoptotic signaling increases sooner and at a greater magnitude compared to 
controls. Therefore, we suggest that the induction of autophagy prior to apoptotic signaling at 
submaximal levels of stress is protective. Underlying this protective response is the ability of 
autophagy to promote the maintenance of mitochondrial viability. The clearance of damaged 
mitochondria through autophagic processes such as mitophagy protects the cell from the 
induction of mitochondrial- mediated apoptosis
235,238-240
. Furthermore, the induction of 
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mitophagy has been shown to improve mitochondrial energy production and allow for rapid 
recovery of energy during cell stress
258,259
. In this work, the loss of membrane potential, 
reduction in mitochondrial membrane integrity, and increase in CASP9 activity was observed in 
the absence of autophagy during CisPT exposure. Therefore, our data strongly suggests that 
autophagy mitigates apoptotic signaling through the maintenance of mitochondrial viability in 
response to submaximal levels of apoptotic stress. However, autophagy may also protect against 
cell death through the degradation of damaged proteins and nuclear remodeling, thereby 
attenuating ER-stress and genomic-stress induced apoptotic signaling
12,252
. Thus, an examination 
of the role of autophagy in the regulation of these pathways of apoptotic stress should be 
examined in future research. 
  Relative to submaximal levels of apoptotic stress, the rapid induction of apoptotic 
signaling at high doses of CisPT was not associated with the same autophagic response. Cell 
death has become better understood as dynamic processes in which several death-related 
processes compete for the determination of cell fate
12,252,259
. Interestingly, caspase signaling is 
one of the main conversation points determining the influence of autophagy and apoptosis on cell 
fate. For example, the immediate upregulation of autophagy-related proteins such as ATG7 has 
been shown to inhibit the activity of CASP9
260
. Furthermore, autophagic processes can hijack 
CASP activation sites such as the DISC and promote autophagy over apoptosis
173
. In contrast, 
the activation of CASP3 has been shown to dismantle autophagic proteins such as BECN1 and 
ATG4D; converting them into pro-apoptotic proteins and inhibiting autophagy
261,262
. In this 
thesis we also observed an attenuation of ATG’s such as BECN1, ATG7, and BNIP3 when 
elevated levels of apoptotic signaling were observed. Therefore, it is possible that in skeletal 
muscle the rapid induction of CASP3 due to high levels of cell stress from CisPT can result in 
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cleavage of ATG’s and mitigate the induction of autophagy. Regardless, the inability to induce 
an autophagic response during high levels of apoptotic stress may have favoured a pro-apoptotic 
balance thus increasing cell death and remodeling.  
 Taken together these experiments demonstrate that autophagy occurs along with 
apoptosis and muscle atrophy as previously shown. However, these cell death-associated events 
are not one in the same. The induction of autophagy during submaximal levels of apoptotic stress 
does not promote the induction of apoptosis, but rather acts as a pro-survival system removing 
factors which can stimulate apoptotic cell death. Conversely, conditions with significant and 
rapid increase in apoptotic signaling may impair the pro-survival response of autophagy and 
promote apoptotic cell death.  
Autophagy is a required process in the recovery from apoptotic stress in myotubes 
 Observations in skeletal muscle show that autophagic puncta rapidly appear during stress 
and persist for days after the stress has been removed
180
. This suggests that autophagy may be 
required in recovery and repair processes in skeletal muscle. Skeletal muscle is a remarkable 
tissue due to its ability to evade complete cell death
247,254
. This is an essential component of 
skeletal muscle as it is a terminally differentiated, long lived, multinucleated cell type
59
. The 
ability to resist cell stress is dependent upon a robust stress response system which includes a 
rapid increase in molecular chaperone proteins such as HSP70, antioxidant systems, and 
autophagy. Furthermore, skeletal muscle can ward off apoptotic insults due to high levels of anti-
apoptotic proteins such as ARC and BCL2. Interestingly, skeletal muscle can also mitigate cell 
stress through the ability to upregulate and mobilize mitochondria for ROS, and Ca
2+
 
buffering
59,197,214,263
. However, one of the most remarkable features of skeletal muscles resistance 
against total cell death/loss is its multinucleated nature.  
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 In mononucleated cell types, cell stress which breaches a certain threshold can elicit 
apoptotic signaling to destroy the cell through a highly regulated process which results in the 
removal of the mutated, damaged, and/or stressed cell
36
. In contrast, following apoptotic 
signaling skeletal muscle fibers are not removed by immune cells; instead they can undergo 
dramatic remodelling
58
. It is important to note that following apoptotic signaling the elongated 
myotube, which shares a common cytosol, is at risk of cell stress being propagated throughout 
the myotube. The induction of degradative systems such as the UPS has been shown to 
contribute to the degradation of cleaved and damaged proteins mediated by CASP in skeletal 
muscle
264
 suggesting that degradative processes may clean up after cell death events. 
Furthermore, an increase in autophagic markers has been found in skeletal muscle several days 
after crush injury and following unloading
243,244
. Our results also support that this autophagic 
process occurs following the removal of apoptotic stresses and during cell recovery. More 
interestingly, our observations add to this knowledge by demonstrating that autophagy is 
essential for the maintenance of mitochondrial viability and attenuation of CASP activity during 
recovery from apoptotic stress. Similar to the observations made in cells undergoing stress, the 
induction of autophagy during recovery from stress was required to promote the restoration of 
the mitochondrial population. It is possible that the induction of autophagy may provide 
metabolic building blocks for intermediary metabolism during times when mitochondria are 
damaged, such as following mitochondrial apoptotic signaling. Importantly, this could provide 
energy potential to sustain other remodeling processes such as protein synthesis and 
mitochondrial biogenesis. Although interesting, these potential actions of autophagy require 
further investigation. Regardless, the removal of damaged mitochondria would help preserve 
myotube viability by limiting the spread of impaired mitochondrial function throughout the 
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mitochondrial network
253
. In support of this, myotubes recovering with impaired autophagy 
showed increased cell death, associated with sustained CASP activity and mitochondrial damage.  
 Skeletal muscle is continuously under conditions in which sub-apoptotic stress occurs. 
For example, with every contraction the skeletal muscle sarcolemma acts as an electrical conduit 
passing a charge directly in to the skeletal myofiber which releases Ca
2+
 into the cytosol at 
potentially toxic levels. The cytosolic influx of Ca
2+
 allows for cross-bridge cycling which 
produces high levels of shear stress to structural proteins within the myofiber
265
. In addition, the 
energy required for this process can be produced through oxidative metabolism which results in 
potentially damaging ROS production
216,265
. Given that muscle is exposed to repeated stressors, 
muscle requires processes to assist in recovery to ensure stressors do not accumulate.  In support 
of our data, and the role of autophagy in recovery processes Lira et al. 2013 demonstrated that 
autophagy is required for skeletal muscle to adapt to exercise
124
. In addition, inhibition of 
autophagy in the absence of perturbations leads to the development of myopathic features and 
impaired contractile function
1
. Finally, in conditions where constant damage and regeneration 
are occurring such as in muscular dystrophies, the forced induction of autophagy can improve 
mitochondrial integrity, cell viability, and mitigate apoptotic signaling
179
.  
 Although autophagy protected the myofiber from apoptotic cell death processes, we were 
surprised that there was no difference in myotube size between autophagy compromised and 
autophagy capable cells after 48 hr of recovery. Previous reports have shown that inhibition of 
autophagy increases myotube diameter in response to unloading and apoptotic stress
106,192
. It is 
important to note that skeletal muscle size does not always directly correlate with function and 
health
266
. Although, we found that cells lacking autophagy during recovery had similar size 
compared to autophagy competent cells in the absence of autophagy, we observed elevated 
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CASP activity and compromised mitochondrial viability during recovery. Under these 
conditions, skeletal muscle metabolic and contractile function could be compromised even 
though size is not altered. Further work to understand the metabolic contribution of autophagy 
during recovery will provide important insight into how to best treat skeletal muscle damage.  
 In response to myotrauma and stress, processes such as autophagy are required to 
improve cell viability. However, autophagy is also involved in regeneration events
1,214
. For 
example, autophagic processes can remove damaged mitochondria and promote mitochondrial 
biogenesis
176,259
. Furthermore, the upregulation of autophagy promotes the export of 
macronutrients, including amino acids from the lysosome which can initiate protein synthesis
267
. 
In addition to these anabolic processes, skeletal muscle is rebuilt after injury through the 
incorporation of new nuclei from a pool of adult stem-like cells called satellite cells
16
. The 
formation of skeletal muscle during myogenesis, satellite cell differentiation and fusion as well 
as the de novo synthesis of new muscle fibers share several biochemical and morphological 
similarities that can be examined in C2C12 cell cultures
26
. The ability of damaged myotubes to 
recover in our experiments may have been partially mediated through the increased 
differentiation and fusion of reserve cells. These reserve cells in differentiated C2C12 cultures 
have been shown to re-enter cell cycle, terminally differentiate, and contribute to myotube 
regeneration
268
. In cells allowed to recover, 3MA inhibited autophagy as well as impaired the 
differentiation and fusion indexes. This likely contributed to the inability to increase myotube 
size during recovery. Together, these effects may have contributed to the poor viability in these 
cells by 48 hr but this inability to regenerate could have dramatic consequences in vivo where 
muscle regeneration may take several days
16
. Therefore, future experiments aimed at 
investigating the role of autophagy in in vivo muscle regeneration will be of importance.  
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Autophagy is required for myoblast differentiation 
 Myoblast differentiation is an essential process in both myogenesis and muscle 
regeneration
16
. Myoblast differentiation is morphologically characterized by the fusion of 
differentiated myoblasts. Once a nascent myotube is formed, additional myoblasts fuse which 
increases the myonuclear number and size of the developing myotube
15
. Underlying the hallmark 
morphological features of myoblast differentiation and myotube formation is a highly regulated 
and hierarchical signaling cascade involving several myogenic regulatory factors (MRF)
15
. For 
example, the expression and transcriptional activity of MYOD and MYF-5, two primary bHLH 
transcription factors, by upstream PAX3/7 co-transcription factors results in the muscle 
specification of the committed myoblast cells. Binding of the E-Box (CANNTG) motif by these 
primary MRFs promotes the expression of myogenin and MRF4, two secondary MRFs 
responsible for the activation of the terminal differentiation, and fusion programs 
17,19,22,23,269
. 
Although the basic signaling networks regulating the withdrawal from cell cycle, terminal 
differentiation and fusion of muscle cells has been well characterized, processes which regulate 
these signaling events, dramatic morphological changes, and organelle remodeling are not as 
well known. Since autophagy can quickly degrade proteins and organelles, autophagy has been 
speculated to contribute to the rapid morphological, biochemical, genetic, and organelle 
remodeling of complex, differentiating cell types
131
. In support of this, research has shown that 
autophagy is required for osteogenic, mesenchymal, erythrocyte, neuroblastoma, glioma-
initiating, and monocyte differentiation
188-190
. Our data now demonstrates that autophagy is also 
required for myoblast differentiation and myotube formation.  
 To begin elucidating the role of autophagy in myoblast differentiation we first aimed to 
identify how this process was regulated. Several signaling events can promote the induction of 
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autophagy, and depending on the signaling pathways responsible; information on the role of 
autophagy is possible. For example, the induction of autophagy through AKT/FOXO3A 
signaling is commonly associated with perturbations to growth hormones, whereas AMPK-
mediated autophagy occurs during intracellular nutrient stress
8,12
. Our data demonstrates that 
JNK, a cell stress kinase which governs several stress signaling pathways and responses
37,54
 is 
partially responsible for the induction of autophagy during myoblast differentiation, suggesting 
the induction of autophagy may be due to cell stress. Interestingly, JNK-mediated autophagy is 
critical for the survival of monocytes as they differentiate into mature macrophages
200
. Similarly, 
in skeletal muscle the induction of JNK during differentiation was shown to be required for 
myoblast survival
57
. Based on these findings we hypothesized that JNK promotes the induction 
of autophagy for the purpose of cell survival. Furthermore, JNK can promote the induction of 
autophagy through the regulation of the BECN1:BCL2 complex
125
. Phosphorylation of BCL2 by 
JNK reduces the sensitivity of BCL2 for BECN1 resulting in their separation and the promotion 
of autophagy
126
. Accordingly, we found that myoblast differentiation was associated with an 
attenuation of BECN1:BCL2 complex formation, an effect which was inhibited by JNK 
inhibition. Furthermore, SP600125 also reduced autophagosomal markers suggesting that JNK 
mediates the induction of autophagy. The discovery that JNK mediates autophagy during 
myoblast differentiation via the BECN1:BCL2 complex, in addition to previous reports 
demonstrating that JNK protects myoblasts from cell death during differentiation, strongly 
suggests that autophagy is required to protect myoblasts from cell stress during differentiation.   
 Myoblast differentiation and myotube formation are associated with and require the 
induction of ER-stress, oxidative stress, metabolic stress, mitogen stress as well as the induction 
of CASP3 activity
30,31,34,37,211
. Our results demonstrate that autophagy plays a vital role in 
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attenuating the level of cell stress involved in myoblast differentiation. For example, we found 
that in the absence of autophagy HSP70 as well as CAPN activity are elevated. These are two 
features commonly observed during ER-stress. Furthermore, we also demonstrated attenuated 
mitochondrial membrane potential, increased permeability transition pore formation, and 
elevated mitochondrial 4-HNE content during early differentiation in shAtg7 cells. This 
suggested that a cellular environment without autophagy promotes mitochondrial damage and 
stress. One way in which autophagy can protect the cell from accumulation of damaged 
mitochondria and declined mitochondrial function is through mitophagy
238
. Mitophagy is a 
selective form of macroautophagy whereby damaged mitochondria are recognized by autophagic 
machinery and specifically degraded via the lysosome
238
. During erythrocyte and lens cell 
differentiation, the clearance of mitochondria requires mitophagy
131
. Similarly, we found that 
myoblast differentiation is also associated with mitophagy, a process which is dependent upon 
ATG7. This lack of mitophagy during differentiation may have promoted ROS generation 
through impaired mitochondria which induced mitochondrial-mediated apoptotic signaling. 
Previous reports have shown that inhibition of mitophagy allows pro-apoptotic factors to be 
released from the damaged mitochondria into the cytosol where they participate in apoptotic 
signaling
12
. As such we found an increase in cytosolic CYTO C and an increase in CASP9 
during myoblast differentiation in absence of autophagy/mitophagy. Together, these data suggest 
that the induction of autophagy/mitophagy is required to protect the differentiating myoblast 
from cell stress and more specifically mitochondrial dysfunction.  
 Apoptotic signaling mediated by CASP3 is essential for myoblast differentiation and the 
formation of mature skeletal muscle
210
. For example, CASP3 induces the cleavage-mediated 
activation of MST1 which is required for the induction of myoblast differentiation
2
. Furthermore, 
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CASP3 also inhibits Twist, a bHLH protein which can prevent the transcriptional activity of 
MYOD
2
. However, these cleavage events only occur during early periods of differentiation. If 
the quantity of CASP3 activity is too great or the transient level of activity prolonged, CASP3 
promotes cell death
210
. Because of the potential lethality of CASP3 activity, research has focused 
on understanding how CASP3 is regulated during differentiation. Fernando et al. found that the 
induction of CASP3 requires p38 activity
2,210
. However, typical canonical apoptotic pathways 
involving CASP8, CASP9, and CASP12 have also been observed
210
. For example, 
pharmacological inhibition of CASP8 reduced MYOD and MHC levels. Furthermore, forced 
expression of a dominant negative FADD protein also attenuates MYOD and MHC 
expression
212
. The induction of CASP12 activity following ER/SR-stress is also associated with 
CASP3 activation and promotion of myotube development
30
. Interestingly, the forced reduction 
of CASP9 activity has been shown to prevent the transient activation of CASP3 and attenuate 
myoblast fusion events
211
. In support of the involvement of mitochondrial-mediated apoptotic 
signaling during myoblast differentiation, previous results have shown that overexpression of 
BCLXL also impairs myoblast fusion and CASP3 activity
211
. Furthermore, the overexpression of 
ARC in cardiac myocytes impairs CASP3 activity and differentiation
270
.  
 The involvement of canonical mitochondrial-mediated pathways of apoptotic signaling in 
skeletal muscle differentiation is inconclusive. For example, although forced inhibition of 
CASP9 attenuates CASP3 and fusion
211
, Bloemberg and Quadrilatero demonstrate that CASP9 is 
not involved in CASP3 activation during C2C12 differentiation
42
. In the present study, we 
observed an increase in cytosolic CYTO C during differentiation which is similar to findings 
from Shaltouki et al.
271
 however; this finding is in contrast to results by Bloemberg and 
Quadrilatero, as well as Murray et al. who did not observe a change to cytosolic CYTO C
42,211
. 
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The reasons for the discrepancies between the current study and results by Murray et al. may be 
due to the cytosolic isolation procedure, whereas the discrepancies between the current study and 
results from Bloemberg et al may be due to the difference in cell type, collection procedure and 
passage number. Regardless, the current work also demonstrates an increase in mitochondrial 4-
HNE and a reduction of mitochondrial membrane potential supporting the observed rise in 
cytosolic CYTO C.  
 Although the exact mechanisms regulating the induction of CASP3 during myoblast 
differentiation are still unknown, observations made in dead myoblasts during differentiation 
demonstrate elevated levels of CASP12, CASP9, and CASP3 compared to healthy differentiating 
cells
29,210
. This observation suggests that cells which survive are able to defend and harness the 
cell stress and CASP3 activity whereas those cells which cannot die via apoptosis. Therefore, to 
improve myoblast differentiation it is important to identify processes which protect the myoblast 
from apoptosis. In the current work we demonstrate that autophagy protects the myoblasts from 
apoptosis during differentiation. In support of this, attenuation of CASP3 via CASP3 and CASP9 
inhibitors partially recovered myoblast differentiation in the absence of autophagy. More 
specifically, our results point to a role of autophagy in regulating the level and temporal kinetics 
of CASP3 activity through the regulation of mitochondrial-mediated apoptotic pathways. An 
increase in mitophagy during early stages of differentiation, although modest, may provide the 
appropriate tempering of CYTO C release required for physiological levels of CASP9 activity to 
promote CASP3 activity. Without autophagy, a loss of mitochondrial viability was associated 
with a greater increase in CASP9 which promoted a robust increase in CASP3 and cell death 
instead of differentiation. In support of these findings, knockdown of histone deacetylase 1 and 2 
resulted in a large increase in myofiber death and attenuated autophagy in perinatal mice
175
. 
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Interestingly, forced induction of autophagy during this period via nutrient restriction improves 
myofiber viability 
175
. In addition, inducible knockdown of ATG5 in MYF5 expressing cells 
results in smaller skeletal muscle and lower myogenic gene expression
206
. Together our data 
provide strong support for the role of autophagy in promoting myoblast differentiation through 
the regulation of caspase activity and apoptotic events.  
CONCLUSION 
 This thesis demonstrates that autophagy is involved in processes determining the 
development, survival, and recovery of skeletal muscle. Both physiological levels of cell stress 
and/or pathological levels of apoptotic stress induced autophagy. Although, autophagy was 
associated with cell stress and cell death, autophagy did not contribute to apoptosis. In fact, 
autophagic processes and increased autophagic flux functioned as pro-survival mechanisms. 
Autophagy was able to govern the magnitude and temporal kinetics of apoptotic signaling 
through the regulation of mitochondrial viability and stress signaling. In this way this thesis 
demonstrates for the first time that autophagy is required and critical in regulating skeletal 
muscle cell death and differentiation.     
Limitations 
 C2C12 myoblast cell lines have been extensively used for several years and have been 
widely accepted as a strong model for myoblast differentiation and myotube formation. 
However, C2C12’s are an immortalized cell line which may not fully recapitulate in vivo 
differentiation. In addition, cells were grown on a 2D culture system and therefore may also 
behave differently than in an in vivo or 3D model system. In addition, culturing of C2C12 
myoblasts for differentiation experiments results in a heterogeneous the cell population. For 
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example, in differentiated cultures, myotubes, differentiating myoblasts, as well as non-
differentiated myoblasts are present. Thus, when differentiated cell cultures were collected, 
samples contained this heterogeneous population. Thus conclusions cannot be made only on 
“differentiated myotubes” as other myogenic cells at different stages of differentiation are 
present. However, comparisons between treatment and genotype groups were made on the same 
day and in cells grown/differentiated for the same duration. Thus in our analyses comparisons 
were made in cultures exposed to the same conditions. Furthermore, in vivo collection of tissue 
will also possess cellular heterogeneity. Further work should be conducted to isolate these 
different subpopulation of cells within differentiating cultures to closely examine the role of 
autophagy on each specific cell subtype and isolated phase of differentiation for example during 
fusion.       
 The use of chemical inhibitors is commonly used in experiments similar to those 
conducted in this thesis. The chemical inhibitors used in this thesis are well documented to 
inhibit thier intended targets and our results are in support of this. For example, 3MA 
significantly inhibited the formation of LC3B-II. Importantly, the effects of 3MA were replicated 
with shAtg7-mediated inhibition of LC3B-II and autophagy. Furthermore, we observed a 
significant increase in BCL2:BECN1 formation in the presence of JNK inhibitor SP600125. 
Moreover, inhibition of CASP3 resulted in a loss of CASP3 activity and inhibition of CASP9 
resulted in a loss of activity in its downstream target CASP3. However, these compounds can 
have non-specific effects. For example, caspase inhibitors have been shown to inhibit several 
proteases in addition to the targeted caspase
272
. Therefore, further work utilizing specific 
measures of inhibition such as shRNA-mediated gene knockdown or site mutinogenesis would 
be valuable to ensure the results observed are in fact solely due to the inhibition of the target.   
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 Stable transfection of any cell type requires the incorporation of foreign DNA into the 
host cells genome. Although in most cases it inserts into a random locus which does not affect 
cell physiology, studies have shown that this knockdown method can have off target effects 
which influence cell death pathways
273
. Although the use of SCR cell lines, which have been 
stably transfected and passed similarly to the shAtg7 cells lines, were used to control for the 
effects of stable transfection and pass number the possibility of the DNA being inserted into the 
same region is unlikely. However, shAtg7 and 3MA experiments displayed similar responses 
suggesting that the off target effects are likely not a significant in effect. When the studies were 
being designed, ATG7 was chosen due to the lack of a direct role in apoptotic signaling. 
However, as this thesis was being edited a study was published demonstrating a direct role of 
ATG7 in CASP9 activity
274
. Therefore, it is possible that effects observed to CASP9 activity in 
the absence of ATG7 may be related to the knockdown of the protein and independent of 
autophagy. However, considering 3MA resulted in similar apoptotic and differentiation defects 
we are confident that our results are due to the inhibition of ATG7 and the lack of autophagy. 
 In the first two studies 3MA was used to inhibit autophagy. 3MA has been shown to have 
off target effects especially when used at high doses
275
. However, we were able to recapitulate 
and confirm the effects using shRNA-mediated knockdown of ATG7. In the third study 
inhibition of autophagy was required in terminally differentiated myotubes which poses 
significant limitations to the ability to transfect efficiently with little to no cell damage. 
Moreover, the inhibition needed to be done on a specific timeline thus making transfection a 
nonviable option. Therefore a limitation to this particular study was the lack of a genetic 
knockdown model. However, considering our previous work with both 3MA and shAtg7 showed 
similar results we are confident in our 3MA data.  
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 In several experiments, analyses were conducted to examine the effect of differentiation 
or CisPT on individual markers of apoptosis/autophagy over several time points. In such cases, 
hypotheses were tested using a one-way ANOVA with post hoc analyses to examine differences 
between time points (effects of differentiation or exposure time). In experiments where either a 
CTRL vs. drug or a CTRL vs. shRNA group was examined, we were only interested in the 
difference between specific groups within a single time point/condition and not in all possible 
comparisons. Therefore, planned T-Tests were used at (but within) each time point. Although 
factorial ANOVA could have been used to test for these differences as well as several additional 
interactions across/between groups, these effects (and all the interactions) were not within the 
scope/interest of these studies. Furthermore, the use of factorial ANOVA’s within the relevant 
cell culture literature
211,42,29,30,214
 is seldom used, likely due to the risk of type II error. For 
example, the use of a two-way ANOVA may have not been able to detect differences in 
situations where temporal changes occurred, especially with low sample sizes. To further add to 
the difficulty is the fact that some of these temporal changes occurred in opposite directions 
during various points during the sampling timeline. Therefore, given the simplicity of our 
experimental conditions, and the specificity of our hypotheses, we feel the data is appropriately 
analyzed, discussed and highly relevant/accurate for the cell biology and muscle biology field.  
  Future Directions 
 The results of this thesis show that autophagy plays a vital role in regulating apoptotic 
events during differentiation as well as in response to cisplatin and during stress recovery. The 
use of primary cell lines with an inducible “on/off’ knockdown model and by using different 
ATG targets would provide further insight into this critical phenomena. Furthermore, 
consideration should be given to repeating key experiments in 3D culture systems which 
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resembles the cell niche. Importantly, examining skeletal muscle differentiation without 
autophagy during myogenesis in vivo would be of great interest as well as confirm the in vivo 
relevance of this work.  Recovery from skeletal muscle apoptosis is essential for the continuation 
of muscle function and health. Although we demonstrated that autophagy is required to promote 
muscle recovery in vitro these experiments should be conducted in animal models since the 
regeneration process in culture is much different than that in vivo.   
 In the first study we demonstrate that autophagy is induced during myoblast 
differentiation, is partially regulated by JNK, and is required to promote the survival of the 
myoblast. However, future research should further investigate the pathways which may regulate 
autophagy during differentiation. For example, JNK inhibition did not completely inhibit LC3II 
content during myoblast differentiation. JNK inhibition only returned LC3II levels to those 
observed in D0 myoblasts suggesting that other signaling pathways are still contributing to the 
formation of the autophagosome. One particular avenue for exploration would be to characterize 
mTOR signaling as it is essential for myoblast differentiation and is also a potent regulator of 
autophagy
8,12
. Considering JNK significantly influences autophagy during myoblast 
differentiation it would be important to understand the mechanisms which promote the induction 
of JNK during myoblast differentiation. This again would provide information regarding 
potential autophagic targets during myoblast differentiation.  
 In the second study we demonstrated that mitophagy is increase during myoblast 
differentiation. Mitophagy is a highly controlled event and future work should be directed at 
better understanding the mechanisms underlying our observation
238
. Furthermore, other specific 
forms of selective autophagy should be investigated during differentiation. For example, ER/SR 
remodeling occurs during myoblast differentiation and the elimination of old/superfluous ER 
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components may require autophagy. In addition, significant remodeling of the cells structure and 
structural proteins occurs during myoblast fusion and myotube formation, again these events 
may require autophagy to degrade structural proteins. It would be interesting to identify whether 
or not autophagy, like the UPS, can degrade specific MRFs which would have major 
implications for the genetic reprogramming of the differentiating cell.  
 We also found that inhibition of autophagy increases in CASP3 and CASP9 activity, 
which resulted in impaired differentiation. Future work should examine the role and importance 
of autophagy or other potential pathways of caspase activation (death receptor, ER-stress and 
DNA damage) on apoptotic cells death.  
 In the third study we identified a role for autophagy in protecting differentiated myotubes 
from cisplatin induced apoptosis. It will be important to see how the inhibition of autophagy 
would affect skeletal muscle in response to cisplatin in vivo. Cisplatin causes significant muscle 
loss in cancer patients
245
. Therefore future research aimed at altering autophagy in vivo via 
dietary/nutritional manipulations may improve muscle viability in patients treated with cisplatin. 
Further, other stressors should be examined to determine if this is a common stress-related 
process. 
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APPENDIX A 
 
Supplemental Figure 1. Qualitative analysis of the effect of 5mM 3MA on AKT 
phosphorylation status during D0, D1, D2, D3, and D5 of C2C12 myoblast differentiation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
